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SUMMARY
First human trials involving neuroprosthetic rehabilitation demonstrated recently that signiﬁ-
cant functional beneﬁts can be achieved with lumbosacral neuromodulation and reorganized
spared projections. However, complete spinal cord injuries (SCI) wholly isolate infralesional
circuits from any supraspinal control, leading to irreversible motor deﬁcits that neuropros-
thetics still fails to address. As axons fail to regrow across the lesion site, neuroregenerative
research after SCI has been dogmatically focusing attention on minimizing the environmental
inhibitions to axon regeneration. In the present work, we demonstrate that spontaneous axon
regeneration failure can be reversed, and that propriospinal axons are able to grow across
complete non-neural lesion cores when the required facilitators are provided. We identiﬁed
three mechanisms needed for propriospinal regrowth : i) enhancing neuronal intrinsic growth
capacities using viral technologies, ii) remodeling the lesion core with growth factors, in order
to densify permissive substrates, and iii) guiding axons chemically across the SCI site.
Propriospinal neurons - that coordinate diﬀerent spinal segments in healthy conditions - are
known to support recovery of locomotion in incomplete models of spinal cord injury. However,
restoring a robust descending bridge of propriospinal axons does not by itself promote any
functional beneﬁt. We hypothesize that a lack of somatosensory feedback to the motor cortex
(M1), together with insuﬃcient descending motor control, may prevent coherent exchange
of information between lumbosacral and cortical motor centers. Therefore, we explored the
neuroregenerative potential of reticulospinal axons - which are projected from the brainstem
to the spinal cord - as a second relay for the descending motor cortical command. Together
with axon guidance and lesion remodeling, our viral manipulation of intrinsic growth programs
induced limited yet signiﬁcant reticulospinal regeneration into the lesion core. In order to
enhance this reticulospinal regrowth, we explored activity-dependent mechanisms of neurite
growth control. As we observed that activity does not recruit growth programs after SCI,
we revealed a possible divergence between the mechanisms that underly reticulospinal axon
regrowth and neurite sprouting. In the mean time, we are developing a somatosensory interface
that aims at restoring sensory feedback to the motor cortex after complete SCI. Based on
hindlimb electromyographic activity, we linked locomotion to optogenetic neuromodulation
of the motor thalamus, and were able to evoke responses in M1 by selectively activating
thalamocortical projections, both before and after complete spinal lesion. Such technology
enables a direct recruitment of thalamic nuclei that gate motor learning and motor planning
at a cortical level. Coming experiments will test wether a strategy combining propriospinal
regeneration with locomotion-dependent thalamocortical modulation is suﬃcient to restore
voluntary stepping after complete SCI.
Key words : Spinal cord injury, Axon regeneration, Propriospinal axons, Reticulospinal tract,
Neuromodulation, Motor thalamus, Cell grafting, Filum Terminale
RÉSUMÉ
Des premiers essais cliniques de réhabilitation neuroprothétique chez l’homme ont récemment
démontré que des bénéﬁces fonctionnels signiﬁcatifs peuvent être obtenu par neuromodula-
tion lombo-sacrée et réorganization des projections nerveuses épargnées. Toutefois, des lésions
complètes de la moelle épinière isolent totalement les circuits infra-lésionnels de tout contrôle
volontaire, causant des déﬁcits moteurs irréversibles que pour l’heure les approches neuropro-
thétiques ne parviennent pas à traiter. Alors que la repousse axonale est tenue en échec au site
de lésion, la recherche en neurorégénération après lésion médullaire a porté dogmatiquement
son attention sur l’entrave des inhibitions environnementales à la re-croissance des ﬁbres. Dans
le présent travail, nous démontrons que l’échec naturel de la régénération axonale peut être
réversé, et que des ﬁbres propriospinales sont capables de croître au travers du tissu cicatriciel
non-nerveux qui compose la lésion. Nous avons identiﬁé trois méchanismes facilitateurs req-
uis et suﬃsants à la repousse propriospinale : i) l’activation des programmes de croissance
intrinsèques des neurones, ii) la densiﬁcation des substrats permissifs par remodelage du tissu
lésionnel et iii) le guidage des axones à travers la lésion.
Les neurones propriospinaux - qui coordonnent diﬀérents segments de la moelle épinière en
conditions normales - sont connus pour promouvoir la récupération motrice lors de lésions
médullaires incomplètes. Cependant, la seule restauration d’un pont descendant propriospinal
à travers une lésion complète ne fournit pas de bénéﬁce fonctionnel. Nous supposons - lors de
lésions médullaires complètes - qu’un manque de retour somatosensoriel vers le cortex moteur
primaire (M1), ainsi qu’un contrôle moteur descendant désorganisé, préviennent l’échange co-
hérent d’information entre les centres corticaux et les circuits lombo-sacrés. Pour y pallier, nous
avons exploré le potentiel régénératif des axones reticulospinaux - lesquelles sont projetés dans
la moelle épinière depuis le tronc cérébral - comme second relai pour les commandes corticales.
Associé au remodelage du site lésé et au guidage des ﬁbres, notre manipulation des programmes
intrinsèques de croissance a permis une régénération réticulospinale faible mais signiﬁcative
dans la lésion. En explorant les mécanismes de croissance des projections neuronales associés
à l’activité électrophysiologique, nous avons révélé de probables divergences entre les détermi-
nants signalétiques de la repousse axonale et de l’arborescence neuronale. En parallèle, nous
développons une interface neuroprothétique somatosensorielle, qui tend à restaurer un retour
sensitif au cortex moteur après lésion médullaire complète. Fondé sur l’activité électromyo-
graphique des membres postérieurs, nous avons appairé à la locomotion une neuromodulation
optogénétique du thalamus moteur qui nous permet d’évoquer des réponses corticales en M1,
ceci en conditions saines et après lésion médullaire complète. Cette technologie nous permet
de recruter spéciﬁquement les noyaux thalamiques qui contrôlent l’apprentissage moteur et la
planniﬁcation des tâches motrices au niveau cortical. Les expériences à venir détermineront si
une approche combinant neuromodulation thalamique et régénération propriospinale permet
de restaurer un contrôle moteur volontaire après lésion complète de la moelle épinière.
Mots clés : Lésion de la moelle épinière, Régénération axonale, Axones propriospinaux, Tract
réticulospinal, Neuromodulation, Thalamus moteur, Transplantation cellulaire, Filum Termi-
nale
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ABBREVIATIONS
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tion)
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BDNF - Brain derived neurotrophic factor (growth fac-
tor)
cAMP - Cyclic adenosine monophosphate (signaling
molecule)
ChR2 - Channelrhodopsin-2 (membrane receptor)
CNO - Clozapine-N-O (drug)
CNTF - Ciliary neurotrophic factor (growth factor)
CNS - Central nervous system (organ)
CPG - Central Pattern Generator (concept)
CREB - cAMP response element binding protein (sig-
naling molecule)
CSPG - Chondroitin sulfate proteoglycan (inhibitory
extracellular molecule)
CST - Cortico-spinal tract (axon tract)
DBS - Deep brain stimulation (neuromodulation tech-
nique)
DCH - Dicopolypeptide Hydrogel (drug vehicle)
DNA - Deoxyribonucleic acid (genetic component)
DREADD - Designer receptor exclusively activated by
designer drug (technic / receptor)
E14 - Embryonic day-14 (time point)
EES - Electric epidural stimulation (neuromodulation
technique)
EGF - Epidermal growth factor (growth factor)
EMG - Electromyography (electrophysiological tech-
nique)
ESC - Embryonic stem cells (cell type)
FES - Functional electrical stimulation (muscle mod-
ulation technique)
FGF - Fibroblast growth factor (growth factor)
FT - Filum Terminale (CNS structure)
GABA - gamma-aminobutyric acid (membrane recep-
tors)
GAG - Glycosaminoglycan (extracellular molecule)
GDNF - Glial-derived neurotrophic factor (growth fac-
tor)
GFAP - Glial ﬁbrillary acidic protein (astrocyte marker)
GFP - Green ﬂuorescent protein (ﬂuorescent marker)
HGF - Hepatocyte growth factor (growth factor)
IFN - Interferon (drug)
IGF - Insulin-like growth factor (growth factor)
IL - Interleukin (cytokine)
iPSC - Induced pluripotent stem cells (cell type)
KCC2 - Potassium-chloride transporter (membrane
channel)
KLF - Kruppel like factor (growth factor)
M1 cortex - Primary motor cortex (CNS structure)
M1/M2 macrophages - Subtypes of activated
macrophages (cell subtypes)
MAG - Myelin associated glycoprotein (inhibitory ex-
tracellular molecule)
MAI - Myelin associated inhibitiory molecules (in-
hibitory extracellular molecules)
MAP2 - Microtubule associated protein 2 (neuronal
marker)
MAPK - Mitogen activated protein kinases (signaling
molecule)
MDL28170 - Calpain inhibitor (survival factor)
MG - Medial gastrocnemius muscle (muscle)
MMP - Metalloproteinase (extracellular molecules)
mTOR - Mammalian target of Rapamycin (signaling
molecule)
mRNA - Messenger ribonucleic acid (genetic compo-
nent)
NGF - Nerve growth factor (growth factor)
NLI - Neurological level of injury (scoring index)
NMDA - N-methyl-D-aspartic acid receptor for Gluta-
mate (membrane receptor)
NSPC - Neural stem and progenitor cells (cell type)
NT - Neurotrophin (growth factor)
OIC - Osteopontin-IGF1-CNTF (growth factor combi-
nation)
OMgp - Oligodendrocyte-myelin-glycoprotein (in-
hibitory extracellular molecule)
OPN - Osteopontin (growth factor)
Section 0.0 Chapter 0 Page 10
PDGF - Platelet derived growth factor (growth factor)
PKA - Protein kinase A (signaling molecule)
PNS - Peripheral nervous system (organ)
PTEN - Phosphatase and tensin homolog (signaling
molecule)
RFP - Red ﬂuorescent protein (ﬂuorescent marker)
RNA - Ribonucleic acid (genetic component)
RtST - Reticulo-spinal tract (axon tract)
SCI - Spinal cord injury (the problem...)
TA - Tibialis anterior muscle (muscle)
TDT® - Tucker Davis Technology (hardware brand)
TNF - Tumor necrosis factor (cytokine)
Tuj-1 - Class III beta-tubulin (neuronal marker)
VA - Ventralis anterior thalamic nucleus (thalamic nu-
cleus)
VEGF - Vascular endothelial growth factor (growth
factor)
vGI - Ventralis gigantocellular reticular nucleus (brain-
stem nucleus)
vGLUT - Vesicular glutamate transporter (membrane
receptor)
VL - Ventralis lateralis thalamic nucleus (thalamic nu-
cleus)
VPL - Ventroposterior lateralis thalamic nucleus (tha-
lamic nucleus)
4-AP - 4-aminopyridine (drug)
5HT - Serotonin or Serotoninergic receptor (neuro-
transmitter / receptors)
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1.1 GENERAL INTRODUCTION
SPINAL CORD INJURY
Spinal Cord Injuries (SCI) impact suddenly and often irreversibly the life of previously healthy
patients. Every year, approximately 40 people out of a million are victim of SCI in the United
States, so that in 2013 ca. 276’000 patients were living with deﬁcits after a spinal lesion
(Center, 2014). As the average age at injury of alive SCI victims seems to become slightly
older (28.7 years in the 1970’s and 42.6 years in the 2010’s), traumatic spinal cord injuries
still mainly aﬀect the physical and psychosocial integrity of young adults, and represent an
economic challenge for health care systems (Singh et al., 2014; Center, 2014).
Clinically, spinal lesions cause acute sensorimotor deﬁcits - which are more or less extended
depending on the level of injury - as well as autonomic sphincter impairments and sexual
dysfunctions. On a transverse axis, SCIs can be anatomically classiﬁed as incomplete or
complete injuries. Incomplete injuries spare some extent of functional neural tissue across
or around the lesion core, which still conducts information from the decisional centers to
the infralesional circuits. Signiﬁcant sparing tends to yield spontaneous reorganization of
circuits associated to partial recovery of function. As the current clinical gold-standard to
chronically treat SCI victims, rehabilitation relies on spared ﬁber tracts and enhances the
neuronal reorganization and recovery of motor functions (Harkema et al., 2011; Asboth et al.,
2018; van den Brand et al., 2012; Wagner et al., 2018). On the contrary, complete SCIs fail
to spare any functional bridge past the lesion, causing a complete and irreversible interruption
of control on the sensorimotor and autonomic system located below the level of injury.
Functionally, several clinical assessment methods have been developed to quantify and charac-
terize SCI-induced impairments (Kalsi-Ryan et al., 2014), however the American Spinal Injury
Association (ASIA) Impairment Scale (AIS) remains the more convenient and widely used.
The ASIA score requires ﬁne examination of sensory and motor functions and categorizes SCIs
into 5 degrees of severity as follows (Kirshblum et al., 2011) :
• ASIA A - Complete. No sensory or motor function is preserved in the last sacral
segments.
• ASIA B - Sensory incomplete. Sensory function is preserved below the neurological
level of injury (NLI), but no motor function is preserved more than three levels below
the NLI.
• ASIA C - Motor incomplete. Motor function is preserved below the neurological
level, but less than half of key muscle functions below the NLI are preserved against
gravity.
• ASIA D - Motor incomplete. Motor function is preserved below the neurological
level, and half or more of key muscle functions below the NLI are preserved against
gravity.
• ASIA E - Normal. No sensorimotor impairment in a patient who used to have prior
deﬁcits.
As mentioned, spontaneous recovery of sensorimotor functions can take place after incomplete
SCI, so that ASIA grading can improve for patients over their clinical evolution, especially for
Section 1.2 Chapter 1 Page 13
patients graded ASIA-B and ASIA-C (Kalsi-Ryan et al., 2014). Successfully, recent eﬀorts
addressed at incomplete spinal cord injuries tend to maximize functional recovery beyond the
slight improvements that can take place spontaneously (Asboth et al., 2018; Harkema et al.,
2011; van den Brand et al., 2012). Unfortunately, anatomically and functionally complete
spinal cord injuries fail to provide suﬃcient sparing to yield any extent of functional improve-
ment. As mature neurons fail to regenerate after Central Nervous System (CNS) injuries,
several biological and technological options are currently explored to restore coherent conduc-
tion of information past complete SCIs.
In the absence of axon sparing, deep biological modulations of the lesion environment are
required to restore neural integrity and voluntary input across complete SCIs. Such modulations
could theoretically rely on coherent axon regrowth across the injured site, which requires i)
precise targeting of neuronal populations, ii) controlled activation of growth programs and iii)
adequate extracellular support. As an alternative, exogenous neuronal relays grafted into the
SCI site could in theory conduct information across the lesion, provided that grafted neurons
need both to receive and provide coherent downstream input.
Diﬀerent classes of molecular targets have been identiﬁed within the lesion core as inhibiting
or supporting axon regrowth. By neutralizing inhibiting molecules and providing facilitat-
ing factors, some interesting extent of axon regrowth has been documented. Similarly, cell
replacement therapies have shown promising anatomical results involving endogenous axon
regeneration into neural grafts (Kadoya et al., 2016). New genetic tools oﬀer nowadays the
possibility to directly manipulate the intrinsic growth capacity of endogenous neurons and
promote functionally-signiﬁcant axon regrowth (Bei et al., 2016; Liu et al., 2017). However,
beyond axon regeneration and/or cell replacement, it becomes clear that successful biological
therapies applied to complete SCIs will require a strongly coherent reorganization of circuits. As
they yield such coherent reorganization in the context of incomplete lesions, neuro-prosthetic
strategies may become interesting candidates to promote relevant rewiring after regeneration.
1.2 SCI ENVIRONMENT
PATHO-PHYSIOLOGY OF SPINAL CORD INJURIES
1.2.1 COURSE OF SPINAL CORD INJURIES
From a biological point of view, spinal cord injuries cause a tissue insult that are time-wise
distributed between immediate primary neural lesions and secondary damages. In the ﬁrst
phase of injury, immediate mechanical lesions take place, involving axonal shearing and neural
compression from dural and extradural origins (Saadoun et al., 2016). The spinal cord insult is
progressively consolidated with a local rupture of the blood-spinal cord-barrier that enables an
inﬁltration of platelets and blood-derived extracellular components, inducing a reorganization
of the extracellular matrix at the site of injury. Laminin, ﬁbrin and collagen form locally a
new scaﬀold to facilitate the inﬂammatory response and the acute remodeling of the injury by
macrophages. Over the following weeks, this inﬂammatory response further insults the peri-
SCI area through mechanisms involving edema and ischemia due to vascular incompetence, as
well as excitotoxicity, DNA-damages through reactive oxygen species and delayed apoptosis in
the vicinity of the lesion (Rowland et al., 2008). During the ﬁrst two weeks of this second
phase, a simultaneous histologic reorganization takes place within the SCI site, giving birth to
a ﬁbrotic lesion core made of ﬁbroblasts, pericytes and endothelial cells (Fernandez-Klett and
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Priller, 2014). This ﬁbrotic lesion core is surrounded by a reactive astroglial scar, that acts
as an interface between healthy neural tissue and the ﬁbrotic non-neural epicenter (Faulkner
et al., 2004). During and after the post-SCI remodeling, the lesion eventually stabilizes to
minimize the volume of the scar tissue, as cystic cavities appear within the lesion core (Burda
and Sofroniew, 2014; Rowland et al., 2008). In parallel, axons retract away from the lesion and
endure Wallerian degeneration, while late-stage apoptotic events take place within the lesion
core (Burda and Sofroniew, 2014). Demyelination and abnormal remyelination of peri-lesional
spared axons have also been documented, which decreases the conduction of information
across the injury via spared ﬁber tracts (McDonald and Belegu, 2006).
1.2.2 ACUTE AND SUBACUTE TOXICITY
VASCULAR DAMAGES AND INFLAMMATORY REACTION
The immediate response to traumatic spinal cord injury induces ischemia and disruption of the
blood-spinal cord barrier, further causing swelling at the damaged site and a neuro-immunologic
reaction. Very acute events induce neuronal and glial cell loss based on two neurovascular
mechanisms : i) immediate necrosis due to the primary hemorrhage and ii) acute apoptosis
caused by nutrients deprivation and local metabolic stress in ischemic conditions (Hagg and
Oudega, 2006). As ischemia resolves, reoxygenation causes a production of reactive oxygen
species, which exert - together with a mitochondrial release of pro-apoptotic molecules - acute
cytotoxicity (Xu et al., 2005; Tanaka et al., 2005).
Besides these immediate damages, traumatic SCIs induce vascular shearing that promotes
permeability of the blood-spinal cord barrier. Together with a cleavage and activation of ex-
tracellular metalloproteinases (Noble et al., 2002), these vascular changes contribute to local
swelling and secondary neural compression (Tator and Fehlings, 1991). In the same time, per-
meabilization of the blood-spinal cord barrier promotes inﬁltration of systemic inﬂammatory
components that follow the resident microglial reaction, especially neutrophils in an early stage
(Beck et al., 2010). The initial innate immunity acutely releases cytokines (e.g. TNF-alpha,
IL-1-beta) and metalloproteinases (e.g MMP-9), which further enhance vascular permeabil-
ity (Donnelly and Popovich, 2008) and can have a direct toxic eﬀect on neurons and glial
components (David and Kroner, 2011). This ﬁrst inﬂammatory reaction is followed by the
recruitment of systemic monocytes - which IFN-gamma induces into pro-inﬂammatory M1
macrophages at the site of injury, together with resident microglia (Kigerl et al., 2009) - and
circulating lymphocytes. The adaptive lymphocyte-based reaction has been shown to recog-
nize myelin-derived components in traumatic SCI contexts, yielding an auto-immune reaction
(Ankeny and Popovich, 2009). Both innate and adaptive inﬂammatory reactions contribute in
a subacute phase to secondary damages, causing neuronal loss and glial reactivity. However,
this ﬁrst phase of neuro-immunologic response is likely crucial to restore immediate tissue
homeostasis (Schwab et al., 2014).
At a delayed stage, a second phase of the inﬂammatory response - mostly guided by anti-
inﬂammatory M2 macrophages - promotes tissue repair (David and Kroner, 2011; Kigerl et al.,
2009). A shift in the cytokine constellation, and especially an up-regulation of IL-4, appears to
promote the M2 phenotype, that subsequently attenuates damaging immunity by the release
of anti-inﬂammatory extracellular mediators (e.g. IL-10) (David and Kroner, 2011). This
secondary phase of reactivity seems to restore homeostasis within immunity, after neuro-
inﬂammation itself promoted immediate integrity of tissue in the very acute context.
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Speciﬁc loss-of-function studies would help deﬁne a precise role for single components of the
immune response after SCI. Better understanding of the compromise made between secondary
damages and immediate integrity restoration might provide acute therapeutics options, as
generic immune suppression has so far failed to provide real beneﬁts (Schwab et al., 2014).
Early polarization of the immune reaction towards M2 macrophage-induced recovery may
constitute a lead to enhance neural tissue sparing.
EXCITOTOXICITY, DEGENERATION AND MYELIN ABNORMALITY
Due to the primary trauma, molecules are liberated from lysed and necrotic cells, and particu-
larly glutamate (Park et al., 2004). With such a sudden increase in glutamate, AMPA, NMDA
and kainate receptors get over-activated (Matute, 2011), likely contributing to an early-phase
neuronal cell death. Glutamate levels remain high after the ﬁrst pathologic release, due to
three mechanisms : i) glutamate re-uptake deﬁciency (Mills et al., 2001b,a), ii) depolarization-
induced reversal of the glutamate transporters’ activity (McAdoo et al., 2000; Li and Stys,
2001) and iii) vesicular release after intracellular Ca2+ increase caused by collapsing ionic gra-
dients (Li and Stys, 2001). Beyond neuronal damages, glutamate-induced excitotoxicity has
been shown to aﬀect glial cells - and especially oligodendrocytes - through apoptotic events
that contribute to white matter disruption and demyelination after SCI (Park et al., 2004).
Mechanical shearing during traumatic SCIs sections or damages axons. In the case of axo-
tomized neurons, distal parts of the axons are subject to Wallerian degeneration as proximal
parts retract away from the lesion in a process termed ’die-back’. The severed neurons gen-
erally survive, but without the ability to regenerate into or around the lesion core (Becerra
et al., 1995; Schwab and Bartholdi, 1996). Causes for this regenerative failure include i) a
lack of neuronal ability to upregulate growth-associated genes (Plunet et al., 2002; Mason
et al., 2003), ii) trophic support deprivation (Plunet et al., 2002) and iii) a down-regulation
of cytoskeletal proteins associated to soma atrophy (Tetzlaﬀ et al., 1991). After retraction
from the SCI site and regenerative failure, some extent of sectioned axons will form terminal
bulbs containing intracellular compartments and enzymes susceptible - in case of rupture and
release - to cause further damages to environing neural tissue (Hagg and Oudega, 2006).
Amongst spared neural tissue, some axons may as well be damaged, even though they did
not undergo complete axotomy. Initial ischemic conditions after SCI and secondary glial dis-
ruption can both cause axon degeneration or further damages to these incompletely severed
ﬁbers, preventing them from conducting information (Hagg and Oudega, 2006). Besides neu-
ronal lesions, damages to oligodendrocytes can as well compromise conduction along spared or
incompletely damaged axons (Sun et al., 2012). Indeed, acute demyelination has been docu-
mented after spinal cord injury (Crowe et al., 1997; Guest et al., 2005; Totoiu and Keirstead,
2005) and contributes to axonal degeneration in other pathological contexts (Irvine and Blake-
more, 2008). After anatomically incomplete spinal cord injuries and beyond initial neuronal
damages, it appears that glial - and especially oligodendroglial - disruption can cause secondary
lesions and put in jeopardy the competence of spared neural tissue to yield spontaneous circuit
reorganization and recovery of function.
1.2.3 ASTROGLIAL SCAR FORMATION
As part of the post-inﬂammation reorganization of the lesion, astrocytes located at the periph-
ery of the injury react by modifying their morphological and functional features. Astrocytes
Section 1.2 Chapter 1 Page 16
used to be considered for long as a cellular substrate for neurons, deprived of a real part in
neural integration or in the conduction of information. However, it is now clearly documented
that astrocytes are a key component for the formation of new synapses, for the development
and stability of neuronal circuits, for neurotransmitter re-uptake, as well as for homeostasis
within the CNS and for the competence of the blood-brain-barrier (Sofroniew and Vinters,
2010).
In response to CNS injuries, astrocytes encounter morphologic and functional transformations
to gather at the periphery of lesions into a layer of astroglia. This process - termed astrogliosis
- gives birth to astrocyte scars with features that are dependent on the type of CNS insult
or disease. According to the mechanism and severity of the CNS insult, astrogliosis is indeed
heterogenous in terms of intensity and histologic outcome, so that reactive astrocytes can
form matrices of variable density, gaining or losing astroglial functions (Anderson et al., 2014;
Wanner et al., 2013). Within the ﬁrst weeks after severe injuries - such as SCI - a dense matrix
of reactive astrocytes gaining function is formed (Anderson et al., 2016), with a gradient of
reactivity decreasing when going from the SCI epicenter to healthy tissue where baseline
astroglial functions are preserved (Wanner et al., 2013).
As determinants and functions of astrogliosis are being explored, it appears that several phe-
notypes of astrocytes can arise depending on the inﬂammatory constellation of the CNS injury
or disease. Indeed, in the context of neuroinﬂammatory and neurodegenerative CNS diseases,
reactive astrocytes express a cytotoxic A1 phenotype. This A1 reactivity involves a loss of nor-
mal astroglial functions, so that the astrocytes’ capacity to support and maintain new synapses
is decreased, as well as their property to phagocyte myelin debris. Moreover, the A1 phenotype
appears to be toxic towards severed neurons and existing synapses in the periphery of the injury
(Liddelow et al., 2017). In the context of ischemia (Zamanian et al., 2012) or after traumatic
axotomy (Liddelow et al., 2017), astrogliosis tends to express an A2 transformation which
appears to promote neuron survival and support axon regeneration (Anderson et al., 2016).
This duality of reactivity phenotypes draws attention on the fact that astrogliosis may play
very diﬀerent roles after spinal cord injury, depending on the neuroinﬂammatory (e.g. multiple
sclerosis, amyotrophic lateral sclerosis, Devic’s neuromyelitis optica) or traumatic etiology of
the lesion.
In traumatic models of SCI even - and long before the A1-A2 discrepancy was shown - as-
trogliosis has been considered as detrimental and targeted for therapeutic considerations. Neg-
ative opinions about SCI-induced astrogliosis are mainly based on the production or inhibitory
molecules by reactive astrocytes, such as chondroitin sulfate proteoglycans (CSPG), that have
been shown to impede axon regeneration (Davies et al., 1997, 1999; Silver and Miller, 2004).
However, parallel work proposes that astrogliosis after traumatic SCI plays a role in restricting
the spread of inﬂammation from the epicenter of the injury. Selective ablation of proliferating
astrocytes (Faulkner et al., 2004), as well as attenuation of astrocyte reactivity (Herrmann
et al., 2008), both induce increased inﬂammation, enhanced demyelination and an extended
size of the lesion site with worsened functional outcome compared to spontaneous astrogliosis.
Also, preventing astrocyte reactivity increases die-back of descending corticospinal and sero-
toninergic ﬁbers, as well as ascending sensory axons (Anderson et al., 2016). Moreover and
in spite of a strong expression of CSPGs, astrogliosis after traumatic SCI has been shown to
produce a supportive extracellular matrix and help ascending sensory axons to regenerate into
the lesion core when proper growth stimuli are provided (Anderson et al., 2016).
Nevertheless and as described above (see 1.2.2), the acute inﬂammatory response to SCIs
appears to involve microglial reactivity and auto-immune features, which theoretically should
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induce A1 astrogliosis. Unveiling how ischemic and traumatic insults promote in facts A2
astrocyte reactivity may provide novel therapeutic leads, in order to manipulate inﬂammation
and optimize the role of astroglial scars. Overall, as astrocytes may have detrimental activities
in other contexts, it appears that traumatic spinal cord injury - which represent a majority of
spinal cord insults - cause the astrocyte component of the scar to exert a balanced eﬀect on
the spinal environment. Preventing astrogliosis after SCI has yet failed to yield reliable and
reproducible beneﬁts, and new therapeutic options may arise based on speciﬁc and optimized
manipulations of the glial scar.
1.2.4 FIBROTIC SCAR FORMATION
As astrogliosis has long been seen as the main barrier to axon regeneration (Davies et al.,
1999), reactive astrocytes have raised more questions than the ﬁbrotic lesion core, so that
the intra-lesional ﬁbrotic component is so far less understood. Nevertheless, recent work
demonstrated that the ﬁbrotic scar strongly inhibits axon regeneration (Soderblom et al.,
2013; Zukor et al., 2013).
After acute inﬂammation is resolved and as astrocytes react to the insult, stromal cells migrate
into the lesion core from locally damaged meninges or peri-vascular regions. In traumatic
injuries that involve local tearing of the meningeal sheets, the ﬁbrotic scar is progressively
formed from meninges-derived ﬁbroblasts, as well as pericytes, endothelia and inﬂammatory
cells. However, in blunt traumatic SCIs that leave the dura intact - such as contusion injuries
- ﬁbroblasts originating from perivascular areas have been demonstrated as a main cellular
source within the ﬁbrotic core (Soderblom et al., 2013). Similarly to the initial inﬂammatory
response to traumatic CNS insults, ﬁbrosis appears to play both beneﬁcial and detrimental
roles. On the one hand, the organization of a ﬁbrotic lesion core appears to contribute to
restoring homeostasis, by protecting surrounding tissue and restoring integrity of the blood-
spinal cord barrier (Kawano et al., 2012). Because inhibiting pericytes’ reactivity after SCI
causes larger lesion compartments, loss-of-function studies have established the ﬁbrotic scar
as a key process to seal the lesion site (Goeritz et al., 2011). On the other hand, this same
ﬁbrotic scar clearly inhibits regeneration by releasing molecules established to be detrimental
to axon regrowth. Amongst these molecules are listed i) axon growth-inhibitory chondroitin
sulfate proteoglycans (CSPGs, e.g. NG2 and phosphacan) (Tang et al., 2003), ii) tenascin-C,
which is inhibitory to neurite extension (Tang et al., 2003), iii) axon-repellent semaphorin 3
(Pasterkamp et al., 1999) and iv) astrocyte-repellent EphB2 (Bundesen et al., 2003).
Either derived from meningeal or vascular origins, intra-lesional ﬁbroblasts have been shown
to express collagen-1α1 (Col1α1). In both contexts, the ﬁbrotic scar is stabilized by 14 days
post-injury and presents with stromal cells embedded in a dense deposition of extracellular
matrix components. In addition to the chemical regrowth inhibition, the physical structure
of the ﬁbrotic scar has been considered as a mechanical barrier to growing axons (Soderblom
et al., 2013).
At a subacute and chronic stage post-injury, both astroglial and ﬁbrotic components of the
SCI lesion have been held responsible for the lack of spontaneous regeneration. However,
while immediate beneﬁts of ﬁbrosis on tissue homeostasis have been shown, evidence gathers
to support its detrimental impact on axon regrowth. On the contrary, reactive astrocytes
seem to support axon regeneration in vivo (Anderson et al., 2016), and neurons tend to prefer
astrocytes to stromal cells when co-cultured in vitro (Shearer and Fawcett, 2001). In order
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to promote axon regeneration, ﬁne manipulations of the scar formation may promote the
organization of permissive endogenous cell substrate. Recent ﬁndings suggest that regrowth
may be improved by i) enhancing A2 astrogliosis and ii) reducing ﬁbrosis to the minima required
for proper wound sealing.
1.2.5 SPONTANEOUS PLASTICITY AND RECOVERY
In spite of detrimental inﬂammatory and histologic reactions, functional recovery can spon-
taneously occur after anatomically incomplete SCI. Clinical statistics show in human patients
that recovery takes place essentially over the ﬁrst 3 months post-injury, but can still positively
evolve over a period of 18 months (Fawcett et al., 2007).
At an early stage, remyelination of demyelinated axons have been proposed as a mechanism
to support spontaneous recovery (Hagg and Oudega, 2006). In addition, animal models
of incomplete injuries have demonstrated a correlation between spontaneous recovery and
plasticity of spared corticospinal projections, involving the recruitment of relay propriospinal
neurons (Weidner et al., 2001; Courtine et al., 2008; Rosenzweig et al., 2010). Reinforcing
the evidence of spontaneous plasticity, studies have shown that cortical reorganization of
sensorimotor representations occurs after SCI. Indeed, sprouting of the motor corticospinal
tract has been shown to reach spontaneously for new target-levels within the spinal cord
after incomplete SCI, thus modifying the motor homunculus (Fouad et al., 2001) and making
connexions with intra-spinal relays located above the injury (Bareyre et al., 2004). Similarly,
sprouting of subcortical structures and spared sensory ﬁbers appears to progressively rewire
portions of the sensory cortex that became silent after spinal lesion. This sensory reorganization
can either restore a same representation as prior to injury (Kaas et al., 2008), or modify the
cortical sensory homunculus(Jain et al., 2008).
Spared neural tissue around incomplete SCIs provides anatomical support to plastic events that
aim at restoring motor supra-spinal input below the injury. In rodents, sprouting of spared
ventral components of the corticospinal tract (CST) was shown to mediate functional recovery
after section of the major dorsal CST, which contains 95% of all corticospinal axons (Weidner
et al., 2001). Moreover, minor ventral and dorsolateral components of the corticospinal projec-
tions were shown to sprout and reach for spared propriospinal neurons at a cervical level. With
a spared access to infra-lesional circuits, these propriospinal ﬁbers restore cortical input to the
lumbar motor centers (Bareyre et al., 2004). In non-human primates with spinal hemisection,
sprouting of the contralateral corticospinal tract was observed, rewiring ipsilateral lumbar cir-
cuits by decussating below the SCI level (Rosenzweig et al., 2010). Similarly, reorganization
and recruitment of decussating propriospinal ﬁbers has been documented to mediate motor
recovery in a rodent model of staggered bilateral hemisections - which is shown as functionally
complete, yet anatomically incomplete. In this model, propriospinal neurons decussate and
bypass the SCI to conduct reorganized supraspinal input across the injury (Courtine et al.,
2008).
In contrast - and likely because of an intrinsic down regulation of growth capacity in adult
neurons (Liu et al., 2011; Sun et al., 2011), combined to a lack of facilitating factors (Richard-
son and Issa, 1984; David and Aguayo, 1981) - severed axons fail to regrow into and across
anatomically complete SCIs. This phenomenon, together with the absence of spared neural
tissue, impedes circuit reorganization and prevents recovery of function. While reorganization
does occur in incomplete SCIs, some extent of neural substrate needs to be spared, in order
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for compensatory mechanisms to yield spontaneous recovery of function. Nevertheless, recov-
ery often remains limited or incomplete in patients victim of severe spinal cord injury. Novel
therapeutic strategies - discussed in the following paragraphs - have been shown to promote
endogenous reorganization of circuits after incomplete lesions. In the future, such strategies -
that enhance endogenous plasticity - may become useful after anatomically complete SCIs, in
order to integrate regenerated axons or grafted neurons into functional circuits.
1.3 RECRUITING SPARED CIRCUITS
Mechanisms for axon regeneration remain partially understood and are currently being inves-
tigated. As regenerative candidate therapies have failed for long to provide consistent and
reproducible recovery of function, strategies have been developed to extract maximum beneﬁt
from spared neural tissue and spontaneous reorganization of circuits. As neuronal excitability
relies on both electrical and chemical phenomenons, pharmacological and electrophysiological
paradigms have been explored to enhance functional recovery after SCI.
1.3.1 PHARMACOLOGICAL MODULATION OF SPINAL SUBSTRATES
Studies have shown in healthy conditions that gait is tuned by Central Pattern Generators
(CPG) located within the lumbar spinal cord (Gerasimenko et al., 2008; Kiehn, 2016), and is
remotely modulated by descending tracts extended from the brainstem (Hentall et al., 2003).
After incomplete SCI, in spite of long tracts’ Wallerian degeneration, propriospinal ﬁbers and
local interneurons can contribute to relay functionally-signiﬁcant supraspinal input to the lum-
bosacral circuits (O’Shea et al., 2017; Zaporozhets et al., 2011; Chen et al., 2018), suggesting
that post-synaptic receptors within the spinal cord remain expressed and available for phar-
macological modulation. In the intact rodent CNS, brainstem control over the lumbosacral
circuitry is mediated by serotoninergic, noradrenergic, dopaminergic and glutamatergic input
(Hentall et al., 2003; Zaporozhets et al., 2011; Asboth et al., 2018), so that monoaminergic
pharmacology has provided candidate molecules to restore or modulate deaﬀerented infrale-
sional circuits after spinal cord injury. Serotoninergic 5HT-2 (e.g. quipazine) and 5HT-1A/7
(e.g. 8-OHDPAT) agonists, as well as dopaminergic agonists (e.g. SKF-82197), have been
shown to recruit lumbosacral centers and potentiate diﬀerent features of the gait pattern
(Musienko et al., 2009; Gerasimenko et al., 2007; Landry et al., 2006). In combination, these
molecules seem to further improve locomotion and act synergistically with electrical modula-
tion of the infralesional spinal cord (Musienko et al., 2009; Courtine et al., 2009). Based on
such evidence, monoaminergic agonists are used by the Courtine Laboratory on a daily basis
to further explore the eﬀects of adjuvant neuroprosthetic therapies.
Independently, in order to restore supraspinal input around incomplete SCIs, improving the
conduction of action potentials may counterbalance demyelination and insuﬃcient remyeli-
nation of spared neural bridges (see 1.2.2). As potassium channel-blocking molecules (e.g.
4-aminopyridine (4-AP) and its derivatives) were shown to enhance conduction of demyelinated
axons in patients with multiple sclerosis (Smith et al., 2000), 4-AP - together with successful
axon regeneration - recently promoted recovery of function in rodent models of spinal hemi-
section (Liu et al., 2017) and optic nerve crush (Bei et al., 2016). In addition, inhibiting
speciﬁc inhibitory interneurons at a local level was shown to improve functional outcomes
after staggered bilateral hemisections of the spinal cord (Chen et al., 2018). While a majority
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of parallel strategies aim at restoring excitability and promoting adequate depolarization, this
recent evidence operates a mechanistic shift, as functional recovery arose from a release -
via KCC2 signaling or selective hyperpolarization - of the peri-lesional inhibition mediated by
GABA-ergic interneurons.
Increasing lumbosacral excitability and conduction of action potentials along spared demyeli-
nated axons may become part of a solution to restore supraspinal input around incomplete
SCIs. Nevertheless, in a context of complete spinal cord injuries, both strategies remain cat-
alytic and are meant to support other paradigms that speciﬁcally aim at restoring voluntary
input across or above the lesion.
1.3.2 MOTOR NEUROPROSTHETICS
As a second option to restore excitability into infralesional circuits, targeted electrostimulation
has been shown to successfully recruit quiescent circuits after incomplete spinal lesion. Indeed,
epidural electrical stimulation (EES) - combined with a pharmacological increase of neuronal
excitability - provides a functional state to the dormant lumbosacral circuits after complete
spinal cord injury (Courtine et al., 2009). Hotspots over the L2 (Ichiyama et al., 2005; Lavrov
et al., 2008) and S1 (Gerasimenko et al., 2007) segments have been identiﬁed in rodents
and induce hindlimb movements when electrically stimulated. Pharmacological and EES in-
terventions appear to act synergistically, so that these interventions alone fail to promote an
infra-lesional functional state (Asboth et al., 2018). Nevertheless, this electropharmacologi-
cally restored functional state essentially generates involuntary hindlimb motion, which diﬀers
from voluntary locomotion at both kinematic and electromyographic levels (Ichiyama et al.,
2008; Antri et al., 2003). In addition to EES and monoaminergic modulation, speciﬁc motor
rehabilitation has since been proved to yield reorganization of supraspinal input and restore
voluntary stepping after staggered double hemisection SCI (van den Brand et al., 2012) or
severe spinal contusion (Asboth et al., 2018). Indeed, motor training appears to recruit pro-
priospinal neurons and induce sprouting of spared reticulospinal axons. Such reorganization
supports supraspinal input to bypass the SCI site and regain access to the potentiated loco-
motor circuitry at a lumbosacral level (Asboth et al., 2018).
Obviously, such electrochemical and neurorehabilitative strategies restore voluntary locomotion
after incomplete SCI based on spared bridges of neural tissue. After complete SCI, and while
robust axon regeneration still fails to restore hindlimb motor function, progresses in brain
decoding have enabled the development of wireless voluntary control over the motor system.
Direct stimulation of muscles (functional electrical stimulation, FES) based on cortical activity
have enabled restoration of grasping (Ethier et al., 2012; Bouton et al., 2016) in a context of
tetraplegia in humans. To recover hindlimb gait patterns, modulation of neural circuits based
on cortical decoding has recently successfully restored weight-bearing locomotion in non-human
primates (Capogrosso et al., 2016) and enabled adjusted hindlimb motor functions in rodents
(Bonizzato et al., 2018) after SCI. Due to complex and sequential activation of muscle groups
during voluntary stepping, modulating neural circuits seems more susceptible to restore natural
gait patterns that FES. Indeed, hotspots are being identiﬁed within the lumbosacral circuitry
that tend to unveil a task-related topography involving muscle synergies (Wenger et al., 2016;
Capogrosso et al., 2016), more than the representation of individual muscles. Nevertheless,
functional electrical stimulation may remain a useful strategy in contexts that compromise
the functionality of the lumbosacral pattern generators (e.g. neuro-degenerative spinal cord
diseases, spinal cord infarcts).
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Figure 1.1: Descending neuronal systems relay motor commands after incomplete SCI. A, Neuropros-
thetic rehabilitation enables recovery of voluntary stepping in incomplete models of SCI, such as staggered double hemisections
or severe spinal contusions. A1, Therapeutic paradigm : robotically enabled locomotor training engages and reorganizes descend-
ing neural networks neuron. A combined delivery of i) infralesional electric neuromodulation and ii) systemically administered
monoaminergic agents restores activity in lumbosacral motor circuits. A2, In a paralyzing staggered double hemisection model,
neuroprosthetic rehabilitation induces the corticospinal tract to reach for propriospinal neurons (van den Brand et al, 2012). A3,
After severe, yet incomplete spinal contusion, the ventrolaterally located reticulospinal tract remains spared. Neuroprosthetic
training increases cortical projections to the reticular formation in the brainstem (Asboth et al, 2018). Reticulospinal axons act
as a descending relay for recovery in contusion models, where propriospinal neurons are severed. B, After complete spinal cord
injury, the descending corticospinal command, as well as all relay axons and ascending somatosensory tracts are interrupted.
Neuroprosthetic training alone does not suﬃce to induce motor beneﬁts.
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Figure 1.2: Regeneration and sprouting after spinal cord injury : deﬁnition. a, Intact axon. b, Axotomized
neuron. c, Axon regeneration : regrowth occurs from the extremity of the severed axon. d, Regeneration : new neurites grow from
severed axons, in a region located close to the SCI site (also termed ’regenerative sprouting’). e, Regeneration : new neurites grow
from severed axon in a proximal region that is remote from the injured site (also termed ’regenerative sprouting’). f, Sprouting :
new neurites grow from spared axons to reinnervate the deaﬀerented targets. (Adapted from Tuszynski and Steward, 2012).
1.4 CURRENT VIEWS ABOUT AXON REGENERA-
TION
Engineering strategies that modulate circuits after complete spinal cord injury remain invasive
and involve implanted material, which can induce inﬂammatory and ﬁbrotic reactions (Karum-
baiah et al., 2013). Neuroprosthetics has been providing key strategies and concepts to recruit
circuits after SCI. However, unveiling the mechanisms that underly axon regeneration in the
adult spinal cord may promote the design of combined biological & engineering therapies, and
eventually promote endogenous reorganization to wean patients of any implanted electronics.
While neuroregeneration is widely used as a generic term, a distinction needs to be made be-
tween sprouting and axon regeneration that may rely on diﬀerent mechanisms. Axon sprouting
has been deﬁned as compensatory extension of new neurites from spared axons (Tuszynski and
Steward, 2012), and may take part to mechanisms of rewiring below incomplete SCIs from
undamaged ﬁbers. However, regeneration includes i) proper axon regrowth from the axo-
tomized ending, ii) extension of new neurites from severed axons in the vicinity of the lesion,
and iii) development of new neurites from injured axons in areas that are remote from the SCI
(Tuszynski and Steward, 2012).
Neuroregenerative hypotheses and strategies after spinal cord injury have mainly relied on
Section 1.4 Chapter 1 Page 23
identifying i) molecular and cellular discrepancies between pre- and post-injury environments,
ii) determinants of axonal growth during development, and iii) biochemical changes that un-
derly axonal maturation and stabilization. The following sections discuss the general concepts
expected to establish permissive requirements for axon regeneration.
1.4.1 AXON REGENERATION : INHIBITING THE INHIBITORS
CHEMOREPULSION
Evidence has now established that axonal growth and ﬁber tracts’ extension during the CNS’s
development involve attractive and repellent molecular gradients. Following SCI, develop-
mental extracellular molecules and membrane receptors are upregulated and may interfere
negatively with the guidance of spontaneously regenerating axons. Two families of chemore-
pellent molecules in particular - semaphorins and ephrins - have been explored and shown
as key guidance cues to pattern axonal tracts during development. Semaphorins have been
identiﬁed as chemorepellents that shape the sensory system through the developing spinal cord
(Messersmith et al., 1995; Behar et al., 1996). Within this molecular family, Semaphorin-IIIA
has been speciﬁcally proposed as a chemorepellent molecule impeding axon regeneration after
SCI. Indeed, Semaphorin-IIIA is produced by the ﬁbrotic component of the SCI scar, and its
inhibition is suggested to promote axon regrowth (Kikuchi et al., 2003). On their side, ephrins
and their Eph receptors (i.e. EphB3 and EphA) - which generate a repellent action on growth
cones during development to promote axonal pathﬁnding - are upregulated after spinal lesion
(Miranda et al., 1999; Willson et al., 2002). Similarly to Semaphorin-IIIA, chemical or genetic
inhibitions of receptors EphA (Goldshmit et al., 2004; Fabes et al., 2007) and/or EphB3 are
suggested to support axonal regeneration (Duﬀy et al., 2012). Manipulating chemorepellent
molecules does appear to enhance axon regrowth after SCI, even though the density of regen-
erated axons remains limited. Whereas the functional beneﬁt of experimental therapies that
target strictly chemorepulsion is debatable, these studies clearly deﬁne a role for chemical guid-
ance in the design of regenerative strategies after SCI. Such approaches may tend to inhibit
or optimize the eﬀects of chemorepellent agents, but can as well aim at providing gradients
of strong chemoattractive molecules to lead regenerating ﬁbers.
PROTEOGLYCANS
Another speciﬁc class of molecules, termed proteoglycans, has been extensively studied to
unveil inhibitory mechanisms after SCI. With a suggested chemorepulsion activity during de-
velopment (Snow et al., 1990b), proteoglycans are a large family of molecules sharing common
structural features that include a core protein carrying covalent glycosaminoglycan (GAG) side
chains. Further speciﬁcities of these side chains deﬁne subfamilies of proteoglycans (e.g. chon-
droitin sulfate, keratin sulphate, heparan sulphate, etc.). Whereas most of these proteoglycans
are acutely and chronically up-regulated following CNS lesion (Fitch and Silver, 1997; Jones
et al., 2003a; Ito et al., 2010), chondroitin sulfate proteoglycans (CSPG) have been speciﬁ-
cally addressed due to their strong and well-documented inhibition of axon regeneration (Silver
and Miller, 2004; Yiu and He, 2006; Jones et al., 2003b; Galtrey and Fawcett, 2007; Andrews
et al., 2012). CSPGs have been suggested to be upregulated by reactive astrocytes following
spinal cord injury, therefore contributing to the belief that astrogliosis opposes both a physical
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and a chemical barrier to axon regrowth (Sharma et al., 2012; Silver and Miller, 2004; Fitch
and Silver, 2008).
The inhibitory CSPG interaction with growing axons has been shown both in vitro - where
CSPGs impede normal growth cone dynamics (Snow et al., 1996) and inhibit neurite out-
growth in spite of permissive laminin (Snow et al., 1990a) - and in vivo where transplanted
sensory neurons fail to extend axons past perilesional proteoglycans (Davies et al., 1997, 1999).
Mechanisms for CSPG-mediated inhibition of axon regeneration have been proposed as direct
or indirect. Growth cones were shown to present diﬀerent potential receptors for CSPGs (e.g.
protein tyrosine phosphatase sigma, leucocyte common antigen-related phosphatase, Nogo re-
ceptors 1 and 3) that induce signaling for cone collapse (Sharma et al., 2012; Fisher et al.,
2011; Shen et al., 2009). Complimentary indirect mechanisms are suggested, that involve
proteoglycan competitive binding with integrins at a growth cone level, thus preventing sup-
portive signaling from extracellular components (Tan et al., 2011). Similarly, competitive
binding with permissive extracellular substrates (e.g. laminins, neural cell adhesion molecule)
can be proposed, thus hiding them to regenerating axons (Zuo et al., 1998; McKeon et al.,
1995). May as well be involved chelation of diﬀerent growth factors (Nandini and Sugahara,
2006; Deepa et al., 2002) that therefore fail to promote axonal regeneration.
Obviously, research eﬀorts have been focused for several decades on inhibiting proteoglycans,
in order to alleviate the negative CSPG drive on axon regeneration after spinal lesion. Diﬀerent
strategies have been developed to disrupt CSPG activity, including neutralization via function-
blocking antibodies (Brown et al., 2012), or targeting downstream molecules and receptors in
the proteoglycan signaling cascade (Shen et al., 2009; Fry et al., 2010; Fisher et al., 2011).
However, the more commonly described inhibition of CSPGs relies on its enzymatic digestion
with chondroitinase ABC or similar agents (McKeon et al., 1995; Bradbury et al., 2002;
Grimpe and Silver, 2004). Such blocking interactions with chondroitin sulfate proteoglycans
have been suggested to promote regeneration of both aﬀerent and eﬀerent axonal tract (Brown
et al., 2012; Fry et al., 2010; Grimpe and Silver, 2004), and induce behavioral beneﬁts (Fisher
et al., 2011; Bradbury et al., 2002). However, it is worth noting that the functional outcomes
were quantiﬁed using subjective scores and were unfortunately not replicated. Furthermore, a
model of speciﬁc dorsal column injury was involved (Bradbury et al., 2002), leaving most of the
descending reticulospinal tracts intact and available for circuit reorganization and spontaneous
functional recovery.
Whereas the inhibitory impact of CSPGs relies on strong evidence, the documented regenera-
tion following CSPG inactivation remains debatable. Indeed, the studies described here above
address either anatomically incomplete injury models, or lesions that are unconvincingly shown
as complete. This leads to possible confusion between real regeneration and sprouting of spared
axonal tracts. As perineuronal networks below spinal lesions include proteoglycans, they are
likely to be partly digested and loosen by chondroitinase, rendering the infralesional tissues
more permeable to neurite outgrowth, i.e. sprouting. Moreover, recent data demonstrate that
proper sensory regeneration can occur into complete SCIs even in the vicinity of proteogly-
cans (Anderson et al., 2016), suggesting that CSPG-mediated inhibition may be less deﬁnitive
than believed and can be overridden by other growth-inducing strategies. The same report
showed as well that reactive astrogliosis is not the sole source of CSPGs after SCI, and ap-
pears to be more beneﬁcial to regenerating axons than the chemical-physical barrier previously
described. Nevertheless, CSPG’s inactivation may as well promote real axon regeneration,
as it diminishes proteoglycan interactions with supportive extracellular components and en-
dogenous growth factors, both elements that are exogenously administered in growth-inducing
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strategies (see 1.4.2). Enzymatic disruption of proteoglycans appears as a promising strategy
to support sprouting and rewiring in incomplete models of SCI, and as a potential paradigm
- in combination with other approaches - to promote axonal regrowth across complete spinal
lesions.
MYELIN-ASSOCIATED INHIBITORS
In parallel of the exploration of proteoglycan-mediated inhibition, oligodendrocyte-derived de-
bris have been the focus of intense investigations and accused of driving toxic signaling onto
growth cones after SCI (Schwab and Bartholdi, 1996). As axon regeneration is known to
occur in the peripheral nervous system (PNS) after nerve injury (David and Aguayo, 1981),
glial diﬀerences between the PNS and the CNS have been explored, leading to the hypothesis
that CNS-myelin may inhibit regrowth, while PNS-myelin is permissive to regeneration (Caroni
and Schwab, 1988a; Schwab and Thoenen, 1985). In a ﬁrst place, two minor myelin proteins
- of 35kD and 250kD - were described in vitro as required and suﬃcient to generate inhibitory
white-matter substrates (Caroni and Schwab, 1988a). Further, a speciﬁc IN-1 antibody tar-
geting these speciﬁc 35kD and 250kD proteins yielded enhanced neural outgrowth in vitro
(Caroni and Schwab, 1988b), and was proposed to promote corticospinal and brainstem-spinal
axon regeneration in vivo (Schnell and Schwab, 1990; Bregman et al., 1995). A decade later,
the 250kD myelin inhibitor was identiﬁed as Nogo and three Nogo-isoforms were documented
as Nogo-A, Nogo-B and Nogo-C (GrandPrÃ© et al., 2000). Subsequently, two other major
CNS-myelin associated components have been identiﬁed as inhibitory : Myelin-Associated-
Glycoprotein (MAG) (Mukhopadhyay et al., 1994) and Oligodendrocyte-Myelin-glycoprotein
(OMgp) (Kottis et al., 2002).
To support the evidence of myelin-associated inhibition, biochemical mechanisms were explored
and identiﬁed a common neuronal receptor - the Nogo receptor NgR1 - for Nogo , MAG and
OMgp (Wang et al., 2002b; Fournier et al., 2001; Domeniconi et al., 2002). Nogo-66 - a
loop of 66 amino acids conserved between Nogo isoforms - appears as the site of interaction
for Nogo with NgR1 (Fournier et al., 2001). Downstream signaling of this Nogo receptor
- after recruitment of NgR1 membrane co-receptors LINGO-1 together with P75 or TROY
(Mi et al., 2004; Park et al., 2005; Wang et al., 2002a) - induces growth cone inhibition
via the Rho/Rho-associated-kinase (ROCK) pathway (Geoﬀroy and Zheng, 2014; Domeniconi
et al., 2005). Interestingly, CSPGs where shown to recruit Nogo receptors NgR1 and NgR3
to mediate inhibition of growth cones (Dickendesher et al., 2012), suggesting cross-talks
and common signaling pathways for proteoglycans (CSPG) and myelin-associated inhibitors
(MAI). However, loss-of-function studies showed that whereas the NgR1 receptor does inhibit
acutely the cytoskeletal dynamics of growth cones when interacting with Nogo-66, MAG or
OMgp, chronic growth cone inhibition by myelin components appears as NgR1-independant
(Chivatakarn et al., 2007; Zheng et al., 2005).
Whereas evidence for CNS-derived myelin inhibition remains strong in vitro, the previous regen-
erative successes obtained in vivo with the IN-1 antibody have been confronted by more recent
studies, in the light of the biochemical understanding of myelin-associated inhibition. Indepen-
dent works have addressed the potential of Nogo, MAG and/or OMgp suppression for axon
regeneration, and two distinct groups showed diﬀerent in vivo eﬀects from myelin-associated
inhibitors (Geoﬀroy and Zheng, 2014). Addressing the injured corticospinal tract (CST), the
ﬁrst study did not show regeneration after deletion of Nogo, MAG, OMgp or all three proteins
(Lee et al., 2010). Conversely, the second demonstrated that Nogo-deleted animals experi-
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enced CST regeneration after Nogo-deletion, that was potentiated by concomitant MAG and
OMgp deletion, but with no regeneration induced by MAG and OMgp deletion only (Caﬀerty
et al., 2010). Additionally, the ﬁrst study quantiﬁed CST sprouting, which was enhanced
by Nogo deletion, and interestingly diminished by MAG deletion. Regarding serotoninergic
descending axons, the second study showed sprouting induced by deleting Nogo alone or in
combination with MAG and OMgp (Caﬀerty et al., 2010), while the ﬁrst documented sero-
toninergic sprouting after MAG or OMgp deletion alone, but without synergistic eﬀects (Lee
et al., 2010). Deletion of all three myelin-associated inhibitors did not yield serotoninergic re-
generation in the ﬁrst study (Lee et al., 2010). These discrepancies between studies, between
in vitro and in vivo eﬀects of myelin suppression, between eﬀects of single myelin inhibitors
and between responses from speciﬁc axonal tracts highlight our likely incomplete understand-
ing of the biochemistry that underlies myelin-associated inhibition. As for CSPG inhibition,
regeneration and sprouting need to be well recognized as Nogo, MAG and OMgp appear to act
diﬀerently on both phenomenons. Indeed, suppressing eﬀects of CSPGs or myelin-associated
inhibitors appear to promote sprouting of descending axonal tracts, while their eﬀect on re-
generation remains debatable. Targeting CSPGs and MAIs may promote sprouting, circuit
reorganization and functional beneﬁts in incomplete models of SCI. However, inducing robust
and convincing functionally-signiﬁcant axon regeneration will likely require more than inhibiting
inhibitors.
1.4.2 AXON REGENERATION : INDUCING AXON REGROWTH
During development, growth programs control the extension of axons throughout the CNS.
Guidance cues act as chemo-attractants or chemo-repellents and direct axons to their expected
target, together with physical barriers (e.g. CSPGs). After neuronal growth is completed, de-
velopmental programs are downregulated, trophic gradients disappear. At the end of neuronal
development, growth cones are morphologically and functionally transformed into pre-synaptic
buttons. Thus, it can be hypothesized that the establishment of synaptic contacts requires
a loss of growth - and possibly regrowth - capacities in adult neurons (Liu et al., 2011). As
diﬀerences between CNS and PNS permissivity to axonal regeneration suggest that environ-
mental factors inhibit axonal regrowth (see 1.4.1), axons still fail to regenerate in models
of injury that cause minimal scarring (Canty et al., 2013; He and Jin, 2016). This further
supports the assumption of an intrinsic incapacity of mature neurons to upregulate growth
programs, in addition to the rise of inhibitory mechanisms after CNS lesion (Goldberg et al.,
2002; Chen et al., 1995). Based on these elements, mechanisms that underly axon growth and
regrowth have been explored, aiming at re-awakening developmental programs and providing
development-like trophic support after axotomy. The ﬁeld of neural regeneration has been
proposing and testing strategies to i) modulate neuronal growth-relevant genes, ii) provide
permissive substrates to regenerating axons and iii) guide axons through trophic factors and
chemoattractive gradients.
SIGNALING DURING AXON DEVELOPMENT
Obviously, axon regeneration can only occur if the axotomized neuron does not undergo apop-
tosis in the ﬁrst place. While inﬂammatory and acute stress mechanisms after injury may
lead to neuronal necrosis or apoptosis, it has been described that axotomy itself can cause
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neuronal death (Huntwork-Rodriguez et al., 2013). Following axotomy, survival and regen-
eration appear however to rely on diﬀerent intracellular mechanisms, as promoting neuronal
survival by deleting tumor-suppressor genes such as p53 or Bcl2 does not promote regen-
eration (Park et al., 2008; He and Jin, 2016). In order to unveil mechanisms susceptible
to induce axonal regrowth, molecular understanding of axonal extension during development
points towards neurotrophins and neuronal activity (Liu et al., 2011). Neurotrophins are a fam-
ily of molecules that include Nerve-Growth-Factor (NGF), Brain-Derived-Neurotrophic-Factor
(BDNF), Neurotrophin-3 (NT3) and Neurotrophin-4 (NT4). Interaction of neurotrophins with
the neuronal receptors TrkA, TrkB and TrkC has been shown to activate signaling cascades
that control axon growth during development (Liu and Snider, 2001; Markus et al., 2002;
Glebova and Ginty, 2005). In the CNS, neuronal activity appears to contribute synergisti-
cally to the neurotrophin-induced axon extension, as electric activity - trough cyclic adenosine
monophosphate (cAMP) upregulation - seems to densify membrane receptors to neurotrophins
(Meyer-Franke et al., 1998; Goldberg et al., 2002; Liu et al., 2011). To address the bases
of the reduced growth capacity following developmental completion, genetic studies propose
several mechanisms. Interestingly, post-mitotic neurons express a molecular complex - known
as the anaphase-promoting complex - while they exit the cell cycle. Inhibition of this complex
has been shown to increase axonal growth in cerebellar neurons (Konishi et al., 2004). The
neuron survival gene Bcl2 is proposed also as a modulator of axon extension during develop-
ment, that is down-regulated at a mature stage (Chen et al., 1997). In addition, modiﬁcations
of gene-expression patterns within the Kruppel-Like-Factors (KLF) family are suggested as a
regulatory mechanism for the reduction of growth capacity in post-mitotic neurons (Veldman
et al., 2007). Within the KLF family, subgroups of factors appear to exert converse eﬀects
on neurite extension (Veldman et al., 2007; Moore et al., 2009). As a speciﬁcally interesting
pathway for the present work, the mammalian Target-Of-Rapamycin (mTOR) has been shown
to decline at the end of development in both the visual system (Park et al., 2008) and the
motor cortex (Liu et al., 2010).
LESSONS FROM CONDITIONING LESIONS
Following axotomy, the sensory system provides a robust model to explore axonal regrow since
“conditioning lesions” were described as a trigger for regeneration. Indeed, studies have been
showing since the 1980s that lesioning the peripheral branch of a dorsal root ganglion neuron
potentiates the regeneration of the injured central branch of the neuron (Richardson and Issa,
1984; Anderson et al., 2016). Comparing the eﬀect of neurotrophins and conditioning lesions,
it appears however that the signaling required for axon regeneration diﬀers from the devel-
opmental cascade (Liu and Snider, 2001), but recruits gene transcription that may reawaken
developmental patterns of protein-expression associated with growth (Liu et al., 2011). Re-
generation likely occurs based on peripheral signals given from the periphery to the soma, such
as an interruption of axonal traﬃcking or new signaling derived from axonal debris (Zhang and
Ambron, 2000). Such retrograde signaling enlightens the role of the local environment at the
site of injury that can potentially modulate intrinsic neuronal growth abilities. Local cytokines
at the site of injury - including ciliary neurotrophic factor (CNTF) (Sendtner et al., 1992) -
have been shown to recruit the growth-associated JAK-STAT pathway, which is required for
conditioning lesion-induced regeneration (Miao et al., 2006). In addition, cAMP-related varia-
tions post-conditioning lesion may promote growth-related gene transcription by i) converting
myelin-associated inhibition into attractive signaling (Song et al., 1997; Cai et al., 2001) and
ii) direct activation of growth-related gene patterns via the cAMP Response Element-Binding
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protein (CREB) (Cao et al., 2006). Moreover, appears that electrical activity at the target of
the peripheral branch exert an inhibition over intrinsic growth programs in sensory neurons that
is alleviated by conditioning lesions (Enes et al., 2010). Further supporting this hypothesis,
an activation of the cAMP/CREB pathway by electrical activity has been demonstrated in
vitro (Fields et al., 1997), whereas electrical activity induces growth cone collapse in sensory
neurons (Fields et al., 1990).
PROMOTING INTRINSIC REGENERATION CAPACITIES
Better understanding of the mechanisms that underly conditioning lesion-induced regeneration
and axonal development have provided candidate molecules and pathways to achieve regrowth
of descending CNS tracts. Extensive attention has been addressed to the mTOR pathway,
since manipulations increasing mTOR levels were shown to induce regeneration in both the
visual system (Park et al., 2008; Bei et al., 2016) and the corticospinal tract (Liu et al.,
2010; Zukor et al., 2013; Liu et al., 2017). Beyond actual regrowth of severed axons, mTOR
targeting, either via Insulin-like-Growth-Factor-1 (IGF1) overexpression or Phosphatase-and-
Tensin-homolog (PTEN) deletion promoted recovery of function (Bei et al., 2016; Liu et al.,
2017). PTEN acts indeed as an inhibitor of the growth-inducing mTOR pathway, whereas IGF1
actives mTOR signaling. Similarly, activation of the Jak-STAT pathway - either genetically in
the sensory system (Bareyre et al., 2011) - or via exogenous application of CNTF in retinal
ganglial cells (Smith et al., 2009) promotes regeneration of axotomized neurons. Synergistic
co-activation of diﬀerent pathways may as well further enhance the robustness of axon regrowth
(He and Jin, 2016). Interestingly, IGF1, together with CNTF and osteopontin - a molecule
believed to potentiate the role of IGF1 on the mTOR cascade - could be substituted to PTEN
deletion and further promote regeneration (Bei et al., 2016). While co-activating diﬀerent
cascades, this manipulations replaced a genetics-based manipulation with a ligand-receptor
signaling activation, which is presented as more prone to clinical translation (He and Jin,
2016).
Additionally, it appears that electrical activity - suggested as detrimental for the regeneration
of sensory axons (Fields et al., 1990) - plays a beneﬁcial role on the extension of neurites
from spared axons (Asboth et al., 2018; van den Brand et al., 2012; Wahl et al., 2014).
With known recruitment of the CREB pathway by activity, cAMP upregulating procudures,
electrical activity or neurorehabilitative training appear as particularly relevant procedures to
promote sprouting, or even axon regeneration. Acute cAMP delivery has indeed been proposed
as a beneﬁcial contribution to reticulospinal regeneration (Lu et al., 2012a), while activity
appears to potentiate mTOR-dependant regeneration after optic nerve lesion (Li et al., 2016).
Obviously other cascades are being investigated to promote CNS axon regrowth, such as KLFs
signaling or the Mitogen-Activated Protein Kinases (MAPK) pathway (He and Jin, 2016).
While our understanding the biochemical requirements for axon regeneration after CNS injury is
eﬀectively progressing, strategies that succeed in activating intrinsic axonal growth machinery
remain for now at a proof-of-concept stage. Indeed, some of the signaling cascades that
regenerative neuroscientists aim at activating are also crucial targets to inhibit for researchers
in oncology (Duzgun et al., 2016). Obviously, inducing organized and controlled growth would
be ideal and safe, and the development of novel viral technologies - including inducible viral
vectors - may bring neuroregeneration a step closer to clinical translation.
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Figure 1.3: Intrinsic mechanisms regulating axon regenerative properties. Diﬀerent mechanisms have been
unveiled, that provide candidate intracellular pathways susceptible to enhance intrinsic growth capacities of axotomized neurons.
These mechanisms appear to be neuron subtype-dependant. Combined manipulations are more likely to induce signiﬁcant axon
regeneration than single interventions, as coordinated events are required for neurite extension. (Adapted from He and Jin, 2016).
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1.5 CELL REPLACEMENT
FACILITATING MATRIX AND RELAYS
Inducing robust axon regeneration has remained elusive and diﬃcult to apprehend, due to
the broad heterogeneity of mechanisms that induce and/or inhibit growth between neuronal
tracts. Instead of exploring incrementally the molecular requirements for endogenous axon
regeneration, a parallel ﬁeld of research has been addressing cell replacement therapies as
supra-molecular manipulations over the SCI site and over the endogenous neural tissue. A
broad variety of cell types has been tested, including Schwann cells, neural stem (or pro-
genitor) cells, olfactory ensheathing cells, oligodendrocyte progenitor cells and stromal cells
(Assinck et al., 2017). The mechanisms that underly the observed or claimed beneﬁts after
SCI and cell grafting remain however incompletely understood and have been reported as :
neuronal relay formation, neuroprotection, endogenous axon regeneration, myelin regeneration
and immunomodulation (Assinck et al., 2017). In the following subsections, we discuss brieﬂy
the beneﬁts and limitations of providing exogenous neuronal relays or supporting cell grafts
into SCI sites.
1.5.1 RELAY GRAFTS : PROMOTING REORGANIZATION
Already back in the 1970’s, Andres Björklund and colleagues assessed the feasibility of grafting
fetal neurons into the injured rat CNS, showing neuronal survival, integration and connectivity
within the injured forebrain (Bjoerklund et al., 1976; Bjoerklund and Stenevi, 1977). Similar
results were obtained a few years later with the successful grafting of fetal spinal cord tissue
into SCI sites (Bregman et al., 1993), opening the door to further developments in neuronal
replacement and ﬁrst human trials (Wirth et al., 2001). Grafting neurons into complete spinal
cord lesions tends to mimics the reorganization of propriospinal neurons and the reach for new
functional relays after incomplete SCIs. Exogenous neurons are expected to provide targets to
sprouting propriospinal axons, in order to further conduct action potentials beyond the com-
plete injury. Following Andres Björklund’s work, studies have been exploring neural stem and
progenitor cells (NSPC) derived from the embryonic E14 spinal cord as a source of exogenous
neuronal relays. Whereas early work already suggested that endogenous axons can grow into
NSPC grafts and reach for transplanted neurons (Reier, 1985; Bregman and Reier, 1986; Jake-
man and Reier, 1991), Mark Tuszynski’s group has been providing extensive evidence that E14
NSPCs can contribute to restore spinal cord integrity after complete transection. In a these
reports, E14 NSPCs - supplemented with a broad cocktail of growth factors and embedded into
a ﬁbrin matrix - were shown to ﬁll successfully the SCI cavity. Grafted cells diﬀerentiated into
both neurons and glia, and extended long-distance axons in both rostral and caudal directions
from the grafted site (Lu et al., 2012c). Moreover, the newly grafted tissue was able to restore
reliable conduction of action potentials across complete transections, as well as some extent
of functional beneﬁts (Lu et al., 2012c). Transitioning to non-human primates was performed
recently, as human spinal cord-derived neural progenitor cells integrated cervical circuits in
rhesus monkeys after being grafted into C7 hemisection lesions(Rosenzweig et al., 2018). In
the same report, cell grafts were shown to improve forelimb motor functions, even though the
score-based assessments and the incomplete model of injury render these beneﬁts debatable
(Rosenzweig et al., 2018). In a context of ethical questioning and with interest into transla-
tional perspectives, eﬀort has been put on replacing NSPCs with human induced pluripotent
stem cells (iPSC), yielding anatomically successful graft integration in rats (Lu et al., 2014).
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Interestingly, Mark Tuszynski’s group has been showing very clearly that grafts derived from
caudalized sources of NSPCs - i.e. stem and progenitor cells derived from the developing spinal
cord - are permissive to the regenerating corticospinal tract (Kadoya et al., 2016). Moreover,
NSPCs appear to self-organize into organotypical dorsal and ventral elements, that are pref-
erentially and respectively innervated by regenerating sensory vs. motor axons (Dulin et al.,
2018). While endogenous axons are able to penetrate the grafts, robust bridging of the injured
site has yet not been achieved with relay-based cell replacement therapies.
Relay grafts appear as a promising strategy to restore anatomical integrity at the SCI site.
However, reproduction studies and corrections have highlighted potential limitations and safety
concerns related with proliferating cell grafts. Indeed, phenomenons such as ectopic metastases
of NSPCs (Steward et al., 2014; Tuszynski et al., 2014) and collagenous partitions of the graft
(Sharp et al., 2014) have been observed after transplantation of E14 neural progenitor cell in
spinal cord lesions. The investigation of cell replacement therapies remains empirical, so that
the mechanisms underlying endogenous regeneration into NSPC grafts are still incompletely
understood. As these grafts are supplemented with survival-promoting factors, unveiling the
eﬀects of the grafted cells, respectively the added growth factors, may allow reﬁning and
optimizing molecule-based neuroregeneration paradigms. Nevertheless, promoting relay-based
reorganization of circuits after SCI - either via cell replacement or with neuroprosthetics 1.3
- has been yielding robust electrophysiological or functional beneﬁts. Restoring voluntary
stepping after complete lesion will likely require supraspinal recruitment of coherent relays, in
a way that is relevant for the work presented in the following chapters.
1.5.2 SUPPORT GRAFTS : PROMOTING ENDOGENOUS REGENER-
ATION
Besides neuronal transplants, diﬀerent cell types have been explored to provide trophic support
and neuroprotection to endogenous tissues, and promote endogenous regeneration (Assinck
et al., 2017). Neuroprotection has been proposed as a mechanism of action for a number
of cell graft sources, including Schwann cells, Oligodendrocyte Progenitor cells, mesenchymal
progenitors and Olfactory Ensheathing cells (Tetzlaﬀ et al., 2011; Raisman, 2001). In the
absence of grafted neurons, neuroprotection remains essentially relevant in incomplete models
of SCI. Nevertheless, Glial progenitors and Schwann cells have been suggested to induce higher
tissue sparing, promote remyelination of spared axons and enhance functional recovery after
spinal contusion (Barbour et al., 2013; Pearse et al., 2004). Besides neuroprotective beneﬁts
and in coherence with the spontaneous myelin abnormalities that occur over the natural course
of SCIs (see 1.2.2), remyelination induced by grafted Schwann cells has been considered as a
mechanism for functional recovery in incomplete SCI models (Biernaskie et al., 2007; Takami
et al., 2002).
On a molecular basis, Schwann cells and bone marrow derived progenitors are known to
produce neuroprotective agents - such as BDNF - in vitro. A loss-of-function study showed
that neuroprotection from grafted bone marrow mesenchymal cells is impeded when the graft
is knocked down for bdnf, suggesting a possible trophic mechanism (Ritfeld et al., 2015).
However, the reduction of BDNF production is correlated with a reduced graft survival that
may decrease the levels of other unidentiﬁed neuroprotective agents secreted by the graft.
In addition, mesenchymal cells have been shown to polarize the post-SCI immune response
towards neuroprotective M2 macrophages, suggesting that non-neuronal cell grafts play a
role as immunomodulators (Nakajima et al., 2012). Beyond neuroprotection and similarly to
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NSPCs (see 1.5.1), grafted Schwann cells, mesenchymal cells and Olfactory Ensheathing cells
are described as supporting tissue able to bridge SCI sites and promote axon regrowth (Lu
et al., 2012b; Xu et al., 1995a; Takeoka et al., 2011). Trophic factors secreted by the grafts
likely contribute to the regenerative eﬀect, which appears to be enhanced by supplemented
and targeted growth agents (Lu et al., 2012b).
While diﬀerent reports have been describing functional beneﬁts after non-neuronal cell grafting
(Assinck et al., 2017), the possible underlying mechanisms are numerous and remain incom-
pletely understood. Beyond the empirical exploration of functional outcomes following cell
grafting into SCI lesions, cell replacement - along with viral manipulations and local admin-
istration of deﬁned molecules - enables to manipulate endogenous tissues in order to identify
the requirements for axon regeneration. Obviously, grafted cells do not only produce the
molecules of interest, but they deliver in addition a constellation of other factors that can be
beneﬁcial or detrimental to regenerating neural tissue. These extra and potentially uniden-
tiﬁed factors provide an appreciable bias to the identiﬁcation of the minimal and suﬃcient
facilitators that promote SCI wound healing and induce axon regrowth. From a translational
point of view, safety concerns arise due to cell sources that are often stem or progenitor and
may keep proliferative properties after transplantation. Nevertheless, unveiling beneﬁcial cell
populations may enable in the future to identify non-neuronal trophic grafts to bridge large SCI
cores and promote robust and safe axon regrowth across complete lesions. Reactive astrocyte
subpopulations may become of interest in this perspective (see 1.2.3 and Liddelow et al. 2017;
Anderson et al. 2016).
1.6 COMBINING PARADIGMS TO RESTORE IN-
TEGRITY
The natural course of spinal cord injuries often leaves patients with chronic sensorimotor and
autonomic deﬁcits. A mechanistic understanding of SCIs provides candidate time points and
processes that therapeutic approaches can interfere with, in order to improve the functional
outcome. Nevertheless, background literature strongly suggests that synergistic strategies
combining multi-pronged interventions are more susceptible to yield robust and reproducible
beneﬁts than single manipulations. Most likely, rehabilitation after SCI should already start
in the ﬁrst hours after the trauma with strategies aiming at optimizing the immune reaction
and reverting the vascular compromission. Such early strategies may enhance axon spar-
ing and myelination, in order to help the subsequent and spontaneous circuit reorganization.
At a subacute stage, reorganizing the SCI site may render the lesion core more friendly to
neuroregenerative interventions, such as cell replacement and/or endogenous axon regrowth.
Chronically, neuroregeneration can aim at restoring a conductive bridge across the injury, that
will further need reorganization to promote coherent and functional rewiring of both aﬀerent
and eﬀerent tracts. When endogenous neuronal relays exist, neuroprosthetics and rehabilita-
tion - which already combine neuromodulation, pharmacology and robotics - may then support
activity-based reorganization of circuits. While neuromodulation can restore lost inputs, phar-
macology may rise excitability in dormant circuits and improve conduction along demyelinated
tracts. In the absence of recruitable relays, neuromodulation may restore long-distance con-
duction of information by detecting activity at origin and stimulating accordingly the relevant
target regions.
Obviously, associating such a broad range of interventions would be strongly invasive and
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morbid for SCI animal models and patients. Eﬀort needs to be devoted to the identiﬁcation
of the minimal and relevant manipulations susceptible to improve signiﬁcantly the functional
outcome and the quality of life. The following chapter relates a signiﬁcant neuroregenerative
breakthrough that guides robust eﬀerent axon regrowth across complete spinal lesions. The
rest of this thesis describes our attempts and current leads to promote functional rewiring of
these regenerated ﬁbers.

Chapter 2
PROPRIOSPINAL AXON
REGENERATION
INDUCING GROWTH ACROSS COMPLETE SPINAL CORD INJURIES
Remark : This chapter is adapted from the published study “Required growth facilitators
propel axon regeneration across complete spinal cord injury”, which is referenced here below.
I, Sabry L. Barlatey, contributed to this project by conducting experiments, performing surgical
procedures and completing anatomical analyses.
Nature. 2018 Sep;561(7723):396-400. doi: 10.1038/s41586-018-0467-6. Epub 2018 Aug 29.
Required growth facilitators propel axon regeneration across com-
plete spinal cord injury
Anderson MA., O’Shea TM., Burda JE., Ao Y., Barlatey SL., Bernstein AM., Kim JH., James
ND., Rogers A., Kato B., Wollenberg AL., Kawaguchi R., Coppola G., Wang C., Deming TJ.,
He Z., Courtine G., Sofroniew MV.
35
Section 2.1 Chapter 2 Page 36
2.1 ABSTRACT
Transected axons fail to regrow across anatomically complete spinal cord injuries (SCI) in
adults. Diverse molecules can partially facilitate or attenuate axon growth during development
or after injury (Tessier-Lavigne and Goodman, 1996; He and Jin, 2016; O’Shea et al., 2017),
but eﬃcient reversal of this failure remains elusive (Sofroniew, 2018). Here, we show that
three mechanisms, which are essential for developmental axon growth but are attenuated or
lacking in adults, (i) neuron intrinsic growth capacity (He and Jin, 2016; Goldberg et al., 2002;
Bradke et al., 2012; Tedeschi et al., 2016; Geoﬀroy et al., 2016; Puttagunta et al., 2014), (ii)
growth-supportive substrate (Letourneau, 1975; Gundersen, 1987) and (iii) chemoattraction
(Campenot, 1977; Sperry, 1963), are all individually required and are in combination suﬃ-
cient to stimulate robust axon regrowth across anatomically complete SCI lesions in adult
rodents. We reactivated the growth capacity of mature descending propriospinal neurons with
osteopontin, IGF1 and CNTF prior to SCI (Duan et al., 2015; Bei et al., 2016), induced
growth-supportive substrates with FGF2 and EGF, and chemoattracted propriospinal axons
with GDNF (Siebert et al., 2010; Deng et al., 2013) delivered via spatially and temporally
controlled release from biomaterial depots (Nowak et al., 2002; Anderson et al., 2016) placed
sequentially after SCI. We show in both mice and rats, that providing these three mechanisms
in combination, but not individually, stimulated robust propriospinal axon regrowth through
astrocyte scars and across non-neural lesion core tissue that was over 140-fold greater than
controls. Stimulated, supported and chemoattracted propriospinal axons regrew a full spinal
segment beyond lesion centers in both species, passed well into spared neural tissue below
injuries, formed terminal-like contacts exhibiting synaptic markers, and conveyed a signiﬁcant
return of electrophysiological conduction capacity across lesions. Thus, overcoming the failure
of axons to regrow across anatomically complete SCI lesions after maturity required the com-
bined sequential reinstatement of multiple developmentally essential axon-growth facilitating
mechanisms. Providing these mechanisms in combination, but not individually, was suﬃcient
to achieve robust regrowth of physiologically active axons across such lesions. These ﬁndings
identify a mechanism-based biological repair strategy for complete SCI lesions to deploy with
rehabilitation paradigms designed to augment functional recovery of remodeling circuits.
PERSONAL CONTRIBUTIONS
In this multicentric collaboration, I - Sabry L. Barlatey - performed stereotaxic spinal surgeries
in rats, contributed to electrophysiological acquisitions, contributed to neuroprosthetic training
and behavioural assessments. I processed CNS tissue and contributed to histological analyses.
I took part in conceiving ﬁgures for the published manuscript and adapted the article (Anderson
et al., 2018) into the chapter presented here below.
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2.2 INTRODUCTION
LESION ENVIRONMENT AFTER SPINAL CORD INJURY
Numerous studies on diﬀerent models of incomplete SCI have shown the relevance of recruiting
propriospinal relays to restore functional downstream input after SCI (Weidner et al., 2001;
Courtine et al., 2008; Rosenzweig et al., 2010). However, in cases of complete injuries that
leave no neural bridge across the lesion core, propriospinal neurons fail to regenerate and
reorganize into the deaﬀerented caudal circuits. We propose here to explore the requirements
for propriospinal axon regrowth across complete SCI, in order to reaﬀerent lumbosacral tissues
and enable caudal circuit reorganization.
Recent neuroregenerative work has been orienting focus on the determinants that may upreg-
ulate growth programs in axotomized neurons. In particular, Zhigang He’s group has been
showing evidence that upregulating the Jak-STAT (Bareyre et al., 2011; Smith et al., 2009)
and mTOR pathway (Park et al., 2008; Bei et al., 2016; Liu et al., 2010; Zukor et al.,
2013; Liu et al., 2017) can promote axon regrowth in deﬁned subpopulations of severed neu-
rons. However, mTOR activation in corticospinal neurons mainly promotes axon regeneration
through severe injuries along astroglial bridges (Zukor et al., 2013), so that ﬁbroblast- and
macrophage-ﬁlled regions of the lesion are bypassed. In cases of complete SCIs that do not
spare glial bridges, enhancing intrinsic growth programs has yet failed to promote axon re-
growth across the non-neural inhibitory lesion core.
As the glial scar has for long been considered a physical and chemical barrier to axon regrowth
(Davies et al., 1997, 1999; Silver and Miller, 2004), new insight strongly suggests that reac-
tive astrocytes can take diﬀerent phenotypes - either beneﬁcial or detrimental to regenerative
processes - depending on the type of insult (Liddelow et al., 2017). A loss-of-function study
demonstrated that reactive astrogliosis in the context of spinal cord injuries exerts a neuro-
protective eﬀect and supports axon regrowth (Anderson et al., 2016). The spontaneously
repellent lesion core remains nevertheless non-permissive to regenerating axons. Debate is
still strong about the regenerative beneﬁts of neutralizing known molecular inhibitors, such
as Myelin-Associated-Inhibitors (MAI) (Lee et al., 2010; Caﬀerty et al., 2010; Geoﬀroy and
Zheng, 2014) and Chondroitin Sulfate Proteoglycans (CSPG) (Fitch and Silver, 2008; Sharma
et al., 2012; Anderson et al., 2016). Interestingly, genetic analyses conﬁrmed that reactive as-
trogliosis expresses CSPGs in spite of its clear support to regenerating ﬁbers (Anderson et al.,
2016). As support molecules such as laminins are required for axon extension (Letourneau,
1975; Gundersen, 1987; Anderson et al., 2016; Plantman et al., 2008), failure of axon regrowth
after spinal axotomy may rely on a lack of supportive extracellular matrix within the lesion
core, more than on an excessive molecular repulsion. As astrogliosis and other non-neural
cells after SCI are able to secrete permissive components of the extracellular matrix, we ex-
plore here an opportunity to upregulate the presence of such molecules within the lesion core.
In addition to an increase in intrinsic neuronal growth capacities and to the reinforcement
of permissive extracellular components, we propose here to investigate the requirements for
exogenous guidance cues.
Section 2.3 Chapter 2 Page 38
2.3 RESULTS
PROPRIOSPINAL REGENERATION ACROSS COMPLETE
SCI
2.3.1 A SUPPORTIVE MATRIX, AXON GUIDANCE & GROWTH INDUC-
TION ARE SUFFICIENT FOR REGROWTH
We tested the hypothesis that failure of adult CNS axons to regrow across complete SCI lesions
was due to a combined lack of multiple mechanisms required for developmental axon growth.
We targeted descending propriospinal neurons because after incomplete SCI they spontaneously
form new intraspinal circuits that relay functionally meaningful information past lesions (Cour-
tine et al., 2008; van den Brand et al., 2012; Jacobi et al., 2015). Thus, short distance
regrowth of transected propriospinal axons across complete SCI lesions has the potential to
ﬁnd new neuronal targets and form new relay circuits. To reactivate intrinsic propriospinal neu-
ronal growth capacity, which is attenuated in adult CNS neurons (He and Jin, 2016; Goldberg
et al., 2002; Bradke et al., 2012; Tedeschi et al., 2016; Geoﬀroy et al., 2016; Puttagunta et al.,
2014), we tested two approaches previously successful with retinal and corticospinal neurons
by using adenoassociated viral vectors (AAV) to deliver either PTEN knockdown (AAV-shPT)
(Zukor et al., 2013), or to express osteopontin, IGF1 and CNTF (AAV-OIC) (Duan et al.,
2015; Bei et al., 2016). To increase axon growth-supportive substrates such as laminin, which
are required for growth of developing and adult axons (Letourneau, 1975; Gundersen, 1987;
Anderson et al., 2016; Plantman et al., 2008), we delivered ﬁbroblast growth factor 2 (FGF)
(Kashpur et al., 2013) and epidermal growth factor (EGF) (White et al., 2008). To se-
quentially chemoattract (Sperry, 1963; Campenot, 1977) propriospinal axons, we delivered
glial-derived growth factor (GDNF) because propriospinal neurons express GDNF receptors
(GDNFR), increase GDNFR expression after SCI (Siebert et al., 2010) and regrow axons into
cell grafts that secrete GDNF (Deng et al., 2013), and because GDNF is lacking from SCI le-
sions (Anderson et al., 2016). To provide temporally controlled and spatially targeted delivery
of growth factors or function-blocking antibodies, we used biomaterial depots comprised of
synthetic hydrogels (Nowak et al., 2002; Anderson et al., 2016) placed sequentially into SCI
lesion centers and into spared neural tissue caudal to astrocyte scar borders (Fig 2.1a). AAV
eﬃciently targeted a majority of propriospinal neurons in the injected area one segment rostral
to SCI lesions, including neurons expressing GDNFR. These manipulations were tested alone
and in combinations ﬁrst in adult mice and then in adult rats by using a severe crush model
of SCI that generates anatomically complete lesions across which there is no spontaneous
regrowth of descending or ascending axons (Anderson et al., 2016).
2.3.2 A SUPPORTIVE MATRIX, AXON GUIDANCE & GROWTH INDUC-
TION ARE REQUIRED FOR REGROWTH
Propriospinal axon regeneration was quantiﬁed as tract-tracer-labeled axons that regrew to
lesion centers or beyond (Fig2.1b-d). Mice with SCI-only or SCI plus empty hydrogel depots
exhibited few or no axons at lesion centers. Individual interventions, AAV-shPT or AAV-OIC
alone, or depots with FGF+EGF alone or GDNF alone, did not signiﬁcantly increase this num-
ber. Combined delivery of all three growth factors, FGF+EGF+GDNF in one or two depots,
but without AAV, led to modest but signiﬁcant increases in axon regrowth. Combined delivery
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Figure 2.1: Stimulated and chemoattracted propriospinal axons regrow robustly across anatomically
complete SCI lesions in mice receiving combined delivery of AAV-OIC plus FGF, EGF and GDNF in
two sequentially placed hydrogel depots. a, Experimental model. D1 and D2, hydrogel depot 1 and 2, respectively.
b, BDA-labelled axons in composite tiled scans of horizontal sections also stained for astrocytes (anti-GFAP (glial ﬁbrillary acidic
protein), left) and cell nuclei (DAPI). Dotted lines demarcate astrocyte proximal (PB) and distal (DB) border around the lesion
core (LC). Dashed line demarcates lesion centre. 1D, one depot; 2D, two depots; GM, grey matter. c, Top, schematic of axon
intercept. Middle, axon intercepts at speciﬁc distances past lesion centers (colour coding and n as in the graph below). Bottom,
areas under axon intercept curves. Dots show n mice per group. NS, not signiﬁcant versus SCI + 1D empty; *P<0.01 versus
SCI + 1D empty, two-way ANOVA with Bonferroni; **P<0.01 versus all other groups and not signiﬁcant versus each other,
***P<0.0001 versus all other groups, one-way ANOVA with Bonferroni. Data are mean± s.e.m. PrSp, propiospinal. d, Surveys
(top) and details (bottom) of BDA-labelled axons. e, Three-dimensional detail of BDA-labelled axon and growth cone expressing
GDNFR in the lesion core.
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of AAV-shPT plus FGF+EGF+GDNF did not signiﬁcantly increase axon numbers compared
with FGF+EGF+GDNF alone or AAV-scrambled plus FGF+EGF+GDNF. In striking contrast,
combined delivery of AAV-OIC plus FGF+EGF+GDNF synergistically facilitated robust pro-
priospinal axon regrowth. In mice with two sequentially placed depots, this regrowth passed
through all lesion compartments, including non-neural lesion core and its proximal and distal
astrocyte scar borders, and penetrated well into spared grey matter (Fig2.1, 2.2, 2.3). In these
mice, total axon regrowth past lesion centers was over 140-fold greater than SCI-only or SCI
plus empty depots (Fig 2.1c). Regrowing propriospinal axons expressed detectable levels of
GDNFR (Fig 2.1e) and followed irregular paths (Fig 2.1d) meeting criteria for appearance of
regrowing, as opposed to spared, axons (Tuszynski and Steward, 2012). BDA tract-tracer did
not label axons of passage, such as serotonin axons. In all cases, no BDA-labeled axons were
present at 3mm past lesion centers conﬁrming that lesions were complete (Fig 2.1b-d).
2.3.3 INDUCING A SUPPORTIVE EXTRACELLULAR MATRIX WITHIN
THE SCI
To dissect cellular and molecular mechanisms underlying this robust axon regrowth, we deter-
mined the impact on axon-substrate interactions of molecular and cellular changes induced by
our interventions (Fig 2.2). FGF+EGF signiﬁcantly increased known axon-supportive substrate
molecules (Gundersen, 1987), laminin, ﬁbronectin and collagen within SCI lesions (Fig 2.2a),
whereas potentially inhibitory chondroitin sulfate proteoglycans (CSPG) (Cregg et al., 2014)
were not signiﬁcantly altered (Fig 2.2g). FGF+EGF signiﬁcantly increased the proliferation
and density of scar-forming astrocytes in borders around non-neural lesion cores (Fig 2.2b),
yet in spite of a near doubling of these cells, stimulated and chemoattracted propriospinal
axons regrew robustly through and beyond proximal (Fig 2.2c) and distal (Fig 2.3a) astrocyte
scar borders in a manner consistent with previous observations for sensory axons (Anderson
et al., 2016). FGF+EGF also increased the perceptible density of stromal cells in lesion core
(Fig 2.2a). Axons transitioned readily from growing along astrocytes in proximal scar borders
to growing along non-neural stromal cells in lesion core (Fig 2.2c), often orientated along
stromal cells or blood vessels and circumventing clusters of inﬂammatory cells (Fig 2.2c).
Some regrowing axons in lesion core were in partial contact with cells expressing Schwann cell
markers. Thus, appropriately stimulated and attracted axons were able to regrow in contact
with multiple cell types. Notably, over 98% of regrowing propriospinal axons in SCI lesions
had at least one surface continually in contact with laminin, whereas axon surfaces in ma-
ture uninjured tissue were rarely in contact with laminin (Fig 2.2d,e). Many regrowing axons
also had contacts with ﬁbronectin or collagen. Simultaneous in vivo delivery of anti-CD29,
an integrin-function-blocking antibody (Anderson et al., 2016; Plantman et al., 2008) pre-
vented the majority of axon regrowth (Fig 2.2f), demonstrating that axon regrowth required
integrin-dependent axon-substrate interactions with laminin, ﬁbronectin or collagen. Never-
theless, upregulation of permissive substrate alone was not suﬃcient to attract activated axon
regrowth into lesion core, such that AAV-OIC plus depots of only FGF+EGF exhibited no sig-
niﬁcant axon regrowth, whereas AAV-OIC+FGF+EGF+GDNF did (Fig 2.1c), demonstrating
that axon regrowth also required chemoattraction. Remarkably, AAV-OIC+FGF+EGF+GDNF
stimulated axons regrew robustly through dense areas of CSPGs, including in direct contact
with brevican or CSPG4 in both astrocyte scars and non-neural lesion cores. This growth
occurred along surfaces with high expression of laminin (Fig 2.2h,i), consistent with obser-
vations that CSPG inhibition is relative rather than absolute, such that increasing laminin
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overrides CSPG presence in vitro (Tom et al., 2004). To probe more broadly the eﬀects of
prolonged FGF+EGF treatment on astrocytes and other cells in SCI lesions, we conducted
genome-wide sequencing of astrocyte-speciﬁc ribosome-associated RNA and RNA from non-
astrocyte cells (Anderson et al., 2016) at two weeks after SCI. At this time point, FGF+EGF
treatment persisted in signiﬁcantly altering substantial numbers of genes relative to SCI only.
The most signiﬁcantly altered gene networks were associated with astrocyte proliferation and
development, and with non-astrocyte inﬂammatory responses, in a manner consistent with our
histological and biochemical evaluations.
2.3.4 CHEMOATTRACTIVE GDNF GUIDES REGENERATING AXONS
ACROSS THE LESION
We next identiﬁed mechanisms required to achieve propriospinal axon regrowth beyond lesion
cores and distal scar borders into spared grey matter. In our early experiments with one depot
of AAV-OIC plus FGF+EGF+GDNF into lesion cores, we noted that propriospinal axons regrew
robustly through proximal astrocyte scar borders and then concentrated around and encircled
depots, but did not pass far beyond. We therefore placed a second depot of GDNF into neural
tissue beyond the distal astrocyte scar. This second depot was injected one week after the ﬁrst
depot so as to sequentially chemoattract propriospinal axons that had regrown into the lesion
core. In mice with two such spatially and temporally separated depots, axons regrew robustly
across lesion cores and distal astrocyte borders, and penetrated well into spared grey matter
beyond the injury, and routinely regrew a full spinal segment past lesion centers (Fig 2.1b-
d), demonstrating that chemoattraction is required to draw regrowth of mature endogenous
axons into spared neural tissue beyond injuries. Notably, the second depot was placed at
9 days after SCI, indicating that GDNF eﬃciently chemoattracted regrowing axons across
already formed distal astrocyte scar borders without altering CSPG levels (Fig 2.3a). Starting
just beyond lesion borders (Fig 2.3b,c), regrowing propriospinal axons that entered spared grey
matter intermingled with NeuN-positive neurons, some of which formed terminal-like swellings
that contacted neurons, colocalized with the pre-synaptic marker, synaptophysin, and were
in apposition with the post-synaptic marker, homer (Fig 2.3b-d). Such contacts were found
distally wherever regrowing axons were present in grey matter, up to a full spinal segment
(1500μm) or more beyond lesion centers. As expected and discussed below, observer scored
over ground locomotion did not improve in these experiments that were focused on dissecting
mechanisms required to achieve axon regrowth across lesions.
2.3.5 REGENERATED PROPRIOSPINAL AXONS CONDUCT ACTION PO-
TENTIALS
We next tested whether our ﬁndings could be extended to rats, whose lesion core pathophys-
iology has been proposed to be more similar to that of humans. As expected, rats exhibited
little or no propriospinal axon regrowth after SCI plus empty hydrogel. Axon regrowth was not
increased by AAV-OIC alone, and only minimally by FGF+EGF+GDNF alone. In striking con-
trast, and consistent with our observations in mice, rats given combined delivery of AAV-OIC
plus two depots of FGF+EGF+GDNF and GDNF exhibited robust propriospinal axon regrowth
through all lesion compartments, and this regrowth routinely reached a full spinal segment or
more past lesion centers and penetrated well into spared grey matter around and beyond the
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Figure 2.2: Stimulated, supported and chemoattracted mouse propriospinal axons regrow through
the proximal borders of astrocyte scars and lesion core stromal cells along laminin that has been
upregulated by delivered growth factors, in spite of CSPG presence. a, Laminin immunohistochemistry (IHC)
images (left) plus quantiﬁcation (middle, percentage stained area), and dot blot plus quantiﬁcation of density (right). *P<
0.01, one-way ANOVA with Bonferroni. TP, total protein. The colour key is used throughout all panels. b, IHC images and
quantiﬁcation (cell number) of astrocyte proliferation and density. *P<0.0005, one-way ANOVA with Bonferroni. c, BDA-
labelled axon regrowth past proximal borders and in the lesion core among CD13+ stromal cells (left) and along laminin (right).
White arrows denote proximal borders. d–f, IHC images (d), quantiﬁcation of axon contact with laminin (e, ***P<0.0001;
Student’s two-tailed t-test, t (9)= 107.4) and axon length per tissue volume (f, *P<0.0005 one-way ANOVA with Bonferroni).
g, CSPG dot blot and quantiﬁcation of density. *P<0.05, one-way ANOVA with Bonferroni. For all graphs, data are mean±
s.e.m. and dots show n mice per group. h, i, BDA-labelled axon regrowth through astrocytes of proximal borders (h) and along
laminin in the lesion centre (i) in spite of dense brevican (BCAN).
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Figure 2.3: Stimulated and chemoattracted mouse propriospinal axons regrow past astrocyte scar
distal borders into grey matter and form synapse-like contacts with neurons. a, b, Surveys and details
(boxed areas) of BDA-labelled axon regrowth across distal borders and into grey matter. c, Detail of b (outlined region) and 3D
view of synapse-like contact of BDA-labelled terminal with the post-synaptic marker, homer, on NeuN+ neuron. d, Synapse-like
BDA-labelled terminals with overlapping pre- and post-synaptic markers, synaptophysin (Syn) and homer.
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second depot (Fig 2.4a,b). Total axon regrowth past lesion centers was over 140-fold greater
in rats with AAV-OIC plus FGF+EGF+GDNF versus SCI with empty hydrogel (Fig 2.4b). The
AAV-derived tract-tracer, RFP, was not expressed in serotonin axons, indicating that labeling
was restricted to axons of the targeted propriospinal neurons. Moreover, in striking contrast
with the robust regrowth of RFP-labeled propriospinal axons, serotonin axons were not at-
tracted to regrow into lesion cores, indicating that our growth factor depots did not simply
alter lesion core environment in a manner that on its own broadly enabled regrowth of all
axon types. Regrowing propriospinal axons that reached spared grey matter intermingled with
NeuN-positive neurons, and some axons formed terminal-like swellings that contacted neurons,
colocalized with pre-synaptic marker, synaptophysin, and were in apposition with post-synaptic
marker, homer (Fig 2.4c). As in mice, observer scored over-ground locomotor score did not
improve in these experiments that probed mechanisms required to achieve axon regrowth, but
which did not involve additional rehabilitation programs to provide use dependent plasticity.
Nevertheless, to look for potential basic functionality of regrown propriospinal axons, we stud-
ied their ability to conduct electrophysiological signals across SCI lesions. Rats with SCI-only
exhibited essentially no conduction above background levels across lesions, whereas rats with
AAV-OIC plus FGF+EGF+GDNF exhibited conduction at about 25% of control levels at 2mm
past lesions, which disappeared by 5mm caudal to lesions (Fig 2.4d), indicating that regrowth
of propriospinal axons across lesions was associated with a signiﬁcant return of conduction
capacity across lesions that correlated with the distance of axon regrowth and approximate
locations of synapse-like contacts.
2.3.6 NEUROPROSTHETICS AND PROPRIOSPINAL REGENERATION
FAILS TO INDUCE FUNCTIONAL RECOVERY
As mentioned above (see 2.3.4 and 2.3.5), no spontaneous recovery of hindlimb movements
occurs in spite of robust axon regeneration. Indeed, the regrowth of propriospinal ﬁbers that
we obtain remains caudally limited by our second depot of guidance cue, suggesting that
regenerated axons are spatially forced by the GDNF gradient and fail to reach functionally
signiﬁcant relays. In the mean time, convincing evidence proposes that propriospinal relays
can be recruited in incomplete models of SCI to support recovery of function (van den Brand
et al., 2012; Courtine et al., 2008). As neuro-rehabilitation seems to increase propriospinal
plasticity and induce reorganization of circuits, we hypothesized that will-powered rehabili-
tation combined with infra-lesional circuits’ activation may induce regenerated propriospinal
axons to sprout and reach coherent targets susceptible to yield recovery of motor functions.
We therefore repeated our strategy involving AAV-OIC+FGF+EGF+GDNF in rats after com-
plete crush injury, and added to the regenerative paradigm the gold-standard neuroprosthetic
rehabilitation established by the Courtine Laboratory (van den Brand et al., 2012; Asboth
et al., 2018). Chronically over three months post-injury, the animals were trained daily for
30 minutes in a robotic postural interface designed to provide body-weight-support. During
these training sessions, infralesional tonic stimulation was delivered over L2 and S1 to recruit
respectively the ﬂexion and extension lumbar hotspots. Systemic monoamines were added as
a pharmacological facilitation of lumbar circuits’ activity : quipazine to modulate extension
muscle groups and 8-OH-DPAT to facilitate ﬂexion components. Due to the high complexity
of this strategy, technical limitations arose. Indeed, several animals could not undergo proper
training after the eﬀects of electric epidural stimulation (EES) were loss during the experi-
mental course. This pilot test left us with a non-statistically signiﬁcant group of 3 animals,
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Figure 2.4: Stimulated and chemoattracted propriospinal axons regrow robustly and conduct elec-
trophysiological signals across anatomically complete SCI lesions in rats after combined delivery of
AAV-OIC plus FGF, EGF and GDNF in two sequentially placed hydrogel depots. a, RFP-labelled axons
in composite tiled scans of horizontal sections. Dotted lines demarcate astrocyte proximal and distal borders around lesion core.
Dashed line demarcates lesion centre (Cn). b, Left, axon intercepts at speciﬁc distances past lesion centers (colour coding and n as
in bar graph). Right, areas under axon intercept curves. *P<0.01 versus all other groups, ***P<0.0001 versus all other groups,
one-way ANOVA with Bonferroni. c, Detail images from the region indicated with an asterisk in a. Left, RFP-labelled axons
among NeuN+ neurons in spared grey matter 2,000 μm past the lesion centre. Top right, 3D detail of the outlined area in the
left panel shows synapse-like contact of BDA-labelled terminal with the post-synaptic marker, homer, on a neuron. Bottom right,
RFP-labelled terminal co-labelled with the presynaptic marker, synaptophysin (Syn) in synapse-like contact with the post-synaptic
marker, homer. d, Left, spinal-cord stimulation and recording sites. Middle, representative individual electrophysiological traces
after spinal cord stimulation. Right, peak-to-peak amplitude of the evoked potential at 2 and 5 mm below lesions relative to the
potential above the lesion in SCI only or SCI + treatment (SCI + AAV-OIC + FGF + EGF + GDNF) or the equivalent distance
in uninjured controls. **P<0.005, ***P<0.0001, one-way ANOVA with Bonferroni. For all bar graphs, data are mean± s.e.m.
and dots show n rats per group.
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including two rats trained without EES. After 3 months of rehabilitation, even though limita-
tions render our preliminary data non-conclusive, no functional beneﬁt could be obtained from
associating propriospinal axon regrowth and neuroprosthetic training.
2.4 DISCUSSION
TRACT SPECIFIC GROWTH PROGRAMS AND GUID-
ANCE
Biological repair of anatomically complete SCI will require axon regrowth across non-neural
lesion cores and their astrocyte limitans borders into spared neural tissue to form new circuits
(O’Shea et al., 2017). A mechanistic understanding of why spontaneous axon regrowth across
such lesions fails in adults is fundamental to creating interventions that augment regrowth
(Sofroniew, 2018). Our ﬁndings, in both mice and rats, strongly support the hypothesis that
regrowth of adult propriospinal axons across anatomically complete SCI lesions fails primarily
because of the simultaneous absence or inadequate presence of three types of mechanisms
essential for facilitating developmental axon growth, (i) neuron intrinsic growth capacity (He
and Jin, 2016; Goldberg et al., 2002; Bradke et al., 2012; Tedeschi et al., 2016; Geoﬀroy
et al., 2016; Puttagunta et al., 2014), (ii) supportive substrate (Letourneau, 1975; Gunder-
sen, 1987), and (iii) chemoattraction (Sperry, 1963; Campenot, 1977). We show that each of
these mechanisms is required, and that providing them in combination, but not individually, is
suﬃcient to achieve robust axon regrowth across such lesions in spite of the continued pres-
ence of putative growth inhibitors. Our ﬁndings markedly extend previous observations that
providing individual growth-facilitating mechanisms on their own is not suﬃcient to achieve
meaningful axon regrowth across complete SCI lesions and that combining certain mechanisms
can partially improve axon regrowth (O’Shea et al., 2017; Sofroniew, 2018; Anderson et al.,
2016; Zukor et al., 2013; Richardson and Issa, 1984; Alto et al., 2009). Importantly, our ﬁnd-
ings demonstrate that chemoattraction is critically required to achieve robust axon regrowth
through and beyond complete SCI lesions into spared neural tissue, and point towards the need
to identify chemoattractants eﬀective for other axon populations desirable to target after SCI.
The diﬀerence in response of propriospinal neurons to AAV-shPT and AAV-OIC is consistent
with previous observations of neuron-type speciﬁc activation requirements (Duan et al., 2015)
and points towards the need to dissect speciﬁc molecular mechanisms regulating growth ca-
pacity of diﬀerent neuronal populations, and to identify means to achieve such activation at
subacute or chronic times after SCI. Although regrowth of propriospinal axons across lesions
was associated with a signiﬁcant return of electrophysiological conduction across lesions, there
was, as expected (Sofroniew, 2018), no detectable improvement of locomotor function, con-
sistent with accumulating evidence that new relay circuits formed after complete SCI cannot
be expected to acquire function spontaneously, but will require targeted rehabilitation proce-
dures that foster their integration into functional networks through use-dependent plasticity
(Sofroniew, 2018; Courtine et al., 2008; van den Brand et al., 2012; Asboth et al., 2018). Our
ﬁndings provide proof-of-concept evidence that robust and physiologically active descending
propriospinal axon regrowth can be achieved across anatomically complete SCI lesions, and
identify a mechanism-based biological repair strategy for such lesions to test in conjunction
with targeted rehabilitation paradigms (Asboth et al., 2018) designed to augment synapse
remodeling and functional recovery of remodeling circuits. Nevertheless, we hypothesize that
functional recovery will require remodeling both aﬀerent and eﬀerent connectivity, based on
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i) reinforced descending input supported by the regeneration of other supraspinal tracts and
ii) restored somatosensory feedback to supraspinal structures. The following chapters address
both these questions individually.
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2.5 MATERIALS AND METHODS
2.5.1 ANIMALS
Mice. All experiments using mice were conducted at
UCLA using C57/BL6 female and male mice. RNA se-
quencing experiments used C57/BL6 mice expressing
an mGFAP-RiboTag transgene generated and charac-
terized as described 19. All mice used were young
adults between 10 weeks and four months old at the
time of spinal cord injury. Mice receiving AAV injec-
tions were between 6 and 9 weeks old at the time
of AAV injection. All mice were housed in a 12-hour
light/dark cycle in a speciﬁc pathogen-free facility with
controlled temperature and humidity and were allowed
free access to food and water. Animal care, including
manual bladder voiding, was performed at least twice
daily or as needed following SCI for the duration of
the experiment. All experiments were conducted ac-
cording to protocols approved by the Animal Research
Committee of the Oﬃce for Protection of Research
Subjects at University of California Los Angeles.
Rats. All surgical procedures in rats were done at
EPFL. Experiments were conducted on young adult
female Lewis rats between two and four months of
age (180-220g body weight) housed three to a cage
on a 12-hour light/dark cycle with access to food and
water ad libitum. Housing, surgery, and euthanasia
were performed in compliance with the Swiss Veteri-
nary Law guidelines. Animal care, including manual
bladder voiding, was performed twice daily following
SCI for the duration of the experiment. All procedures
and experiments were approved by the Veterinary Of-
ﬁce of the canton of Vaud and the Veterinary Oﬃce
of the canton of Geneva (Switzerland).
2.5.2 SURGICAL PROCEDURES
REGENERATIVE SURGICAL PROCEDURES FOR
MICE
All surgeries on mice were performed at UCLA under
general anesthesia with isoﬂurane in oxygen-enriched
air using an operating microscope (Zeiss, Oberkochen,
Germany), and rodent stereotaxic apparatus (David
Kopf, Tujunga, CA). AAV injections were made two
weeks prior to SCI to allow time for molecular ex-
pression and were targeted at propriospinal neurons
between one and two segments rostral to planned
locations of SCI lesions after laminectomy of a sin-
gle vertebra. AAV (see below) were injected into 2
sites (1 on each side of the cord) x 0.25μl (AAV2/9
OPN: 1x10^13, IGF: 5x10^12, CNTF: 5x10^12 gc/ml
in sterile saline) 0.6 mm below surface at 0.1μl per
minute using glass micropipettes (ground to 50 to 100
μm tips) connected via high-pressure tubing (Kopf) to
10μl syringes under control of microinfusion pumps.
Severe crush SCI were made at the level of T10 af-
ter laminectomy of a single vertebra by using No. 5
Dumont forceps (Fine Science Tools, Foster City, CA)
without spacers and with a tip width of 0.5mm to com-
pletely compress the entire spinal cord laterally from
both sides for 5 seconds19,33-35 (Extended Data Fig.
1). Hydrogel depots were injected stereotaxically into
the center of SCI lesions 0.6 mm below surface at
0.15μl per minute using glass micropipettes (ground
to 50 to 100 μm tips) connected via high-pressure tub-
ing (Kopf) to 10μl syringes under control of microin-
fusion pumps, two days after SCI 36. Tract-tracing
of propriospinal neurons was performed by injection
of biotinylated dextran amine 10000 (BDA, Sigma)
10% wt/vol in sterile saline injected 2 x 0.4μl into the
same rostral segments targeted with AAV injections
as described above. In animals receiving two hydro-
gel depots, the second depot was placed 1mm below
the SCI 9 days post SCI. Timelines of all injections
are provided in Extended Data Figure 1. All mice re-
ceived analgesic prior to wound closure and every 12
hours for at least 48 hours post-injury. Animals were
randomly assigned numbers and evaluated thereafter
blind to experimental condition.
REGENERATIVE SURGICAL PROCEDURES FOR
RATS
All surgeries on rats were performed at EPFL under
general anesthesia with isoﬂurane in oxygen-enriched
air using an operating microscope (Zeiss, Oberkochen,
Germany), and rodent stereotaxic apparatus (David
Kopf, Tujunga, CA). AAV injections were made two
weeks prior to SCI to allow time for molecular ex-
pression and were targeted at propriospinal neurons
one and two segments rostral to planned locations
of SCI lesions after laminectomy of a single verte-
bra. AAV were injected into 4 sites (2 on each
side of the cord) x 0.25μl (AAV2/9 OPN: 1x10^13,
IGF: 5x10^12, CNTF: 5x10^12 gc/ml in sterile saline)
1.1 mm below the surface at 0.2 l per minute using
glass micropipettes connected via high pressure tub-
ing (Kopf) to 10l syringes under control of microin-
fusion pumps. Severe crush SCI were made at the
level of T10 laminectomy of a single vertebra by using
No. 2 Dumont Forceps (Fine Science Tools, Foster
City, CA) without spacers and with a tip of 0.5mm
to completely compress the entire spinal cord laterally
from both sides for 5 seconds (Extended Data Fig.
1). Hydrogel depots were injected stereotaxically into
the center of SCI lesions 1.1 mm below the surface at
0.2μl per minute using glass micropipettes connected
via high pressure tubing (Kopf) to 10μl syringes under
control of microinfusion pumps, two days after SCI.
One week later, a hydrogel depot was placed 2mm
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below the SCI. During the same surgery, tract-tracing
of propriospinal neurons was performed by injection
of AAV2/5 red ﬂuorescent protein (RFP, University
of Pennsylvania Vector Core, 2.612x10^13 gc/ml) in-
jected 4 x 0.25 μl into the same rostral segments tar-
geted with AAV injections as described above. Time-
lines of all injections are provided in Extended Data
Figure 1. All rats received analgesia (buprenorphine
Temgesic, ESSEX Chemie AG, Switzerland, 0.01-0.05
mg per kg, s.c.) and antibiotics (Baytril 2.5%, Bayer
Health Care AG, Germany, 5-10 mg per kg, s.c.) were
provided for 3 and 5 days post-surgery, respectfully.
Animals were randomly assigned numbers and evalu-
ated thereafter blind to experimental condition.
NEUROPROSTHETIC SURGICAL PROCEDURES
FOR RATS
All surgeries on rats were performed at EPFL under
general anesthesia with isoﬂurane in oxygen-enriched
air using an operating microscope (Zeiss, Oberkochen,
Germany). A skin incision is made along the sagittal
suture of the skull and the connective tissue and the
muscles covering the skull are separated. The skull
is thoroughly dried and four stainless steel screws are
ﬁrmly inserted into the exposed bone. An amphenol-
recording unit is placed between the screws and rigidly
aﬃxed to the bone using dental cement. Multi-
stranded, teﬂon-coated stainless steel wires connected
to gold plated amphenol pins in the recording unit
are passed subcutaneously to the thoracic column.
Chronic electrodes were conceived as windows in the
teﬂon coating and were attached to the dura mater
(8.0 Ethilon) in order to elicit spinal cord reﬂexes. At
the end of the procedure, the muscle fascia (5.0 Vy-
cril) and the skin (4.0 Ethilon) were sutured in layers.
All rats received analgesia (buprenorphine Temgesic,
ESSEX Chemie AG, Switzerland, 0.01-0.05 mg per kg,
s.c.) and antibiotics (Baytril 2.5%, Bayer Health Care
AG, Germany, 5-10 mg per kg, s.c.) were provided for
3 and 5 days post-surgery, respectfully. Animals were
randomly assigned numbers and evaluated thereafter
blind to experimental condition.
2.5.3 ADENO-ASSOCIATED VIRUSES
(AAVs)
Various adeno associated viral vectors (AAV) were
used to deliver either scrambled control AAV
(AAV2/1-scrambled: 5x10^12 gc/ml) or PTEN
knockdown (AAV2/1-shPTEN: 5x10^12 gc/ml)23; or
to express the growth factors osteopontin (OPN),
IGF1 and CNTF (AAV2/9 OPN: 1x10^13 gc/ml;
AAV2/9 IGF-1: 5x10^12 gc/ml; AAV2/9 CNTF:
5x10^12 gc/ml)14,15; or to express green ﬂuores-
cent protein (GFP) as a reporter protein (AAV2/9
GFP: 2x10^13 gc/ml) or red ﬂuorescent protein (RFP)
as an axonal tract-tracer (AAV2/5-RFP: 2.612x10^13
gc/ml)(University of Pennsylvania Vector Core).
2.5.4 HYDROGEL DEPOTS WITH GROWTH
FACTORS & FUNCTION-BLOCKING
ANTIBODIES
Biomaterial depots were prepared using well char-
acterized diblock copolypeptide hydrogels that are
CNS biocompatible, biodegrade over several weeks
in vivo and provide prolonged delivery of bioac-
tive growth factors in CNS tissue for two or more
weeks after injection18,19,37,38. Diblock copolypep-
tide hydrogel K180L20 was fabricated, conjugated
with blue ﬂuorescent dye (AMCA-X) and loaded with
growth factor and antibody cargoes as described36-
38. Cargo molecules were as follows: Human
recombinant FGF2, EGF and GDNF were pur-
chased from PeproTech (Rocky Hill, NJ): (i) Human
FGF2 (FGF-basic) (154 a.a.) Cat#100-18B-100UG,
Lot#091608 C0617; (ii) Human EGF Cat#AF-100-
15-100UG, Lot#0816AFC05 B2317; (iii) Human
GDNF Cat#405-10-100UG, Lot#0606B64 A2517.
Integrin-function-blocking Hamster anti-rat CD29
monoclonal antibody was purchased from BD Bio-
science (San Diego, CA) as a custom order at
10.3mg/ml (product #624084; lot#7165896). Freeze
dried K180L20 powder was reconstituted to 3.0% or
3.5% wt/vol in sterile PBS without cargo or with
combinations of FGF2 (1.0μg/μl), EGF (1.0μg/μl),
GDNF (1.0μg/μl) and anti-CD29 (5μg/μl). Diblock
copolypeptide hydrogel formulations were prepared to
have G´ (storage modulus at 10 rad s-1) between 75
and 100 Pascal (Pa), somewhat below that of mouse
brain at 200 Pa37,38.
2.5.5 HINDLIMB LOCOMOTOR EVALUA-
TION & ANIMAL INCLUSION CRITE-
RIA
Two days after SCI, all mice or rats were evaluated
in open ﬁeld and all animals exhibiting any hindlimb
movements were not studied further. Rodents that
passed this inclusion criterion were randomized into
experimental groups for further treatments and were
thereafter evaluated blind to their experimental con-
dition. At 2,7,14 days and 28 days after SCI, hindlimb
movements were scored using a simple six-point scale
in which 0 is no movement and 5 is normal walking34.
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2.5.6 HISTOLOGY & IMMUNOHISTOCHEM-
ISTRY
After terminal anesthesia by barbiturate overdose
mice or rats were perfused transcardially with 4%
paraformaldehyde and spinal cords processed for im-
munoﬂuorescence as described19,33-35. Primary an-
tibodies were: rabbit anti-GFAP (1:2000; Dako,
Santa Clara, CA); rat anti-GFAP (1:1000, Ther-
moﬁsher, Grand Island, NY); chicken anti-GFAP
(1:1000, Novus Biologicals, Littleton, CO); rabbit
anti NeuN (1:1000, Abcam, Cambridge, MA); rab-
bit anti-GDNFR-a (GDNF-receptor alpha) (1:1000,
Abcam, Cambridge, MA); sheep anti-BrdU (1:300,
Maine Biotechnology Services, Portland, ME); rab-
bit anti-HSV-TK (1:1,000, 35,39); goat anti-CD13
(1:1000, R&Dsystems, Minneapolis, MN); rabbit anti-
Laminin 1 (1:100, Sigma, St.Louis, MO); rabbit anti-
Fibronectin (1:500, Millipore, Burlington, MA); rabbit
anti-Collagen 1a1 (1:300, Novus Biologicals, Littleton,
CO); mouse anti-NeuN (1:2000, Millipore, Burling-
ton, MA); mouse anti-CSPG40 (1:100, Sigma); rab-
bit anti-Brevican (BCAN) (1:300, Novus Biologicals,
Littleton, CO); guinea pig anti-NG2 (CSPG4) (Drs.
E.G. Hughes and D.W. Bergles41, Baltimore, MA);
rat anti-PECAM-1 (1:200, BD Biosciences, San Jose,
CA); guinea pig anti-homer1 (1:600, Synaptic Sys-
tems GmbH, Germany); rabbit anti-Synaptophysin
(1:600,Dako, Santa Clara, CA); rabbit anti-RFP
(1:1000, Rockland,Limerick,PA); chicken anti-RFP
(1:500, Novus Biologicals, Littleton, CO); goat anti-
GFP (1:1000, Novus Biologicals, Littleton, CO). Flu-
orescence secondary antibodies were conjugated to:
Alexa 488 (green) or Alexa 405 (blue) (Molecular
Probes), or to Cy3 (550, red) or Cy5 (649, far
red) all from (Jackson Immunoresearch Laboratories).
BDA tract-tracing was visualized with streptavidin-
HRP plus TSB Fluorescein green or Tyr-Cy3 (Perkin
Elmer). Nuclear stain: 4’,6’-diamidino-2-phenylindole
dihydrochloride (DAPI; 2ng/ml; Molecular Probes).
Sections were coverslipped using ProLong Gold anti-
fade reagent (InVitrogen, Grand Island, NY). Sec-
tions were examined and photographed using decon-
volution ﬂuorescence microscopy and scanning confo-
cal laser microscopy (Zeiss, Oberkochen, Germany).
Tiled scans of individual whole sections were prepared
using a x20 objective and the scanning function of
a Leica Aperio Versa 200 Microscope (Leica, Wetzlar,
Germany) available in the UCLA Translational Pathol-
ogy Core Laboratory. Composite survey images were
prepared from tiled scans of multiple sections from
the same animals oriented and overlaid using Imaris
® software (9.1.2 64 Bit, Bitplane, Oxford Instru-
ments,Abingdon, U.K.).
2.5.7 AXON QUANTIFICATION
Axons labeled by tract tracing using BDA or RFP
were quantiﬁed using image analysis software (Neu-
roLucida®, 9.14.5 32 Bit, MicroBrightField, Willis-
ton, VT) operating a computer-driven microscope reg-
ulated in the x, y and z axes (Zeiss) by observers blind
to experimental conditions. Using NeuroLucida ®,
lines were drawn across horizontal spinal cord sections
at SCI lesion centers and at regular distances beyond
(Fig. 1c, Extended Data Fig. 3a,b) and the number of
axons intercepting lines was counted by observers blind
to experimental conditions. Multiple sections through
the middle of the cord where propriospinal axons were
densest, were counted per mouse or rat and expressed
as total intercepts per location per animal. To deter-
mine eﬃcacy of axon transection after SCI, we exam-
ined labeling 3mm distal to SCI lesion centers in mice
and 5mm distal to lesion centers in rats, with the in-
tention of eliminating animals that had labeled axons
at this location on grounds that these mice may have
had incomplete lesions. However, essentially all mice
or rats that had met the strict behavioral inclusion
criterion of no hindlimb movements two days after se-
vere crush SCI, exhibited no detectable axons 3mm or
5mm, respectively, distal to SCI lesions regardless of
treatment group.
2.5.8 QUANTIFICATION OF IMMUNOHIS-
TOCHEMICALLY STAINED AREAS
Sections stained for laminin 1, ﬁbronectin, collagen
1a1 or CSPG were scanned using constant exposure
settings. Single channel immunoﬂuorescence images
were converted to black and white and thresholded
(Fig. 2a) and the amount of stained area measured
in diﬀerent tissue compartments using NIH Image J
(1.51) software19.
2.5.9 QUANTIFICATION OF ASTROCYTE
PROLIFERATION & DENSITY
To quantify astrocyte proliferation and the number
of astrocytes in the immediate scar border previously
deﬁned as zone 135, we used a well characterized
transgenic mouse line that expresses thymidine kinase
(TK) in astrocyte cell bodies and thereby facilitat-
ing quantiﬁcation of cell number and co-localization
with other markers35. To quantify the proportion of
newly proliferated astroglia in the scar boarder, we in-
jected daily single doses of the cell division marker,
bromodeoxyuridine (BrdU, Sigma), 100 mg/kg/day
dissolved in saline plus 0.007N NaOH on days 2-7 fol-
lowing SCI. Newly proliferated astrocytes quantiﬁed by
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determining the percentage of astrocytes stained for
both GFAP,TK and BrdU in zone 135. Total astro-
cyte numbers in the immediate scar border (zone 1)35
were determined by counting the number of cells per
deﬁned tissue volume. Cell counts were performed us-
ing stereological image analysis software (StereoInves-
tigator®, 9.14.5 32 Bit, and NeuroLucida®, 9.14.5
32 Bit, MicroBrightField, Williston, VT) operating a
computer-driven microscope regulated in the x, y and
z axes (Zeiss).
2.5.10 DOT BLOT
For dot blot immunoassay of laminin 1, ﬁbronectin,
collagen 1 or CSPG, spinal cord tissue blocks were
lysed and homogenized in standard RIPA (radio-
immuno-precipitation-assay) buﬀer. LDS (lithium do-
decyl sulfate) buﬀer (Life Technologies) was added
to the post-mitochondrial supernatant and 2μL con-
taining 2μg/uL protein was spotted onto a nitrocel-
lulose membrane (Life Technologies), set to dry and
incubated overnight with primary antibodies: rab-
bit anti-Laminin 1 (1:4000, Sigma, St.Louis, MO);
rabbit anti-Fibronectin (1:7000, Millipore, Burlington,
MA); rabbit anti-Collagen 1a1 (1:7000, Novus Biolog-
icals, Littleton, CO); mouse anti-chondroitin sulfate
antibody (CS-56, 1:3000, Sigma Aldrich), an IgM-
monoclonal antibody that detects glyco-moieties of all
CSPGs40. Immunoreactivity was detected on X-ray
ﬁlm with horse radish peroxidase (HRP)-conjugated
secondary antibody (1:5000) and chemiluminescent
substrate (ThermoFisher, Grand Island, NY). Densit-
ometry measurements of immunoreactivity were ob-
tained using ImageJ software (NIH) and normalized
to total protein (Ponceau S) density43. Raw images
of dot blots are provided as Supplementary ﬁgure 1.
2.5.11 ISOLATION & SEQUENCING OF RNA
FROM ASTROCYTES AND NON-
ASTROCYTE CELLS
Using mice expressing an mGFAP-RiboTag transgene,
RNA was evaluated as previously described19 from
uninjured mice, and mice two weeks after SCI after
treatment with hydrogel depots that either contained
no cargo (empty depots) or delivered FGF+EGF (Ex-
tended Data Fig. 1a). Brieﬂy, spinal cords were
rapidly dissected out of the spinal canal and the cen-
tral 3mm of the lower thoracic lesion including the
lesion core and 1mm rostral and caudal were rapidly
removed and snap frozen in liquid nitrogen. Hemag-
glutinin (HA) immuno-precipitation (IP) of astrocyte
ribosomes and ribosome-associate mRNA (ramRNA)
was carried out as described44. The non-precipitated
ﬂow through (FT) from each sample was collected
for analysis of non-astrocyte total RNA. HA and FT
samples underwent on-column DNA digestion using
the RNase-Free Dnase Set (Qiagen) and RNA puriﬁed
with the RNeasy Plus Micro kit (Qiagen). Integrity of
the eluted RNA was analyzed by a 2100 Bioanalyzer
(Agilent) using the RNA Pico chip, average RIN =
7.9 + 1.4. RNA concentration determined by Ribo-
Green RNA Assay kit (Life Technologies). cDNA was
generated from 5ng of IP or FT RNA using the Nu-
gen Ovation® 2 RNA-Seq Sytstem V2 kit (Nugen).
One μg of cDNA was fragmented using the Covaris
M220. Paired-end libraries for multiplex sequencing
were generated from 300 ng of fragmented cDNA us-
ing the Apollo 324 automated library preparation sys-
tem (Wafergen Biosystems), enriched over 10 cycles of
PCR cycles and puriﬁed with Agencourt AMPure XP
beads (Beckman Coulter). All samples were analyzed
by an Illumina NextSeq 500 Sequencer (Illumina) us-
ing 75-bp pair-end sequencing. The number of reads
obtained are between 38.0 to 71.0M (avg 52.1M). Se-
quences were aligned to mouse mm10 genome using
STAR aligner (2.4.0j). Uniquely aligned reads were
between 57.1 to 87.0% (avg 73.9%). Read counts
were determined using HT-seq (0.6.0). Diﬀerential
expression analysis was conducted using Bioconductor
EdgeR package (3.20.1) after removal of low count
genes (5 counts for at least two samples). Three sam-
ples from astrocyte samples were excluded due to low
RIN values (<5.7), no samples were excluded for non-
astrocyte samples.
2.5.12 RAT ELECTROPHYSIOLOGY
Terminal electrophysiological assessments were carried
out as previously described45 four weeks after SCI.
Brieﬂy, animals were anesthetized with urethane (1.5
g/kg; i.p.) and core body temperature was maintained
at 37°C using a self-regulating heated pad connected
to a rectal probe. Depth of anesthesia was continually
monitored by assessing withdrawal reﬂexes and respi-
ratory rate. After laminectomy to expose the injury
site and 7mm rostral and caudal to the lesion site by
removal of one vertebra on either side of the injury, the
dura was removed, and the exposed spinal cord was
covered with warm mineral oil to prevent drying. For
stimulation, a tungsten bipolar concentric electrode
was positioned intraspinally at the rostral-most point
of the laminectomy. A silver ball electrode was used
to record any evoked activity from the surface of the
exposed spinal cord at various locations (above, 2mm
below, and 5mm below lesion). Stimulation was de-
livered in 200 μs square wave pulses at the maximum
amplitude possible before large motor responses were
evoked (typically between 600 μA and 800 μA) and at
a frequency of 0.75 Hz using a STG 4004 stimulus gen-
erator (Multi Channel Systems). Evoked activity was
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ampliﬁed and recorded using an A-M systems diﬀeren-
tial ampliﬁer, PowerLab and LabChart Pro acquisition
and analysis system (AD Instruments). For analysis,
30 traces from each recording site were averaged and
the peak to peak amplitude of the evoked potential
was quantiﬁed.
2.5.13 RAT NEUROREHABILITATION PRO-
CEDURES
After surgery, rats recovered for 7 days before neu-
rorehabilitation began. Locomotor neurorehabilitation
was conducted bipedally on a treadmill or overground
with vertical robotic support. Standing and stepping
enabling agents were used as facilitators and associ-
ated epidural L2 and S1 tonic stimulation and admin-
istration of pharmacological agents as a combination
of quipazine (5-HT2A/C, 0.2-0.3 mg/kg) and 8-OH-
DPAT (5-HT1A/7, 0.05-0.2mg/kg). The tasks were
performed on a daily basis for approximately 30 min-
utes per day, over a period of 8 weeks. Epidural stim-
ulation was delivered tonically at 40 Hz with a pulse
duration of 0.2ms, injecting an intensity of current
chosen individually for each animal depending on the
observed muscle twitch tresholds (ca. 100-300uA). A
robotic body weight support system was used to allow
rats to adopt a comfortable bipedal or quadrupedal
position. Step training is conducted using sophisti-
cated robotic systems developed at the University of
California, Los Angeles (Robomedica, Inc) and at the
EPFL. The animal was restrained in a comfortable har-
ness that was attached to a half-tube at one end of
the body weight support device. A robotic control sys-
tem counterbalanced inertia and enabled to determine
precisely the amount of weight that the subject had
to carry.
2.5.14 BEHAVIORAL ASSESSMENTS
Assessments of functional recovery were conducted
during bipedal and quadrupedal locomotion over-
ground. The bipedal task was supported by our
robotic interface (Robomedica, Inc, UCLA) that de-
livers adapted bodyweight support. Both tasks
were pharmacologically enabled with quipazine (5-
HT2A/C, 0.2-0.3 mg/kg) and 8-OH-DPAT (5-
HT1A/7, 0.05-0.2mg/kg), and complimentary L2-S1
tonic stimulation (40Hz, 0.2ms, 100-300uA) was de-
livered. Retro-reﬂective markers were placed on the
relevant joins (iliac crest, hip, knee, tarse, toe) to en-
able locomotion tracking and motion analysis. A sys-
tem of 12 infrared cameras (Vicon motion analysis)
was used to capture recordings of the motor tasks.
Runs were recorded and a three-dimensional recon-
struction of the movements was obtained, in order to
analyze gait parameters.
2.5.15 STATISTICS, POWER CALCULA-
TIONS, GROUP SIZES & REPRO-
DUCIBILITY
Statistical evaluations of repeated measures were
conducted by one-way ANOVA with post hoc in-
dependent pair wise analysis as per Bonferroni,
or by Student’s t-test (Prism®, 7.0c, GraphPad,
San Diego, CA). For one-way ANOVA statistical
evaluations, F-values are reported in the format
F(df1, df2)=X. The degrees of freedom are computed
as, df1=k-1, where k is the number of compared
treatments and df2=n-k where n is the total number
of samples across the treatment groups. For Stu-
dent’s two-tailed t-test (Prism®, 7.0c, GraphPad,
San Diego, CA), t value and degrees of freedom (df)
are reported in the format t(df)=X. Power calcu-
lations were performed using G*Power Software V
3.1.9.242. For quantiﬁcation of histologically-derived
neuroanatomical outcomes such as numbers of axons
or percent of area stained, group sizes were used that
were calculated to provide at least 80% power when
using the following parameters: probability of type I
error (alpha) = .05, a conservative eﬀect size of 0.25,
3-10 treatment groups with multiple measurements
obtained per replicate. All graphs show mean values
plus or minus standard error of the means (S.E.M.) as
well as individual values as dot plots. All bar graphs
are overlaid with dot plots where each dot represents
the value for one animal to show the distribution
of data and the number (n) of animals per group.
Files of all individual values are provided as source
data. The main experiments testing propriospinal
axon regrowth across SCI lesions in animals treated
with SCI+AAV-OIC+2D+FGF+EGF+GDNF and the
main control groups (SCI+2D+FGF+EGF+GDNF,
SCI+1D-empty) were repeated independently three
times in mice and three times in rats with similar
results. Other experiments testing propriospinal
axon regrowth across SCI lesions in animals in
additional control groups (SCI+AAV-OIC+1D-empty,
SCI+AAV-OIC+1D+FGF+EGF+GDNF, SCI+AAV-
shPT+2D+FGF+EGF+GDNF, SCI+AAV-
OIC+1D+FGF+EGF, SCI+1D+FGF+EGF+GDNF,
SCI-only) were repeated independently at least twice
in mice with similar results.
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3.1 ABSTRACT
Required mechanisms have been identiﬁed for robust and excitable axon regeneration across
complete spinal cord injuries. However, we hypothesize that the persistent interruption of
any somatosensory feedback to the motor cortex contributes to the absence of spontaneous
functional beneﬁts in spite of propriospinal regrowth. Restoring such feedback would enable
directional control and recruit the cortical and subcortical structures involved in motor planning
and motor learning. While mechanisms of sensory axon regrowth are quite well documented
(Anderson et al., 2016; Kadoya et al., 2009; Lu et al., 2004), functional regeneration of the
sensory system remains at the moment irrealistic. Intra-spinal sensory relays have yet not been
identiﬁed and precise long-distance guidance of regenerating aﬀerent to forebrain structures
remains technically challenging. Evidence suggests that rapid somatosensory feedback to the
motor cortex (M1) - integrated with outputs from the basal ganglia and from the cerebellum -
occurs via rostral thalamic nuclei (Lemon and van der Burg, 1979; Gao et al., 2018; Anderson
and DeVito, 1987). The motor thalamus has recently been shown as a key structure for motor
learning (Tanaka et al., 2018), suggesting the rostral thalamic nuclei as potential targets for
somatosensory neuromodulation after spinal cord injury. Following the concepts of a brain-
spine-interface that restored wireless supraspinal control over SCIs (Capogrosso et al., 2016;
Bonizzato et al., 2018), we propose here to design a muscle-brain-interface to restore thalamo-
cortical feedback to M1 when muscle activity is detected. During neuroprosthetic rehabilitation
after complete spinal lesion, thalamic neuromodulation triggered by automated stepping may
cause cortical reorganization and promote the recruitement of regenerated axon bridges.
PERSONAL CONTRIBUTIONS
In this promising yet preliminary study, I - Sabry L. Barlatey - contributed to design experiments
and piloted the feasibility of the project. I performed stereotaxic brain injections, implanted
optic ﬁbers for optogenetic modulation, took part in acute electrophysiological recordings,
performed surgical spinal cord injuries and contributed to all other surgeries. I designed and
contributed to behavioral training and assessment, both in healthy conditions and after spinal
cord injury. I processed CNS tissue, performed histological analyses and acquired microscopy
images. I supervised the analysis of chronic cortical recordings. I wrote the chapter presented
here below and conceived the ﬁgures.
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3.2 INTRODUCTION
CLOSING THE LOOP
Regenerative approaches have been able to restore electrophysiological conduction of infor-
mation across complete SCIs (Anderson et al., 2018; Lu et al., 2012c). However, functional
recovery of hindlimb movements has remained absent or insuﬃciently robust. We hypothesize
that such a lack of behavioral beneﬁts can arise either i) from an irrelevant integration of
lesion-bridging axons within caudal circuits, ii) from an insuﬃcient supraspinal control across
the injury or iii) from a lack of sensitive feedback to the volitional locomotor centers. As
we successfully propelled propriospinal axons across complete lesions (Anderson et al., 2018),
current paradigms have been showing that functional reorganization of circuits can be achieved
with neuroprosthetic rehabilitation (van den Brand et al., 2012; Asboth et al., 2018). However,
combining propriospinal regrowth and neurorehabilitation still fails to promote motor recovery
(see2.3.6), suggesting that additional input - either downstream control or upstream feedback
- needs to be restored.
As dense propriospinal regrowth and rewiring is expected to provide robust and relevant sub-
strate for downstream control after injury (Courtine et al., 2008; Weidner et al., 2001; Rosen-
zweig et al., 2010), we explored options to add relevant sensory feedback to the motor cortex
after complete SCI. Early studies in cats suggest that the rostral thalamus - and especially the
nuclei ventralis lateralis (VL) and ventroposterior lateralis (VPL) - acts as a relay for rapid
somatosensory input to the motor cortex (M1) (Mackel and Miyashita, 1992, 1993; Lemon
and van der Burg, 1979). Further, thalamo-cortico-thalamic loops of motor control were un-
veiled, that are modulated by inputs from the cerebellum, from the basal ganglia and from
the hypothalamus (Anderson and DeVito, 1987). Recently, motor control has been shown in
rodents to arise both from frontal cortical regions and cerebellar nuclei. A co-dependance be-
tween the frontal cortex and the cerebellum was demonstrated to maintain motor preparatory
activity in both structures, and a thalamic relay was conﬁrmed on the cerebello-cortical output
(Gao et al., 2018). Further dissecting the thalamo-cortical interactions, it is now established
that a signiﬁcant population of axons originating in the VL thalamic nucleus reach directly for
pyramidal neurons in the primary motor cortex (Yamawaki and Shepherd, 2015; Hooks et al.,
2013; Tanaka et al., 2018).
Beyond relaying somatosensory, striatal and cerebellar inputs towards the primary motor cor-
tex during motor tasks, rostral thalamic areas are also involved in motor learning (Tanaka
et al., 2018). Aﬀerent from the dorsal striatum and from the deep cerebellar nuclei recruit
thalamo-cortical projections and shape layers L1 and L3 of the primary motor cortex during
motor learning(Tanaka et al., 2018). Functional subdivisions of the motor thalamus have
been anatomically established with a ﬁrst area relaying basal ganglia input to layer L1 in M1
(Kuramoto et al., 2015; Arbuthnott et al., 1990; Rubio-Garrido et al., 2009) and a second
region relaying cerebellar input to layers L3 and L5 (Shigematsu et al., 2016; Kuramoto et al.,
2009). As rostral components of the motor thalamus appear to exert inhibitory activity on
the motor cortical layer L1, the caudo-lateral glutamatergic portion tends to project to deeper
layers Kuramoto et al. (2009). This thalamocortical circuit organization clearly suggests that
the motor thalamus provides M1 with both positive and negative feedbacks, depending on the
circumstances. However, the precise interplay of somatosensory aﬀerent within the complex
cortico-subcortical motor circuitry remains incompletely understood.
As the rostral thalamus acts as a key structure for multiple input integration and feedback
to the motor cortex, we propose here to appose optogenetic neuromodulation to the motor
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thalamus after complete SCI. When correctly timed with automated muscle activity, such
technology would enable the restoration of locomotion-based feedback to M1. Further neu-
roprosthetic rehabilitation combining axon regeneration and motor thalamic neuromodulation
can potentially allow M1 to reorganize reticulospinal relay neurons (Asboth et al., 2018) and
regenerated propriospinal axons (Anderson et al., 2018; Courtine et al., 2008) into functional
motor circuits.
3.3 RESULTS
THALAMOCORTICAL RECRUITMENT AFTER COM-
PLETE SCI
3.3.1 CRUSH SCI INTERRUPTS PERIPHERAL FEEDBACK TO THE MO-
TOR CORTEX
In order to conﬁrm somatosensory input to the M1 region, our ﬁrst interest was to test elec-
trophysiologically the primary motor cortex response to peripheral and spinal electrical stimuli.
In naive healthy rats anesthetized under urethane, we successfully evoked somatosensory re-
sponses in the motor cortex by stimulating either i) the contralateral sciatic nerve or ii) the
dorsal columns at a lumbar level (Fig 3.1e-f). We measured a delay of response included in
a range from 10ms to 12ms when stimulating respectively the dorsal columns and the sciatic
nerve. As direct conduction (ca. 10 [m/sec]) would tend to elicit faster evoked potentials,
the measured latencies suggest that evoked responses are indirect and involve chemical neu-
rotransmission. During the same procedure, we performed a thoracic T10 crush SCI. After
resolution of the acute spinal shock, sciatic nerve and dorsal column stimulation were repeated
and showed a complete abolition of all any somatosensory response in M1. Sciatic stimulation
still induced a fast aﬀerent response at the caudal border of the lesion, whereas no evoked
activity could be elicited above the SCI, conﬁrming the complete interruption of lumbosacral
input with a crush model of spinal cord injury (Fig 3.1f).
3.3.2 LUMBOSACRAL CIRCUITS PROVIDE DIRECT FEEDBACK TO THE
ROSTRAL THALAMUS
Next, we sought to identify potential targets for feedback neuromodulation after spinal cord
injury. Our ﬁrst interest was to determine the somatosensory targets that are aﬀerented by
lumbosacral locomotor centers in rats. We injected an AAV-DJ-hSyn-mGFP-synaptophysin-
mRuby viral vector to label all anterogradely all ascending tracts from the lumbosacral L1 to
S1 spinal levels (Fig 3.1a). The viral technology involved enabled in addition the labelling of
synapses within the aﬀerented regions. Broad anatomical analysis unveiled four somatosensory
relays : i) the rostral thalamus (Fig 3.1b4-c-d), ii) the periaqueductal gray matter, iii) the
lateral parabrachial nucleus, iv) diﬀuse relay neurons in the brainstem (Fig 3.1b1-3). The
periaqueductal gray matter has been shown as a key structure in pain- and fear-related neuronal
circuits (Basbaum and Fields, 1978; Qi et al., 2018), while the lateral parabrachial nucleus
has been associated to sleep/wake behavior and metabolic functions (Kroeger et al., 2017;
Yahiro et al., 2017). Amongst all four somatosensory relays, the motor thalamus appeared as
the more promising target for neuromodulation, due to its know interplay with the M1 area.
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Figure 3.1: Lumbosacral aﬀerent reach brainstem and thalamic relays, and provide rapid somatosen-
sory feedback to the motor cortex. A. CLARITY overview and cross-section topography of somatosensory aﬀerences
at a thoracic spinal cord level. Axon labelling with AAV-DJ-hSyn-mGFP-synaptophysin-mRuby reveals somatosensory aﬀerences
(green) located in the dorsal columns and in the ventrolateral white matter. B. Brainstem and forebrain analysis of primary relays
show multiple somatosensory relays. B1. Diﬀuse axon terminations in the brainstem. B2. Projections to the lateral parabrachial
nucleus. B3 Dense axon termination matrix in the periaqueductal grey matter. B4. Somatosensory relay in the rostral thalamus.
C. Confocal aquisition at a higher magniﬁcation (20x) of lumbosacral projections to the rostral thalamus in B4 showing GFP
labelling of axons (green), mRuby labelling of presynaptic buttons (red) and nuclei staining with Dapi. D. CLARITY aquisition of
the forebrain somatosensory projections, with a higher magniﬁcation conﬁrming direct axonal aﬀerences to the rostral thalamus.
E. Electrophysiological design. Electrical stimuli were applied to the sciatic nerve and to the dorsal columns. Recordings were
performed with a silver ball electrode placed on the motor cortex and on the dorsal columns, before and acutely after complete
SCI. F. Electrophysiological traces conﬁrmed motor cortical responses to electrostimulation before injury, that were minimally
delayed from sciatic nerve stimulation compared to dorsal colum stimulati. Acute recordings after complete thoracic T10 SCI
showed a complete abolition of motor cortex responses to the infralesional stimuli. With sciatic nerve stimulation, lumbosacral
responses were preserved after SCI, while thoracic T8 responses were abolished, conﬁrming an interruption of conduction at the
injured level.
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3.3.3 THALAMO-CORTICAL PROJECTIONS CAN BE RECRUITED AF-
TER COMPLETE CRUSH SCI
As we conﬁrmed direct innervation of the motor thalamus by somatosensory lumbosacral
axons, we next explored anatomically the thalamocortical projections that originate in the
rostral thalamus. To do so, retrograde AAV9-Cre was injected throughout the motor cortex
and the red anterograde viral tracer AAV8-ﬂex-rComet was delivered to the motor thalamus.
As expected, direct thalamic aﬀerent to the layer L5 of the motor cortex were observed (Fig
3.2c, Fig 3.2d1). Acute optogenetic recruitment of these thalamo-cortical axons conﬁrmed the
motor thalamic input into M1. Relying on the retrograde AAV9-Cre viral vector administered
into the motor cortex in healthy rats, we selectively transduced Channelrhodopsin-2 (ChR2)
into motor thalamo-cortical neurons. Under terminal and acute anesthesia with urethane,
we stimulated optically the rostral thalamus and recorded evoked ﬁeld potentials from the
motor cortex using a silver ball electrode (Fig 3.2a). Single optic pulses (10 [ms], 20 [ms], 30
[ms], 40 [ms]) successfully elicited cortical responses, that appeared as stereotypical biphasic
evoked potentials involving a short early response and a second broader potential. Interestingly,
variations of the light pulse duration did not interfere with the length of the cortical response
(Fig 3.2d2). However, variations of the light intensity appeared to impact the latency of
the cortical response without interfering with its amplitude (Fig 3.2d3). We next tested if
a somatosensory deaﬀerentation of the motor thalamus causes acute modiﬁcations on the
thalamo-cortical feedback. During the same procedure, a complete T10 crush injury was
performed, and thalamocortical optic stimulations and recordings were repeated 10, 30, 45 and
60 minutes post-injury. An acute and sustained post-injury CNS shock strongly diminished the
amplitude of the cortical evoked responses, which started to recover progressively between 45
and 60 minutes post-SCI (Fig 3.2d4). Acutely after complete SCI, thalamo-cortical projections
appear to remain functional and available for neuromodulation after complete SCI.
3.3.4 CHRONIC NEUROMODULATION OF THALAMO-CORTICAL PRO-
JECTIONS
As we conﬁrmed that thalamocortical aﬀerent can selectively be recruited using optogenetic
tools, we further investigated the feasibility and eﬀects of rostral thalamic stimulation during
locomotion. Again, AAV9-Cre was injected into the motor cortex and AAV-Flex-ChR2 was
infused into the motor thalamus. Eight weeks later and during a single surgery, rats received
i) an optic ﬁber on the ChR2-expressing thalamus, ii) a 32-channel micro-electrode array in
the motor cortical layer L5, and iii) electromyographic electrodes in muscles tibialis anterior
(TA) and medial gastrocnemius (MG) (See Fig 3.3a). In healthy conditions and during steady
walking on a treadmill, we ﬁrst applied single optic pulses at a 3Hz frequency on the motor tha-
lamus. This gait-independent stimulation pattern aimed at recognizing stereotypical responses
in M1 following optic stimulation. Treadmill locomotion was chosen as it enables long periods
of cyclic and stable cortical activity. Neural data was ﬁltered, and ﬁring rate per electrode was
computed and averaged over a 50ms period, starting from the beginning of the stimulus. A
stereotypical increase in the ﬁring rate (ca. 20ms) was observed starting from the beginning of
the stimulus, directly followed by a depression in the overall motor cortical activity (ca. 20ms)
(See Fig 3.3b). We compared this response to representative 50ms of non-stimulated activity,
extracted from the same recording as an average between all 50ms intervals without thalamic
stimulation. The averaged ﬁring rate without stimulation did not show any stereotypical M1
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Figure 3.2: Direct projections from the rostral thalamus can be selectively recruited to evoke aﬀerent
potentials in the primary motor cortex. A. Experimental design. AAV-Flex-Channelrhodopsin2 was injected into the
rostral thalamus for selective expression of ChR2, dependent on the retrograde AAV9-Cre delivered to the primary motor cortex.
A custom optic ﬁber was implanted with a 30° angle on the rostral thalamus and cortical evoked potentials were acutely recorded
under terminal anesthesia with a silver ball electrode. B. Histological sections showing the tract followed by the optic ﬁber onto
the rostral thalamus. C. Anatomical exploration of direct thalamic aﬀerent to multiple layers in the motor cortex. Selective AAV-
Flex-rComet was delivered into the rostral thalamus, relying on a retrograde AAV9-Cre delivered to the motor cortex. D. Acute
electrophysiological recruitement of thalamocortical projections. D1. Histological expression of ChR2 in the rostral thalamus with
axonal projections to the motor cortex. D1A and D1B show the ChR2-YFP expressing thalamocortical projections, while D1C
and D1D show the optogenetically targeted somas located in the rostral thalamus. D2. Recordings from the motor cortex with
silver balls electrodes, correlated to the length of the single optic pulses delivered to the rostral thalamus. Biphasic responses
were observed, with a maximal amplitude correlated to 20ms pulses. 100% of the laser power (ca. 30mW) was applied. D3.
Variations in the delay of response for the second phase of the biphasic cortical response, depending on the laser intensity. D4.
Responses in the motor cortex observed at 10, 30, 45 and 60 minutes post-complete crush SCI. As the ﬁrst component of the
response was preserved, a recovery of the second component took place from 45 minutes post-SCI on, while the CNS shock was
resolving.
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activity, conﬁrming that the cortical response is caused by optogenetic stimulation of thalamo-
cortical aﬀerent. Interestingly, 3Hz stimulations with pulse durations of 10ms or 20ms elicited
similar cortical modulations, causing in both cases a primary 20ms rise in activity, followed by
a 20ms refractory phase.
Still in healthy conditions, we then sought to link optic stimulation in the motor thalamus
with hindlimb activity. Real-time acquisition of EMG activity in the tibialis anterior muscle
was computed and a detection threshold was set at 60% of the mean TA peak-activity. EMG
detection then triggered thalamic optic stimulation during steady locomotion on a treadmill.
Concomitant neural data recordings were computed and compared between runs, either without
stimulation, with 20Hz stimulation, or with 40Hz thalamic stimulation. Based on our previous
gait-independent observations, the pulse duration was set at 10ms to avoid tetany at a 40Hz
frequency. We then extracted and averaged the neural activity during the trains of stimuli,
or over the corresponding time intervals on control runs without stimulation. Stereotypical
activity was observed in the three conditions, that - we assume - corresponds to the alternation
between volitional ﬂexion and extension. However, thalamocortical stimulation appeared to
pace the M1 activity, as a clear synchrone refractory period follows the ﬁrst stimulus on most of
the channels, in both 20Hz and 40Hz optic stimulation conditions. Such synchrone depression
in the ﬁring rate was not observed in the non-stimulated control runs (See Fig 3.3c).
As no macroscopic modiﬁcation of the healthy gait pattern was observed with motor thala-
mic stimulation, we conﬁrmed here that gait-dependent thalamo-cortical recruitment can take
place during locomotion. Gait-Independent stimulations cause a synchrone increase in the
motor cortex layer L5, that is conserved when stimulation is linked to locomotion. The M1
modulations caused by thalamic stimuli share conserved patterns between the diﬀerent stim-
ulation patterns that we tested. For further applications in post-SCI conditions, we propose
EMG-linked thalamocortical stimulation, with 10ms pulses delivered at a 20Hz frequency.
3.3.5 RESTORING SOMATOSENSORY FEEDBACK AFTER COMPLETE
SCI
In order to further establish the somatosensory neuroprosthetic paradigm, animals implanted
with a motor cortical TDT array, an ipsilateral rostro-thalamic optic ﬁber and EMG electrodes
received a complete crush spinal cord injury. Functional training for bipedal treadmill stepping
took place daily for two weeks, until automated spinal walking was restored. In order to restore
infralesional functionality of circuits during training, monoaminergic drugs were associated to
electric epidural simulation applied to the lumbosacral levels L2 and S1. Neurophysiological
assessments were repeated as described under 3.3.4, and cortical activity was compared in
the presence or absence of rostrothalamic neuromodulation linked to TA electromyographic
detection. Similarly to the cortical pacing observed in healthy conditions, trains of stimulation
successfully restored feedback to M1, recognized with a presence of synchrone neuronal ﬁr-
ing, followed by synchrone cortical depression (See Fig 3.4). These observations conﬁrm the
availability of thalamocortical projections following complete SCI, and oﬀer the perspective
of combinations with regenerated descending axon tracts, in order to close a functional loop
between motor and somatosensory inputs during locomotion after complete spinal lesion.
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Figure 3.3: Rostral thalamus stimulation paces the motor cortex during normal healthy walking. A.
Experimental design. Thalamocortical projections are selectively activated by optogenetics, in an electromyographic dependent
manner during normal walking. B. [Left] Continuous 3Hz stimulation was delivered during steady treadmill walking and neural
activity was recorded. A spike detection software extracted neuronal ﬁring at each electrode of the TDT array. The ﬁring rate was
calculated using a sliding window of 20ms. [Right] Neuronal ﬁring was isolated at all optic stimulations and averaged, revealing a
stereotypical modulation of M1 following motor thalamus activation. This synchrone initial increase was followed by a synchrone
depression in neuronal activity. C. Recordings were obtained without thalamocortical stimulation, or with optic stimulation timed
with detected electomyographic activity in the muscle tibialis anterior C1. Without stimulation,the averaged M1 ﬁring rate per
electrode follows a continuum with stereotypically increased activity on selected channels, coordinated in time with TA activity.
C2. Superposed to basic cortical activity linked to locomotion, optic trains of stimulation in the rostral thalamus induce synchrone
neuronal ﬁring, followed by synchrone depressions in ﬁring rate. Overall, this data demonstrates our ability to induce feedback in
M1 using rostral thalamus neuromodulation.
Section 3.4 Chapter 3 Page 62
Figure 3.4: Thalamic neuromodulation evokes gait-related cortical activity after complete SCI. A.
Experimental design. Thalamocortical projections are selectively activated by optogenetics after complete SCI, in an electromyo-
graphic dependent manner, during automated stepping on a treadmill. B. Cortical recordings were acquired with or without optic
stimulation, timed with detected electomyographic activity in the muscle tibialis anterior (TA). Note that channels 17 to 24 show
activity that is comparable to pre-SCI conditions. Other channels were likely silenced over time due to well-known progressive
ﬁbrosis around the electrodes. B1. Without stimulation, the averaged M1 ﬁring rate does not show any stereotypical pattern
during TA activity, as post-SCI stepping is automated and spinal. B2. After SCI, optic trains of stimulation in the deaﬀerented
rostral thalamus still induce synchrone neuronal ﬁring in M1, followed by synchrone depressions in ﬁring rate. These observations
demonstrate that EMG-based thalamic neuromodulation is able to provide properly timed somatosensory feedback to the motor
cortex above complete spinal cord injuries.
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3.4 DISCUSSION
SPECIFIC THALAMOCORTICAL FEEDBACK
The promising data that we demonstrate in the present chapter remain for now preliminary.
Nevertheless and beyond previous literature, our anatomical tracings, our electrophysiological
experiments and our successful neuromodulation of thalamocortical projections suggest that
the rostral thalamus may become a relevant target for restoring feedback in M1 after complete
spinal cord injury.
In healthy conditions, no macroscopic behavioral modiﬁcation was observed from stimulating
optically the motor thalamus. However, broad analysis of cortical neural activity demonstrates
that the applied stimuli exert a pacing activity on the motor cortex. In healthy conditions, the
absence of functional eﬀects can derive from diﬀerent other aﬀerent sources involved in motor
planing and motor control. While a clear enhancement in cortical ﬁring rate was observed as
a response to rostral thalamic stimulation, the depression that follows the initial response is
extended beyond the expected refractory period of neurons (ca. 1-3ms). Interplays between
M1 and the sensory cortex, the premotor cortex and/or other subcortical structures can con-
tribute to inhibit functional eﬀects of thalamocortical recruitment, and prevent macroscopic
modulations of the gait cycle.
As a priority, we intend in a near future to combine thalamocortical neuromodulation - applied
as described in the result section above - with propriospinal axon regeneration (Fig 3.5). This
procedure would theoretically enable to close the loop of aﬀerent and eﬀerent inputs between
the motor cortex and infralesional circuits. As previous work in severe incomplete injuries has
shown recovery of function from propriospinal sprouting (Courtine et al., 2008; van den Brand
et al., 2012), we hope to obtain with this strategy a conduction of cortical activity to the
infralesional circuits after complete SCI, and potentially muscle responses. However, we need
as a preamble to demonstrate electrophysiologically that thalamocortical stimulation is able
to elicit responses in the healthy spinal cord, in order to hypothesize a potential recruitment
of propriospinal neurons 3.3.4.
The motor cortex has been shown to contribute to restoring movement after SCI (Asboth et al.,
2018; van den Brand et al., 2012; Liu et al., 2017). One could propose, instead of inducing
thalamo-cortical modulation, to directly stimulate M1 in phase with muscle activity in order to
provide feedback to the primary motor cortex. However, stimulating M1 would generate whole
cortical column activity and directly recruit cortico-spinal projections. Rational for targeting
the rostral thalamus relies in its integration of multiple aﬀerent, computed into ﬁne output
to speciﬁc layers of the cortex. Beyond activation of the corticospinal tract, thalamocortical
neuromodulation may enable reorganization of layer-dependent functions, in a manner that can
mimic motor learning. In order to reinforce this rational and as the mapping of entering inputs
to the motor thalamus remain - to our knowledge - incomplete, exhaustive anatomical and
functional dissection of these inputs is required. Retrograde viral vectors delivered to the rostral
thalamus will enable whole CNS anatomical analysis, in order to identify the structures involved
in thalamocortical activation and inhibition. Progress has been reported in our understanding
of subcortical and cerebellar interplays controlling motor functions (Gao et al., 2018; Tanaka
et al., 2018). In order to fulﬁll this understanding, studies based on in vivo calcium imaging,
behavioral assessments, and optogenetic modulations of thalamic aﬀerent can demonstrate
ﬁnely the relevant inputs that modulate motor functions and link speciﬁc cortical modulations
to each source of input (e.g. somatosensory, cerebellar, striatal). Subsequently, functional
mapping of the rostral thalamus itself and functional dissection of its inputs to M1 will enable
Section 3.4 Chapter 3 Page 64
Figure 3.5: Propriospinal axon regrowth combined with motor thalamus neuromodulation. IGF1-
CNTF-Osteopontin, lesion remodeling and propriospinal axon guidance will be applied after complete crush spinal cord injury.
Thalamocortical optogenetic neuromodulation will be implemented in order to provide M1 with somatosensory feedback over the
lesion. Neuroprosthetic training, enabled with electric epidural stimulation, monoaminergic pharmacology and a robotic interface
will assess the functional beneﬁts induced by this combined sensorimotor strategy.
targeted neuromodulation of selected neuronal populations that project to the motor cortex,
depending on the wanted modulations (e.g. direct corticospinal ﬁring, motor planning, motor
learning reinforcement).
Our primary aim in the current pipeline is to restore thalamus-dependent feedback from the
lumbosacral circuits to the motor cortex. However, the sensory modality of this feedback (i.e.
proprioceptive, touch or pain) remains uncertain. Retrograde anatomical tracing from the
motor thalamus would enable topographic analysis of the thalamic aﬀerent in the spinal cord,
in order to conﬁrm the type of sensory input. As rapid somatosensory feedback to M1 has been
demonstrated in early studies, our tracings and acute electrophysiological recordings suggest
potential monosynaptic aﬀerent from lumbosacral circuits to the motor cortex. Herpes viral
technologies - that enable anterograde labelling of axon tracts and their targets by jumping one
synapse - will test this hypothesis in a short term. Currently, the protocol applied in the present
chapter recruits all outputs from the rostral thalamus to M1. Doing so, we recruit - along
with lumbosacral, striatal and cerebellar targets - neurons that receive aﬀerent from cervical
and thoracic segments. In order to selectively recruit somatosensory feedback associated to
hindlimb locomotion, sophisticated viral combinations may enable to recognize the speciﬁc
aﬀerent contribution of lumbosacral circuits. As an example, Herpes viral vectors carrying Cre
could be delivered to the lumbar and sacral cord, while a Flex-Channelrhodopsin2 vector is
administered into the motor cortex. An optic implant in the rostral thalamus would then only
recruit neuronal targets of lumbosacral somatosensory axons.
In order to provide coherent feedback to M1, we need to map the topography of activity in the
rostral thalamus during gait, in order to recognize potential hotspots respectively associated to
hindlimb ﬂexion and extension. Calcium imaging - a technic that enables live microscopic visu-
alization of neuronal ﬁring with an implanted lens - would provide mapping information during
normal walking in healthy animals. This method would require the infection of lumbosacral
circuits with a non-G-deleted rabies vector carrying Ca2+ dependent ﬂuorescent markers. Such
functional mapping would enable real-time and alternate neuromodulation of neuronal popu-
lations associated to ﬂexion/extension in the motor thalamus. To do so, dual expression of
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blue-light and red-light responding opsins in the rostral thalamus could enable, with a single
optic ﬁber, using a split optic cable and two distinct lasers (blue and red), to provide alter-
nate thalamocortical stimulation depending on electromyographic detection of function and
extension.
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3.5 MATERIALS AND METHODS
3.5.1 ANIMALS
Lewis rats were involved in the reported experiments
in accordance with the swiss veterinary legislation ap-
plied in Geneva. Local veterinary committees accred-
ited the procedures under Licence #GE28/17. All
wild-type Lewis rats were obtained from Charles River
[Les Oncins, Saint Germain sur l’Arbresle, France].
3.5.2 ADMINISTERED VIRUSES
OPTOGENETIC VIRUSES
Adeno-Associated Viral (AAV) vectors were com-
bined to induce selective membrane expression of
Channelrhodopsin-2 (ChR2) - a blue light-sensitive na-
trium channel. ChR2 was used as a fusion-protein with
eYFP, in order to trace the successfully infected axon
tracts. Retrograde AAV9-CMV-Cre [1x10^14vg/mL,
kindly provided by Prof. Aebischer’s group, EPFL] was
infused into the middle and deeper layers of the motor
cortex [AP -0.5, -1.5, -2.5 / ML 1.5, -3.0, DV -1.5 /
alpha=0° / 500nL per site] for retrograde expression
of the Cre-dependance. Neurotropic AAV5-Ef1a-DIO-
ChR2-eYFP [4x10^12vg/mL, UNC vector core] was
injected into the ipsilateral rostral thalamus [AP -1.7
/ ML +2.2 / DV -5.6 / alpha=0° / 250nL per site] for
selective expression of ChR2-eYFP in direct thalamo-
cortical neurons that project to the motor cortex.
TRACING VIRUSES
Adeno-Associated Viral (AAV) vectors were combined
to anterogradely label sensory input to the forebrain
that originate in lumbo-sacral segments. Neurotropic
AAV5-CMV-Cre [1x10^13vg/mL, kindly provided by
Prof. Aebischer’s group, EPFL] and AAV-DJ-hSyn-
Flex-mGFP-2A-synaptophysin-mRuby [Stanford core
facility] were mixed 1:1 and co-injected over 6 sites
per side over the T13 and L1 vertebral levels [1mm
AP spacing / ML -0.65 / DV -0.9 / 250nL per site].
This viral combination enables global labeling of an-
terograde somatosensory ﬁbers projecting to forebrain
areas. Axons appear in ﬂuorescent green and synapses
are shown in ﬂuorescent red.
3.5.3 SURGICAL PROCEDURES
CORTEX AND THALAMUS INJECTIONS
All rats were maintained under anesthesia with Isoﬂu-
rane in a rodent cranial stereotaxic apparatus (David
Kopf, Tujunga, CA). A midline skin incision was per-
formed to expose the skull and recognize Bregma and
Lambda. Both Bregma and Lambda were vertically
aligned and a craniotomy was performed using a ﬁne
drill to expose the fronto-parietal cortex. Injections
took place using micro-glass pipettes (50-100um tip
width) with six sites of injection in the left motor cor-
tex (M1) and one single site in the motor thalamus
(mThal). The motor cortex was stereotaxically and
vertically targeted using the previously described coor-
dinates for rats : -0.5mm, -1.5mm and -2.5mm caudal
from Bregma, 1.5mm and 3mm lateral from midline
and -1.5mm ventral from the cortical surface. The
motor thalamus was stereotaxically and vertically tar-
geted using following established coordinates for rats
: -1.7mm caudal from Bregma, 2.2mm lateral from
midline and -5.6mm ventral from the cortical surface.
Injected viral suspensions were prepared to enable the
concentrations and injection volumes speciﬁed under
3.5.2. Infusions were performed at 2nL/sec and a two
minutes delay was respected before slow withdrawal
of the pipette. The skin was ﬁnally closed using non-
resorbable 4-0 sutures.
CRUSH SPINAL CORD INJURY
Rats were maintained under anesthesia with Isoﬂu-
rane. A dorsal midline incision was performed and
muscles were carefully detached to access the pos-
terior aspects of the spine. Using a surgical micro-
scope (Zeiss, Oberkochen, Germany), the inferior in-
terspinous ligament was removed with n°5 Dumont
forceps (Fine Science Tools, Foster City, CA) at the
targeted thoracic level (T8 or T10). A complete
laminectomy was performed with n°2 forceps (Fine
Science Tools, Foster City, CA) and the cord was lat-
erally compressed for ﬁve seconds using tweezers with
a tip width of 0.5mm. The back muscles and skin were
ﬁnally closed with respectively resorbable 6-0 and non-
resorbable 6-0 sutures.
THALAMUS OPTIC FIBER IMPLANTATION
Optic implants were custom made to optimize the
ﬁber length and access the targeted rostral thalamus.
Multimodal optic ﬁber (200 μm core diameter, 0.22
NA, Thorlabs) was mounted inside 200um wide fer-
rules (Thorlabs, Newton, NJ) and the contact sur-
face for light input was ﬁnely polished. Optic ﬁber
implantation was performed in rats during a single
surgery, together with implantations of an ipsilateral
cortical electrode array, of lumbosacral L2-S1 spinal
electrodes and of contralateral electromyographic elec-
trodes. Eight weeks were respected between the AAV-
ChR2 injection and the optic ﬁber implantation, in or-
der to ensure proper expression of the ChR2 channel.
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All rats were maintained under anesthesia with Isoﬂu-
rane in a rodent cranial stereotaxic apparatus (David
Kopf, Tujunga, CA). The headskin and the previous
left-sided craniotomy were re-exposed and four stain-
less steel screws were ﬁrmly inserted into the exposed
bone to stabilize and ﬁx the implanted devices. To
enable concomitant implantation of an ipsilateral cor-
tical electrode array, the optic ﬁber was brought on the
motor thalamus with a 30° angle back tilt reported to
the vertical axis. A small burr hole was performed
caudally to the fronto-parietal craniotomy on the left
side (-5.27mm caudal from Bregma, 2.2mm lateral
from midline). The path to the rostral thalamus was
pre-punctured using a micro-glass pipette (50-100um
tip width) and the optic ﬁber was implanted with a
30° angle (DV -6.1mm from the cortex surface). The
exposed cortical surface was protected using biocom-
patible glue and the optic ﬁber was ﬁxed with dental
cement.
CORTICAL ELECTRODE ARRAY IMPLANTATION
32-channel micro-electrode arrays were obtained from
Tucker-Davis-Technologies (ZIF2010-32, Tucker-
Davis-Technologies TDT, Alachua, FL). During the
same surgery and after thalamus optic ﬁber implanta-
tion (see 3.5.3), the left motor cortex was re-exposed
and the dura mater was open. The TDT array was
brought to the cortical surface (centered at -1.5mm
caudal from Bregma and 2.3 lateral from midline)
and lowered into the cortical layer L5 (-1.4mm from
the cortical surface). After test recordings, the
32-channel micro-electrode array was ﬁxed together
with the optic ﬁber using dental cement.
NEUROPROSTHETIC ELECTRODE IMPLANTA-
TION
This procedure was conducted during a single surgery
together with the implantation of a cortical TDT array
(see 3.5.3) and a thalamic optic ﬁber (see 3.5.3). An
amphenol-recording unit (Omnetics Connector Corpo-
ration, USA) was placed on the right fronto-parietal
bones and rigidly aﬃxed using dental cement. Mul-
tistranded, teﬂon-coated steel wires connected to the
amphenol pins in the recording unit were passed sub-
cutaneously to the thoracic column. Using an op-
erating microscope (Zeiss, Oberkochen, Germany),
chronic electrodes were conceived as windows in the
teﬂon coating and were attached to the dura mater
(8.0 Ethilon) over lumbosacral levels L2 and S1 in or-
der to elicit spinal cord reﬂexes. In order to implant
electromyographic electrodes (EMG), incisions were
performed over the tibialis anterior muscle (TA) and
over the medial gastrocnemius (MG) muscle. Pairs of
wires were subcutaneously passed to the incisions and
windows were performed in the teﬂon coating to con-
ceive chronic EMG electrodes. Electrodes were passed
into the respective TA and MG muscles and ﬁxed to
the fascia. Finally, the muscle fascia (5.0 Vycril) and
the skin (4.0 Ethilon) were sutured in layers.
SPINAL INJECTIONS
Spinal injections in rats were performed under gen-
eral anesthesia with Isoﬂurane using an operating mi-
croscope (Zeiss, Oberkochen, Germany) and rodent
stereotaxic apparatus (David Kopf, Tujunga, CA). A
midline incision was performed to access the dorsal
column and laminectomies were carried out to expose
the spinal cord under the vertebral levels T13 and
L1. Injections took place using micro-glass pipettes
(50-100um tip width). AAV5-CMV-Cre and AAV-DJ-
hSyn-Flex-mGFP-2A-synaptophysin-mRuby were co-
injected into the spinal cord at 6 sites on each side,
using the following coordinates : 1mm anteroposte-
rior spacing, 0.65mm lateral from midline and -0.8
dorsoventral from the cord surface. 250nL were in-
jected per site at 3nL per second and 2 minutes
were respected before careful withdrawal of the glass
pipette. At the end of the procedure, the muscle fas-
cia (5.0 Vycril) and the skin (4.0 Ethilon) were sutured
in layers.
3.5.4 ACUTE ELECTROPHYSIOLOGY
SENSORY EVOKED POTENTIALS
Terminal electrophysiological assessments were carried
out in naive rats. Brieﬂy, animals were anesthetized
with urethane (1.5 g/kg; i.p.) and core body tem-
perature was maintained at 37°C. A craniotomy was
drilled over the motor cortex as described under 3.5.3
and laminectomies were performed to expose the tho-
racic levels T8, T10 and T12. A hindlimb incision
was performed on the contralateral side to the cran-
iotomy ; the sciatic nerve was isolated, punctured with
a silver needle electrode and sectioned below the site
of stimulation. The dura was then removed on all
CNS exposed sites and tissues were protected using
mineral oil. For spinal stimulation, a tungsten con-
centric electrode was positioned intraspinally on the
level of interest. A silver ball electrode was used to
record any evoked activity from the surface of the mo-
tor cortex or from the dorsal spinal cord. Sciatic nerve
stimulation was performed using a silver needle elec-
trode. Healthy recordings were obtained, followed by
a T10 complete crush SCI (performed as described
under 3.5.3) and a repetition of the evoked potentials
in acute post-lesional conditions. Stimulation was de-
livered in 200 μs square wave pulses at the maximum
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amplitude possible before large motor responses were
evoked (typically between 600 μA and 800 μA) and at
a frequency of 0.75 Hz using a STG 4004 stimulus gen-
erator (Multi Channel Systems). Evoked activity was
ampliﬁed and recorded using an A-M systems diﬀeren-
tial ampliﬁer, PowerLab and LabChart Pro acquisition
and analysis system (AD Instruments). For analysis,
30 traces from each recording site were averaged and
the peak to peak amplitude of the evoked potential
was quantiﬁed.
ACUTE THALAMO-CORTICAL RECRUITMENT
Eight weeks after AAV-ChR2 injection (see 3.5.2),
acute electrophysiological assessments were performed
to assess the feasibility of recruiting thalamocorti-
cal projections optogenetically. Animals were anes-
thetized with urethane (1.5 g/kg; i.p.) and core body
temperature was maintained at 37°C. An optic ﬁber
was implanted on the rostral thalamus as described
under 3.5.3 and ﬁxed using dental cement. The ip-
silateral motor cortex was re-exposed and the dura
mater was removed. A silver ball electrode was used
to record evoked activity from the surface of the mo-
tor cortex. Motor thalamic optic stimulation was per-
formed using an optic cable transmitting pulses from a
blue laser (Laserglow, 473 nm Blue DPSS Laser Sys-
tem) to the implanted ﬁber. Intensity of the stim-
uli is estimated to range from 35 to 50 mW/mm2.
Laser pulses were provided by an external stimulator
(A-M Systems) to enable precise control of stimula-
tion parameters. Recordings were obtained in healthy
conditions, before a T10 complete crush SCI was per-
formed (see 3.5.3). Thalamus optogenetic stimuli and
cortex surface recordings were then repeated in acute
post-lesional conditions.
3.5.5 HISTOLOGY & IMMUNOHISTOCHEM-
ISTRY
After terminal anesthesia by barbiturate overdose, rats
were perfused transcardially with 4% paraformalde-
hyde and the CNS was retrieved and processed for
immunoﬂuorescence. Primary antibodies were: rabbit
anti-GFAP (1:2000; Dako, Santa Clara, CA); guinea-
pig anti-NeuN (1:100, Millipore, Burlington, MA);
chicken anti-GFP (1:500, Abcam, Cambridge, MA).
Fluorescence secondary antibodies were conjugated
to: Alexa 488 (green), 555 (red) or 647 (far red)
(Molecular Probes). Nuclear stain was added using
4’,6’-diamidino-2-phenylindole dihydrochloride (DAPI;
2ng/ml; Molecular Probes). Sections were cover-
slipped using Mowiol mounting medium (Sigma, Saint
Louis, MO). Tiled scans of individual whole sections
were prepared using a x20 objective and the scan-
ning function of a Leica Aperio Versa 200 Microscope
(Leica, Wetzlar, Germany). Sections were examined
and photographed using deconvolution ﬂuorescence
microscopy and scanning confocal laser microscopy
(Zeiss, Oberkochen, Germany).
3.5.6 CLARITY AND 3D-IMAGE ACQUISI-
TION
Rats were perfused with 4% paraformaldehyde and tis-
sue was postﬁxed overnight. CLARITY was then ap-
plied to clear the tissue. Brain hemispheres were incu-
bated for 2 days at 4°C in bis-free acrylamide solution
with 4% paraformaldehyde. Nitrogen gas was ﬂushed
in the incubation tubes for 5 seconds to remove oxy-
gen, and the containing tube was incubated in a 37°C
water bath until polymerization (ca. 3 hours). The
gel was processed and tissue was immersed in a clear-
ing solution for 4 days, with daily medium exchange.
Samples were then rinsed with PBS (0.1M) and tri-
ton (0.1%) overnight and incubated in Histodenz for
24 hours. Imaging ﬁnally took place using a custom-
made light-sheet ﬂuorescence microscope.
3.5.7 NEUROREHABILITATION PROCE-
DURE
After spinal cord injury, rats recovered for 7 days be-
fore neurorehabilitation began. Locomotor neurore-
habilitation was conducted bipedally on a treadmill
with vertical robotic support. Standing and step-
ping enabling agents were used as facilitators, com-
bining epidural L2 and S1 tonic stimulation and the
pharmacological association of quipazine (5-HT2A/C,
0.2-0.3 mg/kg) and 8-OH-DPAT (5-HT1A/7, 0.05-
0.2mg/kg). The task was performed on a daily basis
for approximately 30 minutes per day, over a period of
2 weeks. Epidural stimulation was delivered tonically
at 40 Hz with a pulse duration of 0.2ms, injecting an
intensity of current chosen individually for each ani-
mal depending on the observed muscle twitch tresh-
olds (ca. 100-300uA). The animal was restrained in a
comfortable harness that was attached to a half-tube
at one end of the body weight support device.
3.5.8 BEHAVIORAL & NEUROPHYSIOLOGI-
CAL ASSESSMENTS
Combined recordings of EMG activity, TDT neural
activity and locomotion were conducted in two con-
ditions. Quadrupedal locomotion was recorded on a
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treadmill (ca. 16cm/s speed) in healthy conditions
prior to injury, in order to obtain baseline cortical ac-
tivity and establish behavioral and neurophysiological
eﬀects of motor thalamic stimulation. A system of 12
infrared cameras (Vicon motion analysis) was used to
record the motor task. Retro-reﬂective markers were
placed on the relevant joins (iliac crest, hip, knee,
tarse, toe) to enable locomotion tracking and correlate
neural activity with gait events. Similar assessments
were performed at the end of the neurorehabilitation
period (see 3.5.7) and automated bipedal locomotion
was recorded on a treadmill, pharmacologically en-
abled with quipazine (5-HT2A/C, 0.2-0.3 mg/kg) and
8-OH-DPAT (5-HT1A/7, 0.05-0.2mg/kg). Compli-
mentary L2-S1 tonic stimulation (40Hz, 0.2ms, 100-
300uA) was delivered. Neural data and EMG activ-
ity were acquired in concomitance, and optic thala-
mus stimulation was delivered following relevant pat-
terns of stimulation. Cortical activity was acquired
as intracortical voltage signals sampled at 24 kHz,
pre-ampliﬁed, digitalized and ﬁltered using a real-time
BioAmp processor (Tucker-Davis Technologies, USA).
EMG signals and Laser ﬁring activity were recorded as
analogic events, together with neural data.
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4.1 ABSTRACT
Propriospinal axon regeneration across complete spinal cord injuries does not promote recov-
ery of function by itself. In addition to our exploration of somatosensory feedback to the
motor cortex, we propose here to investigate other descending tracts on a regenerative as-
pect. Diﬀerent tracts have been shown to reorganize in diﬀerent models of incomplete SCI,
so that corticospinal projections are able to reach for new relays, either at a spinal level,
or in the brainstem. we hypothesize that regenerating reticulospinal ﬁbers, in addition to
propriospinal axons, would enhance the conduction of motor commands to the lumbosacral
circuits by providing a second possibility of relay for the corticospinal tract. Indeed, recent
evidence demonstrated that neuroprosthetic rehabilitation causes the motor cortex to recruit
spared reticulospinal projections as descending relays after severe spinal contusion. Based on
our mechanistic understanding of propriospinal axon regeneration, we ﬁrst combined lesion
core manipulation with mTOR activation to achieve reticulospinal axon regrowth. We docu-
mented limited, yet signiﬁcant reticulospinal regeneration into the SCI site. As neuroprosthetic
training was shown to promote reticulospinal neurite extension, we next tested wether chronic
activity by itself can recruit neuronal growth programs in the brainstem after complete SCI. We
aimed at activating the CREB and MAPK pathways by either i) evoking activity in the reticular
formation using optogenetics or ii) enhancing intracellular cAMP levels with viral DREADD
technology. The growth permissive matrix was densiﬁed within the lesion core using a combi-
nation of EGF and FGF. BDNF and GDNF were associated as guidance cues. As reticulospinal
axon regrowth could not be observed following activity-based modulation, signiﬁcant sprout-
ing of reticulospinal ﬁbers was obtained into the healthy grey matter located above the injury.
These observations suggest that requirements and/or facilitators for sprouting and regrowth
are distinct in reticulospinal neurons. Independent identiﬁcation of the mechanisms underlying
sprouting and axon regrowth will be necessary in order to reinforce downstream conduction of
information across complete SCI.
PERSONAL CONTRIBUTIONS
In this study, I - Sabry L. Barlatey - designed experiments and piloted the feasibility of the
project. I performed stereotaxic brainstem injections, implanted optic ﬁbers for optogenetic
modulation, and performed surgical spinal cord injuries. I designed and contributed to be-
havioral assessments. I processed CNS tissue, performed histological analyses, acquired mi-
croscopy images and quantiﬁed axon regeneration. I wrote the chapter presented here below
and conceived the ﬁgures.
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4.2 INTRODUCTION
REINFORCING BRAINSTEM CONTROL ACROSS COM-
PLETE SCIs
Spinal neuromodulation and rehabilitation have been able to promote functional beneﬁts after
incomplete spinal cord injury in both rodents (Asboth et al., 2018; van den Brand et al., 2012)
and humans (Angeli et al., 2018; Wagner et al., 2018). After incomplete spinal cord injury,
sprouting of spared axons supports re-establishment of downstream control over lumbosacral
circuits. The extend and location of spare tracts relies on the model of injury. Indeed, a sig-
niﬁcant population of propriospinal neurons remains spared in a staggered double-hemisection
model, and their recruitment and reorganization contribute to functional recovery (van den
Brand et al., 2012; Courtine et al., 2008). In both the staggered double-hemisection and
the dorsal contusion models, brainstem neuronal relays undergo neurorehabilitation-induced
plasticity. During neuroprosthetic training in the staggered double-hemisection model, part of
the supraspinal motor control reaches for spared and reorganizing propriospinal neurons via
serotoninergic brainstem neurons (van den Brand et al., 2012). With a dorsal spinal contusion,
some extent of reticulospinal glutamatergic control located ventrolaterally in the spinal cord
remains spared and sprouts both above and below the injury during neurorehabilitation (Asboth
et al., 2018). However and after complete crush SCI, whereas our recent work enabled the
restoration of a robust propriospinal bridge across the lesion (Anderson et al., 2018), no spon-
taneous recovery of hindlimb movements could be observed. Therefore, we hypothesize that
reinforcing downstream control across complete injuries with brainstem-derived axon regrowth
may facilitate the conduction of motor commands to lumbosacral circuits. Complimentary
neurorehabilitation may then promote reticulospinal sprouting both above and below the crush
injury, promoting interactions with regenerated propriospinal neurons to encourage coherent
motor control as described in the dorsal contusion model (Asboth et al., 2018).
Evidence has been gathered that diﬀerent axonal tracts respond to diﬀerent growth program
activators (He and Jin, 2016). As corticospinal, propriospinal and alpha-retinal-ganglial axons
have been demonstrated to regrow when mTOR signaling is upregulated (Ozdinler and Macklis,
2006; Liu et al., 2017; Anderson et al., 2018; Duan et al., 2015) no such manipulation has yet
been experimented on brainstem-spinal structures to our knowledge. So far, intrinsic growth
programs in reticulospinal neurons have been suggested to respond to the activity-related
signaling pathway cAMP-CREB (Lu et al., 2012a). The role of CREB signaling in neurons has
been extensively studied for its sensitivity to activity and neurotrophins, and for its implication
in neurite outgrowth (Moore and Goldberg, 2011). Indeed, deﬁciencies for CREB were shown
both in vitro and in vivo to decrease neurite growth in both peripheral (Lonze et al., 2002) and
cortical neurons (Redmond et al., 2002). Additionally, increasing CREB activity was shown
to enhance sensory axon regeneration after dorsal column lesion (Gao et al., 2004). Exploring
activity-related signaling in sensory neurons, CREB activation was shown to respond to cAMP
elevation induced by electrical activity (Fields et al., 1997). Interestingly, CREB downstream
signaling includes transcription of the neurotrophin-gene bdnf (Moore and Goldberg, 2011).
Among other interesting signaling cascades, alterations in the MAPK signaling have been
demonstrated after injury to the visual system (Belin et al., 2015), while the MAPK cascade
is involved in neuronal survival and axonal growth after lesion (He and Jin, 2016). Further,
MAPK was shown in vitro to be recruited by electrical activity together with CREB (Fields
et al., 1997), based on cAMP and Protein kinase A (PKA) signaling (Waltereit and Weller,
2003).
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Figure 4.1: Neuroprosthetic training induces reticulospinal sprouting and functional recovery. Neu-
ronal activity promoted by neuroprosthetic rehabilitation has been shown to induce sprouting from spared
axon tracts, e.g. reticulospinal projections in a model of dorsal contusion. We hypothesize that reticulospinal
neurites fail to penetrate the injured site in spite of activity, due to the lack of a permissive extracellular matrix
and guidance. By remodeling the injured site and providing axon guidance, we further hypothesize that chronic
activity may allow reticulospinal projections to grow into the lesion core, by activating sprouting and/or axon
growth programs.
As much as growth-related signaling varies from a tract to another, axon guidance appears
to be tract-dependent. Only little evidence of reliable cues or molecular agents has been
gathered in order to provide reticulospinal axons with guidance. Combined to brainstem
activation of CREB signaling with a single cAMP injection, reticulospinal ﬁbers were shown to
regrow into a mesenchymal graft on a BDNF-dependant manner (Lu et al., 2012b). Further,
combined delivery of BDNF and NT-3 within the lesion - in addition to Schwann cell grafting
- was proposed as a robust distant activator of brainstem-originating axons Xu et al. (1995b).
Additionally, GDNF delivered at the SCI site was suggested to reduce die-back from the reticular
formation (Dolbeare and Houle, 2003). We propose here to explore reticulospinal regeneration
by applying a multi-pronged regenerative approach that combines i) upregulation of intrinsic
reticulospinal growth programs, ii) lesion site remodeling iii) axon guidance. As previously
described, we propose to remodel the SCI site using a combination of EGF and FGF, in order
to enhance permissive extracellular matrix components within the injury. Based on previous
work, we chose to combine the neurotrophins BDNF and GDNF as chemoattractants within
the lesion site. In order to activate axon growth programs, we investigated a virus-based mTOR
upregulation that was previously shown to generate robust regeneration in other severed tracts.
Finally, due to the sprouting induce by neurorehabilitation, we explored neuronal activity and
camp-dependent signaling as potential candidates for intrinsic growth activation (Fig 4.1).
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4.3 RESULTS
SIGNALING DIFFERS BETWEEN SPROUTING AND
AXON REGROWTH REGENERATION
4.3.1 LOW RETICULOSPINAL RESPONSE TO mTOR SIGNALING
As a ﬁrst reticulospinal manipulation, we tested wether combined mTOR and Jak-STAT acti-
vation using the viral association [AAV-IGF1, AAV-CNTF and AAV-OPN] can yield robust axon
regrowth of the reticulospinal system into complete SCI sites. Two weeks prior to injury, we
co-injected IGF1-CNTF-OPN into the gigantocellular reticular nuclei (vGI) in wild-type mice.
The animals then received an anatomically complete crush spinal cord injury that wholly in-
terrupts descending axon tracts. In order to support axon regeneration at the SCI level, we
primed lesion core remodeling on the second day post-injury using EGF and FGF embedded in
biocompatible Dicopolypeptide Hdrogel (DCH). This growth factor association was previously
shown to enhance laminins within the injured site, as a requirement for propriospinal axon
regeneration (see 2). In order to attract potential regenerating axons into the lesion, BDNF
and GDNF were added as chemoattractant molecules to the DCH hydrogel, together with the
molecular remodeling association of EGF and FGF (Fig 4.2d).
As we sought here to identify the requirements for reticulospinal growth, we did not add
any chemoattractant below the injury. Nevertheless, the described multi-pronged strategy
did induce some extent of reticulospinal regrowth into the lesion core, which did not extend
beyond the caudal SCI border due to the absence of caudal chemotropic guidance (Fig 4.2a-b).
However, even though the obtained regeneration is signiﬁcant, we estimate that the density
of axons that penetrate the lesion core remains too sparse to support any functional beneﬁt.
Indeed, the absolute number of axons crossing the lesion center was ten folds lower that the
propriospinal regrowth obtained with the same strategy (Fig 4.2c). This anatomical experiment
study suggests that IGF-1/CNTF/OPN recruits part of the intracellular signaling required for
reticulospinal axon regrowth. However, proper intracellular targets will need to be identiﬁed
in order to promote dense reticulospinal regeneration across complete SCIs.
4.3.2 DREADD-INDUCED cAMP ELEVATION FAILS TO INDUCE RETIC-
ULOSPINAL AXON REGROWTH
Previous evidence suggests that a single cAMP injection on its own recruits reticulospinal
axon growth programs after spinal cord injury (Lu et al., 2012b). However, concomitant
guidance with BDNF was provided in this study by genetically-modiﬁed mesenchymal cells.
In order to exclude side-contributions from the graft, we aimed at reproducing similar axon
regeneration using molecular and controlled axon guidance, together with SCI remodeling. On
day-2 following complete crush spinal cord injury, vGLUT2-Cre mice received an intralesional
depot of EGF, FGF, GDNF and BDNF, embedded in DCH hydrogel (Fig 4.3d). As described
under 4.3.1, EGF/FGF aimed at densifying the permissive extracellular matrix within the lesion
core, while BDNF and GDNF were used as reticulospinal guidance cues. In order to promote
sustained and chronic cAMP elevation in glutamatergic reticulospinal neurons, the clozapine-
N-O (CNO) dependent virus AAV5-hsyn-DIO-rM3Ds-mCherry virus was injected into the vGI
two weeks before SCI (Fig 4.3a). Such DREADD (designer receptors exclusively activated by
designer drug) Gs-protein-targeted virus was previously shown to enhance intracellular cAMP
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Figure 4.2: IGF1-CNTF-Osteopontin induce signiﬁcant, yet insuﬃcient axon regrowth after com-
plete crush spinal cord injury. A, Tile scans showing descending reticulospinal axons (red) labelled with non-Cre-dependant
AAV-RFP and astroglial GFAP (cyan) to delimit the lesion core. A1. Complete absence of reticulospinal regeneration in a con-
trol crush spinal cord injury, after lesion remodeling with EGF/FGF and axon guidance with BDNF/GDNF, but without growth
program induction. A2. Tile Scan showing limited, yet signiﬁcant reticulospinal regeneration when AAV-IGF1-CNTF-OPN is
added to lesion remodelling and axon guidance. B. 10x magniﬁcation of the regenerated reticulospinal axons into the lesion core.
Viral tracing of reticulospinal ﬁbers with ubiquitous AAV5-RFP, immunostaining for GFAP (cyan). C. [Left] Quantiﬁcation of
regenerated axons that cross the lesion center (absolut number of axons). [Right] Direct comparison of regenerated propriospinal
and reticulospinal axons with IGF1-CNTF-OPN overexpression, showing insuﬃcient regrowth from reticulospinals. ***P<0.0001,
one-way ANOVA with Bonferroni. D. ExperimentaI design. AAV-IGF1-CNTF-OPN were co-injected into the reticular formation
without Cre-dependance to upregulate mTOR and Jak-STAT signaling. EGF/FGF were used as lesion remodelling agents and
BDNF/GDNF were added as guidance cues.
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levels and signaling (Ferguson et al., 2013). As a pharmacological enhancement of electrical
activity-like signaling, CNO was given twice daily to recruit the DREADD-Gs pathway.
Conversely to previously published work, we did not obtain any reticulospinal axon regrowth
with DREADD-induced cAMP elevation (Fig 4.3b-c). However, limitations reside in the
mCherry reporter added to the viral construct, which is known for being of poor ﬂuorescent
intensity and of poor reliability. Proper injection and activation of the DREADD-Gs virus could
not be conﬁrmed, in spite of immunohistochemical enhancement of mCherry. Nevertheless,
additional tracing of the reticular formation with Biotin-Dextran-Amine (BDA) conﬁrmed the
absence of regenerative eﬀects, that we impute to a deﬁcient activation of growth programs.
4.3.3 CHRONIC ACTIVITY FAILS TO INDUCE RETICULOSPINAL AXON
REGROWTH
Viral and pharmacological elevation of cAMP fails to promote reticulospinal axon regrowth.
In a context of neuroprosthetic rehabilitation, activity was shown to promote reticulospinal
sprouting (Asboth et al., 2018). Therefore, we further tested the hypothesis that intracellular
mechanisms may be shared between axon regrowth and sprouting when proper lesion remod-
eling and axon guidance are provided. To do so and to activate activity signaling that may
be camp-independent, we replaced the previous DREADD-rM3Ds modulation with chronic
stimulation of the reticular formation using optogenetics. Transgenic mice expressing Chan-
nelrhodopsin2 under the neuronal promoter Thy1 (Thy1-ChR2) were implanted two weeks
before injury with a single midline optic ﬁber to co-activate both vGI nuclei in the reticular
formation (Fig 4.4a). The Thy1 genetic background was chosen due to the abundant Thy1
expression from neuronal structures involved in motor functions. Stimulation parameters where
chosen based on a previously established pattern in vitro, which demonstrated that 10Hz ac-
tion potentials induce intracellular cAMP elevation in sensory neurons, as well as CREB and
MAPK upregulation (Fields et al., 1997). Before injury, baseline recordings of optogenetically
evoked motor responses were obtained and showed tonic hindlimb extension correlated with
the trains of stimulation (Fig 4.4b). The animals were then injured with a complete thoracic
T10 crush SCI. As mentioned above, mice received a depot of EGF/FGF on the second day
post-injury, that was supplemented with BDNF and GDNF as reticulospinal chemoattractants.
After injury, chronic vGI stimulation was conducted for four weeks on a daily basis, as two
sessions of 90 minutes per day [10Hz, 5ms pulses, 5-seconds-ON / 5-seconds-OFF].
As expected, terminal recordings of optogenetically evoked motor responses showed in all
animals that the lesions remain functionally complete in spite of chronic vGI stimulation (Fig
4.4c). Reticulospinal tracing with AAV2/5-RFP revealed that chronic stimulation, together
with lesion remodeling and axon guidance, fails to induce regrowth into the lesion core (Fig
4.4d, Fig 4.5d).
4.3.4 CHRONIC ACTIVITY RESCUES RETICULOSPINAL PROJECTIONS
ABOVE THE LESION
In order to establish that sprouting and axon regeneration rely on distinct mechanisms, we
evaluated the density of reticulospinal projections at a cervical level. Reticulospinal projections
to the grey matter were quantiﬁed over the cervical C6 to C9 segments and compared between
i) the vGI-stimulated group, ii) healthy control mice, and iii) crush injury control animals traced
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Figure 4.3: Chronic cAMP elevation fails to recruit growth programs in spite of lesion remodeling
and axon guidance. A. ExperimentaI design. DREADD viral vectors were administered in vGlut2-Cre mice to induce
selective expression of the protein Gs-dependant receptor rM3Ds in glutamatergic neurons. Clozapine-N-O was given twice daily
to activate the rM3Ds receptor, induce intracellular cAMP elevation, and upregulate the cAMP downstream signaling. EGF/FGF
were administered into the injury to remodel the complete crush lesion, supplemented with BDNF and GDNF for reticulospinal
axon guidance. B. Quantiﬁcation of regenerated axons that cross the lesion center (absolut number of axons), showing no
signiﬁcant regrowth with pharmacological cAMP elevation. One-way ANOVA with Bonferroni. C. Tile scans showing descending
reticulospinal axons labelled with Biotin Dextran Amine and revealed in Cy3 (red), together with an immunohistochemical
revelation for astroglial GFAP (cyan) to delimit the lesion core. C1. Complete absence of reticulospinal regeneration in a control
crush spinal cord injury, after lesion remodelling with EGF/FGF and axon guidance with BDNF/GDNF, but without cAMP
elevation. C2. Tile Scan showing no reticulospinal regeneration in spite of chronic cAMP elevation, lesion remodelling and axon
guidance. D. 10x magniﬁcation of the lesion core, showing no axon regrowth but a clear rest of the molecular depot.
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Figure 4.4: Optogenetic targeting of the reticular formation recruits motor circuits, but fails to
induce reticulospinal regrowth after complete SCI. A. ExperimentaI design. Mice expressing Channelrhodopsin2
constitutively under the Thy-1 neuronal promoter were implanted with an optic ﬁber on the vGI nuclei. Chronic optic stimulation
was delivered on a daily basis to recruit activity-driven signaling. EGF/FGF were administered into the injury to remodel the
complete crush lesion, supplemented with BDNF and GDNF for reticulospinal axon guidance. B. Pre-SCI evoked motor responses.
Trains of stimulation provoke tonic bilateral extension in the hindlimbs. C. At 4 weeks post-injury and after chronic stimulation
in the vGI, optic stimulation does not evoke motor responses in the hindlimbs. D. Tile scans showing descending reticulospinal
axons traced with an ubiquitous AAV2/5-RFP viral vector (red), together astroglial GFAP (cyan) revealed immunohistochemically
to delimit the lesion core. D1. Complete absence of reticulospinal regeneration in a control crush spinal cord injury, after lesion
remodeling and axon guidance, but without vGI stimulation. D2. Tile Scan showing no reticulospinal regeneration in spite of
chronic optogenetic stimulation in the reticular formation, lesion remodelling and axon guidance.
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Figure 4.5: Chronic stimulation in the reticular formation rescues reticulospinal projections to the
grey matter above the lesion. A. Schematic showing the quantiﬁcation method for sprouting or neurite protection.
Transverse sections were taken from C6 to C9 and reticulospinal coverage was quantiﬁed as a percentage of the grey matter
expressing the RFP. B. Representative histologic sections from the vGI-stimulated group [left], the injured control group [middle]
and the healthy control group [right] showing RFP-labelled reticulospinal axons (red), counterstained with nucleus-labelling Dapi
(blue) for grey matter delimitation. Black/white sections depict the used thresholding for RFP measurements. C. Quantiﬁcation
of reticulospinal coverage in the grey matter, cumulated from C6 to C9, showing an increased density of reticulospinal projections
in vGI stimulated animals, compared to injured controls. One-way ANOVA with Bonferroni. D. Quantiﬁcation of regenerated
axons that cross the lesion center (absolut number of axons), showing no signiﬁcant regrowth with chronic vGI stimulation.
One-way ANOVA with Bonferroni.
for reticulospinal axons with AAV2/5-RFP (Fig 4.5a-b). As reticulospinal projections into the
grey matter were strongly reduced above the injured level in the injured control group, chronic
vGI stimulation exhibited a signiﬁcantly higher aﬀerentation from reticulospinal axons at a
cervical level. This anatomical data suggests that chronic activity either recruits sprouting or
regenerative sprouting programs, or exerts a protective eﬀect on neurites after axotomy (Fig
4.5c).
4.4 DISCUSSION
DISSOCIATED PATHWAYS FOR SPROUTING AND AXON
REGROWTH
Axon regrowth after spinal cord injury has now been established as a problem of multiple vari-
ables that requires i) proper intrinsic activation of growth programs, ii) adequate remodeling
of the SCI lesion core and iii) speciﬁc axon guidance (see 2 and Anderson et al., 2018). In
order to focus our eﬀort on intrinsic induction of growth, we chose here to apply lesion remod-
eling with EGF/FGF and chemoattraction with BDNF/GDNF, and consider these strategies
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as established. In this context, over-expression of IGF1-CNTF-Osteopontin were able to in-
duce some extent of regrowth into the SCI site, suggesting that EGF/FGF and BDNF/GDNF
are able to act as reliable manipulations to play their respective role. A concern arises when
regrowth is compared between reticulo- and propriospinal axon with lesion remodeling and
guidance only. Indeed, and in the absence of any external upregulation of growth programs,
laminin densiﬁcation and chemoattraction induce a low but signiﬁcant extent of propriospinal
regrowth into the lesion core (Fig 2.1c). No similar anatomical beneﬁt could be obtained
from the reticulospinal system. This suggests that either i) optimal extracellular substrates for
regrowth diﬀer between axon types, so that EGF/FGF induce a semi-permissive environment
for reticulospinal axons that can be reﬁned, or ii) BDNF/GDNF is a suboptimal combination
of reticulospinal guidance cues. The second option appears more likely, as laminin exerts con-
served eﬀects over neuron survival and/or neurite support between diﬀerent types of neurons
(Plantman et al., 2008; Anderson et al., 2018; Hall et al., 2008). On the other hand and
based on developmental studies, guidance and repulsion mechanisms to vary between neuronal
subtypes, in order to form distinct axonal tracts.
Similarly to axon guidance, intrinsic growth programs are known to be neuron subtype-
dependent, so that speciﬁc and targeted signaling will be required to induce axon regrowth
(He and Jin, 2016). Activating the mTOR pathway only by silencing PTEN has yielded ro-
bust regeneration of the corticospinal tract (Zukor et al., 2013; Liu et al., 2010), but failed
to induce propriospinal axon regrowth (Anderson et al., 2018). The beneﬁt of using IGF1-
CNTF-Osteopontin co-expression relies on the co-activation of diﬀerent regenerative pathways,
including mTOR and Jak-STAT. Our data in the present chapter suggests that signaling in-
duced by IGF1-CNTF-Osteopontin likely recruits axon growth programs via cross-talks with
other intracellular cascades. mRNA analysis of the exact intracellular modulations produced
by these three growth factors in the reticular formation may be interesting, in order to identify
overlaps with other growth-relevant pathways that can subsequently be explored. As another
option, mRNA sequencing of the developing reticular formation during axogenesis can provide
candidate intracellular cascades to recruit after injury. However, signaling requirements may
diﬀer between fetal development and post-lesional regeneration.
Our exploration of neuronal activity as a potential neurite growth inductor was motivated by
recent work from our laboratory that associated reticulospinal sprouting to volitional motor
training (Asboth et al., 2018). As a ﬁrst insight, our results suggest that cAMP-signaling
alone fails to induce axon regrowth in reticulospinal neurons, in spite of lesion remodeling and
axon guidance that promote low but signiﬁcant regeneration with IGF1-CNTF-Osteopontin
overexpression. However, these ﬁndings remain non-conclusive, due to a limited reliability
of the mCherry ﬂuorescent reporter, that prevented us to conﬁrm robust activation of the
DREADD-cAMP virus with Clozapine-N-O.
cAMP levels are known to be enhanced by electrical activity (Fields et al., 1997), but neuronal
ﬁring may as well recruit other molecular pathways involved in neurite extension. Optogenetic
activation of the reticular formation evoked robust neuronal activity that was conﬁrmed with
kinematic recordings. One could argue that Thy1-ChR2 mice express Channelrhodopsin2 in
the corticospinal tract located close below the reticular formation, in a range that our optic
implant may stimulate. Nevertheless, activation of the corticospinal tract would also recruit
cortical projections to the reticular formation. Such a mechanism would induce neuronal ac-
tivity at the desired location, in a manner that mimics volitional neurorehabilitation on the
reticulospinal tract. As an experimental limitation, intracellular signaling may vary between
direct optogenetically-induced depolarization or synaptic neuronal activation. Nevertheless and
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in spite of chronic activity, the regenerative failure observed in the lesion core demonstrates that
neuronal ﬁring induces intracellular signaling that is not a key determinant for reticulospinal
axon regrowth. Considering published evidence, these pathways include camp-dependent cas-
cades (Fields et al., 1997). Interestingly, previous work demonstrated axon regrowth with a
single injection of cAMP into the reticular formation (Lu et al., 2012a). However, this study
combined cAMP signaling with mesenchymal cell grafting that secreted BDNF in the lesion
cavity, involving a mechanistic bias that currently suggests pro-regenerative eﬀects from the
graft.
As chronic activity rescued reticulospinal projections to supralesional segments of the spinal
cord, diﬀerent mechanisms may be involved. Activity may either i) protect reticulospinal
neurites in axotomized neurons, ii) induce proper sprouting in axotomized neurons, or iii)
activate neurite extension programs in intact reticulospinal neurons that reach for segments
located above the injury. This last possibility prevents the deﬁnitive conclusion that sprouting
programs or neurite-protective programs diﬀer from axon regrowth signaling. Labelling severed
reticulospinal axons selectively with a Cre-Flex viral combination and repeating our chronic
activity experiment could determine the anatomical mechanism that underlies neurite rescue.
At an intracellular level and as neuroprosthetic rehabilitation is known to induce reticulospinal
sprouting, mRNA sequencing applied in an incomplete model of SCI after volitional motor
training would provide candidate pathways that can be explored and modulated in the future.
Section 4.5 Chapter 4 Page 83
4.5 MATERIALS AND METHODS
4.5.1 ANIMALS
B6 mice were involved in the described experiments in
accordance with the swiss veterinary legislation ap-
plied in Vaud and Geneva. Local veterinary com-
mittees accredited the experiments under Licenses
#VD2771 and #GE28/17. All wild-type B6 mice
were obtained from Charles River [Les Oncins, Saint
Germain sur l’Arbresle, France]. Transgenic mice line
were obtained from the Jackson Laboratory [Bar Har-
bor, ME, USA] and bred in our own animal facilities
in Lausanne and Geneva.
4.5.2 ADMINISTERED MOLECULES AND
VIRUSES
DREADD VIRUSES & CNO-MEDIATED ACTIVA-
TION
Adeno-Associated Viral (AAV) vectors were used
to induce selective expression of the Gs-coupled
rM3Ds receptor : neurotropic rAAV5-hsyn-DIO-
rM3Ds-mCherry [10^12vg/mL, Addgene] was injected
for intracellular cAMP elevation into the vGI nucleus
of B6.vGlut2-Cre mice. The mCherry reporter was
meant to label in red ﬂuorescence the successfully in-
fected neurons. Bilateral injections were performed in
the vGI nuclei [AP -5.6, -5.8 / ML +0.3, -0.3 / DV
-5.6, 200nL per site]. Activation of the DREADD re-
ceptor was conducted with intraperitoneal injections
of Clozapine-N-O, prepared in NaCl 0.9% (5mg/mL),
twice daily (0.03mL i.p.).
TRACING VIRUSES AND DYES
The neurotropic AAV2/5-CAG-RFP [1x10^13vg/mL,
University of Pennsylvania Vector Core] Adeno-
Associated Viral (AAV) vector was used to antero-
gradely label reticulospinal axons. Bilateral injections
were performed in the vGI nuclei [AP -5.6, -5.8 / ML
+0.3, -0.3 / DV -5.6, 200nL per site]. Axons appear
in ﬂuorescent red during anatomical analysis. Alterna-
tively, biotinylated dextran amine (BDA, 10’000MW,
Invitrogen) was used as a non-viral tracer. BDA was
prepared as a 10% solution in sterile NaCL and in-
jected into the vGI nuclei [AP -5.6, -5.8 / ML +0.3,
-0.3 / DV -5.6, 400nL per site]. During tissue anal-
ysis, BDA was enhanced and revealed by conjugation
with ﬂuorescent dyes.
VIRAL EXPRESSION OF GROWTH FACTORS
Three diﬀerent Adeno-Associated Viral vectors (AAV)
were combined to express the growth factors Os-
teopontin (OPN), IGF1 and CNTF (AAV2/9-OPN:
1x10^13 gc/ml; AAV2/9-IGF-1: 5x10^12 gc/ml;
AAV2/9-CNTF: 5x10^12 gc/ml, kindly provided by
Professor Zhigang He’s group, Harvard). The viral as-
sociation (1:1:1) was injected into the vGI nuclei [AP
-5.6, -5.8 / ML +0.3, -0.3 / DV -5.6, 200nL per site]
in wild-type mice. This combination has been shown
to recruit axon growth programs that rely on mTOR
and Jak-STAT upregulation.
HYDROGEL DEPOT WITH GROWTH FACTORS
AND GUIDANCE CUES
For sustained delivery, growth factors and guidance
cues were embedded in a biocompatible hydrogel. Bio-
material depots were prepared using well characterized
diblock copolypeptide hydrogels (DCH) that are CNS
biocompatible, biodegrade over several weeks in vivo
and provide prolonged delivery of bioactive growth fac-
tors in CNS tissue for two or more weeks after in-
jection. Diblock copolypeptide hydrogel (kindly pro-
vided by Pofessor Deming’s group, UCLA) was loaded
with growth factors and guidance molecules. Cargo
molecules were as follows: Human recombinant FGF2,
EGF, BDNF and GDNF (PeproTech, Rocky Hill, NJ).
Freeze dried DCH powder was reconstituted to 3.0%
or 3.5% wt/vol in sterile PBS with a combination of
FGF2 (1.0μg/μl), EGF (1.0μg/μl), BDNF (1.0μg/μl)
and GDNF (1.0μg/μl). The combined biomaterial
with cargo was then injected into the SCI lesion core
[DV -0.6, 1uL] as a single site depot.
4.5.3 SURGERIES
CRUSH SPINAL CORD INJURY
Mice were maintained under anesthesia with Isoﬂu-
rane and Ketamine. A dorsal midline incision was per-
formed and muscles were carefully detached to access
the posterior aspects of the spine. Using a surgical
microscope (Zeiss, Oberkochen, Germany), the infe-
rior interspinous ligament was removed with n°5 Du-
mont forceps (Fine Science Tools, Foster City, CA)
at the targeted thoracic level (T8 or T10). A com-
plete laminectomy was performed with n°2 forceps
(Fine Science Tools, Foster City, CA) and the cord
was laterally compressed for ﬁve seconds using tweez-
ers with a tip width of 0.5mm. For SCI site labelling,
the mice were then suspended in a rodent stereotaxic
frame (David Kopf, Tujunga, CA) and 100nL of dark
dye was microinjected using glass pipettes (50-100um
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tip width) controlled by micro-infusion pumps. The
back muscles and skin were ﬁnally closed with respec-
tively resorbable 6-0 and non-resorbable 6-0 sutures.
SCI REMODELING AND AXON GUIDANCE
A single depot of DCH-EGF/FGF/BDNF/GDNF was
performed on the second day post injury. Mice were
maintained under anesthesia with Isoﬂurane. A mid-
line skin incision was performed and the previous sur-
gical wound was reopened using n°5 Dumont forceps
(Fine Science Tools, Foster City, CA) to re-expose
the SCI site. The animal was suspended in a rodent
stereotaxic frame (David Kopf, Tujunga, CA) and a
single midline site was injected with 1uL (2nL/sec) of
DCH loaded with bioactive components (cf. 4.5.2)
(-0.6mm ventral from the cord surface). The back
muscles and skin are ﬁnally closed with respectively
resorbable 6-0 and non-resorbable 6-0 sutures.
BRAINSTEM INJECTIONS AND TRACING
All mice were maintained under anesthesia with Isoﬂu-
rane and Ketamine. A midline skin incision was per-
formed to expose the skull and recognize Bregma and
Lambda. Both Bregma and Lambda were vertically
aligned and a craniotomy was performed using a thin
drill to expose the dorsal aspects of the cerebellum.
Injections took place using micro-glass pipettes (50-
100um tip width) with two targets on each side over
the ventral gigantocellular nucleus (vGI). The vGI nu-
cleus was stereotaxically addressed using the previ-
ously described coordinates for mice : -5.6mm and
-5.8mm caudal from Bregma, +/-0.3mm lateral from
midline and -5.6mm ventral from the cerebellar sur-
face. Injected viral suspensions or solutions were pre-
pared to allow for the desired volume as listed under
4.5.2. Injection took place at 2nL/sec, with respect
of a two minutes delay before slow withdrawal of the
micro-glass. For injections-only surgeries (cf. 4.5.3),
the skin was ﬁnally closed using non-resorbable 4-0
sutures.
BRAINSTEM OPTIC FIBER IMPLANTATION
Optic implants were custom made to optimize the
ﬁber length and access the targeted rostral thalamus.
Multimodal optic ﬁber (200 μm core diameter, 0.22
NA, Thorlabs) was mounted inside 200um wide fer-
rules (Thorlabs, Newton, NJ) and the contact sur-
face for light input was ﬁnely polished. Optic ﬁber
implantation was combined with RtST tracing and
performed in Thy1-ChR2 mice, which express consti-
tutively the Channelrhodopsin2 membrane protein in
motor-related neuronal structures.
All mice were maintained under anesthesia with Isoﬂu-
rane in a rodent cranial stereotaxic apparatus (David
Kopf, Tujunga, CA). Skull exposure and craniotomy
were conducted as described under 4.5.3, and three
stainless steel screws were ﬁrmly inserted into the ex-
posed bone to stabilize and ﬁx the implanted optic
ﬁber. After puncturing the dura mater at the site of
entry, a single optic implant located on the midline
was lowered ventrally to the vicinity of both vGI nu-
clei (-5.7mm from Bregma, 0mm from midline and
-5.6mm ventral from the cerebellar surface). The ex-
posed cerebellar surface was then protected using bio-
compatible silicon and the optic implant was ﬁxed with
dental cement.
4.5.4 BEHAVIORAL ASSESSMENTS
Evoked motor responses were conducted prior to in-
jury and at a terminal stage after chronic optogenetic
stimulation in the reticular formation. The animal was
restrained in a bipedal position overground, in a com-
fortable harness that was attached to a half-tube at
one end of a body weight support device. A system
of 12 infrared cameras (Vicon motion analysis) was
used to record the motor response. Retro-reﬂective
markers were placed on the relevant joins (iliac crest,
hip, knee, tarse, toe) to enable postural tracking and
correlate motor responses with optic stimuli. Trains
that corresponded to the chronic pattern of stimula-
tion were given and postural responses were recorded
and analyzed.
4.5.5 CHRONIC OPTOGENETIC STIMULA-
TION
Mice were kept free-moving in the cage and optic
stimulation took place using blue lasers (470nm wave-
length) and optic cables connected to the implanted
optic ﬁbers using ferrule-to-ferrule sleeves. The cor-
rect implantation of the ﬁber was conﬁrmed prior to
SCI via optic motor-evoked potentials (MEPs), show-
ing hindlimb extension and forelimbs tremor as a re-
sponse to rhythmic 5ms optic pulses. Chronic opto-
genetic stimulation in the reticular formation was per-
formed daily for two weeks prior and four weeks after
spinal cord injury. Two 90-minute-long sessions were
conducted daily, during which the mice were exposed
to 5-second-long optic bursts (5ms pulses, 10Hz) with
a 5-second-long pre-train delay. Based on previous
work, 5ms pulses were delivered to eﬃciently recruit
reticulospinal circuits. A frequency of 10Hz was cho-
sen for stimulation, as such frequency ranges were
shown to upregulate CREB and MAPK signaling in
sensory neurons in vitro Fields et al. (1997).
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4.5.6 IMMUNOHISTOCHEMISTRY AND HIS-
TOLOGY
After terminal anesthesia by barbiturate over-
dose, mice were perfused transcardially with 4%
paraformaldehyde and the CNS was retrieved and pro-
cessed for immunoﬂuorescence. Primary antibodies
were: rabbit anti-GFAP (1:1000 - Dako, Carpinteria,
CA); chicken anti-RFP (1:500, Novus Biologicals, Lit-
tleton, CO). Fluorescence secondary antibodies were
conjugated to: 555 (red) or 647 (far red) (Molecu-
lar Probes). The non-viral BDA tracer was revealed
using Tyr-Cy3 (Jackson Immunoresearch Laborato-
ries). Nuclear stain was added using 4’,6’-diamidino-2-
phenylindole dihydrochloride (DAPI; 2ng/ml; Molecu-
lar Probes). Sections were coverslipped using Mowiol
mounting medium (Sigma, Saint Louis, MO). Tiled
scans of individual whole sections were prepared us-
ing a x10 objective and the scanning function of a
Leica Aperio Versa 200 Microscope (Leica, Wetzlar,
Germany).
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5.1 ABSTRACT
The ﬁeld of spinal cord regeneration has been interested for decades in replacing the scarred
lesion core with exogenous neural tissue. Previous work aimed at grafting modiﬁed stromal
tissue to express facilitating factors and induce endogenous tracts’ regeneration. In parallel,
cell engineering enabled other groups to restore spinal cord integrity after complete injury using
Embryonic Stem Cells (ESCs) and induced Pluripotent Stem Cells (iPSCs). However, apart
from the ethical questions that arise from the use ESCs, these approaches have failed so far
to yield signiﬁcant and reproducible recovery of stepping after Spinal Cord Injury (SCI).
Some eﬀort has been provided by diﬀerent groups to propose autologous neural cell replacement
options in diﬀerent models of brain disorders. Autologous grafting of cortex-derived neural
progenitor cells enabled signiﬁcant recovery of function in non-human primates after toxic
stroke and in the context of Parkinson’s disease. At the caudal end of the CNS, in vitro studies
revealed the Filum Terminale (FT) - an embryonic rest located within the cauda equina - as
a source of adult neurogenesis, providing both astrocytes and neurons when processed and
cultured.
In the present study, our strategy aims at explanting the FT from inbred adult rats, culture the
obtained biopsy and develop neurospheres in vitro, that are subsequently grafted into the lesion
core after complete SCI in an autologous-like approach. Satisfying neural tissue was obtained in
vitro, showing free-ﬂoating neurospheres developed over 3-4 weeks of culture. When plated,
these neurospheres formed new neural networks combining mature MAP2-positive neurons
and GFAP-positive astrocytes. However, grafting of full neurospheres failed to promote the
formation of neural bridges across complete SCIs. We hypothesize that a low cell dynamic,
together with macrophage-related toxicity and failure to integrate endogenous circuits, are
responsible for poor graft survival in spite of co-injected survival factors and lesion remodeling.
PERSONAL CONTRIBUTIONS
In this study, I - Sabry L. Barlatey - designed experiments and piloted the feasibility of the
project. I performed surgical spinal cord injuries, Filum Terminale biopsies and spinal stereo-
taxic surgeries. I established and performed the in vitro development of adult Filum Terminale
derived neural tissue. I conducted in vitro tissue processing and histological analyses. I pro-
cessed ex vivo CNS tissue, performed histological analyses, acquired microscopy images and
quantiﬁed graft survival. I wrote the chapter presented here above and conceived the ﬁgures.
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5.2 INTRODUCTION
ADULT SOURCES OF NEURAL PROGENITOR CELLS
Neuroprosthetic rehabilitation applied after incomplete SCI has enabled robust and sustained
recovery of function in rodents (Asboth et al., 2018; van den Brand et al., 2012), non-human
primates (Capogrosso et al., 2016) and human patients (STIMO). However, the occurrence
and extent of functional recovery has been shown to rely on the reorganization of spared
supraspinal input (Asboth et al., 2018) around the lesion core. As mentioned in the previous
chapters, functional recovery after more severe SCI will require the re-establishment of a tis-
sue bridge that can be recruited by robotic neuroprosthetic rehabilitation. We demonstrated
recently that axon regeneration can be achieved across non-neural lesion cores and conduct
action potentials into caudal tissues (see 2 and Anderson et al. (2018)). However, the model of
complete crush SCI that we used remains very controlled and only causes an infra-millimetric
gap between supra- and infralesional tissues. In large and severe models of spinal cord in-
jury, molecular-based manipulation of the lesion core may not suﬃce to produce the required
dense bridge of permissive extracellular matrix that is required for axon regrowth. Cell replace-
ment therapies oﬀer the opportunity to replace wide lesion cores with growth permissive cell
substrates (Assinck et al., 2017; Kadoya et al., 2016; Dulin et al., 2018).
Neural stem and progenitor cells have been studied for decades with a successful integra-
tion into host tissues and permissive eﬀects over endogenous axon regeneration (Reier, 1985;
Bregman and Reier, 1986; Jakeman and Reier, 1991). Systematic studies in rats have recently
established E14 neural stem and progenitor (NSPCs) cell grafting as an eﬃcient strategy to re-
place non-neural complete lesion cores with both exogenous neurons and glia. Further, NSPC
grafts extend long-distance axons in both rostral and caudal directions from the lesion site and
restored electrophysiological conduction across the SCI (Lu et al., 2012c). Host axons regen-
erating into the graft support also the hypothesis that grafted NSPC cells may get involved as
neuronal relays after maturation Dulin et al. (2018); Kadoya et al. (2016)Similar and success-
ful results were obtained with grafts of induced pluripotent stem cells (iPSCs) into complete
injury sites in rats (Lu et al., 2014). Transitioning to non-human primates, human spinal cord
derived progenitor cells grafted to a cervical hemisection improved forelimb motor functions
(Rosenzweig et al., 2018). Our objective was at ﬁrst to combine E14 NSPC grafts with neuro-
prosthetic rehabilitation (van den Brand et al., 2012) in a rat model of complete SCI, in order
to evaluate the synergistic potential of both approaches combined for the recovery of voluntary
locomotion. However, our ﬁrst attempts to replace lesion sites with NSPCs produced similar
results as reproduction studies. Indeed, reevaluation of the NSPC-based therapy demonstrated
that the grafts tend to keep high proliferative properties, extend anarchic axonal projections
and form ectopic deposits throughout the CNS (Steward et al., 2014; Tuszynski et al., 2014).
Additionally, a non-negligeable number of rat subjects showed collagenous partitions of the
graft, susceptible to impede action potential conduction across the lesion (Sharp et al., 2014).
Due to the undesired behavior of NSPC transplants, we focused our interest on establishing
a novel cell replacement strategy based on an adult source of progenitor cells with a lower
proliferation kinetics. Diﬀerent groups have reported adult progenitor cells in the rodent and
non-human primate CNS. Jocelyne Bloch’s group has been demonstrating that a population
of neural progenitor cells - identiﬁed as Doublecortin-positive cells (Bloch et al., 2011) - is
distributed across the primate neocortex and can be expanded in vitro into neurospheres and
neural tissue that combine neurons and astrocytes (Arsenijevic et al., 2001). This adult cell
source enables cortical biopsies from non-dominant areas to be grown in vitro and grafted in the
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vicinity of a lesion site in the same individual. Such autologous transplantations bypass ethical
and immunological concerns of other cell replacement therapies. When grafted in the periphery
of motor cortex injuries induced with ibotenic acid, Doublecortin progenitors were reported to
colonize the injured site, integrate into the damaged regions, diﬀerentiate into mature neural
tissue and promote functional beneﬁts (Kaeser et al., 2011). In a Parkinsonian model in non-
human primates, Doublecortin cells grafted into the caudate nucleus and appeared to ease
Parkinsonian functional signs and promote local striatal and distant neuroprotective eﬀects
on the substantia nigra (Brunet et al., 2009; Bloch et al., 2014). So far, no tumorous
transformation or aggressive behavior have been reported with this source of cells (Kaeser
et al., 2011; Brunet et al., 2005). However, adult neocortex-derived tissue has only been
successfully grown from human and non-human primate biopsies, as rodents seem to lack of
similar progenitor cells.
Caudalized progenitor cells - i.e. stem and progenitor cells that originate from the developing
spinal cord - have been shown to survive and integrate better than forebrain NSPCs in host
spinal tissues (Kadoya et al., 2016; Lu et al., 2012c). Therefore, neocortex-derived progenitor
cells may be of a suboptimal origin for grafting into SCI sites. Several groups have described
the adult Filum Terminale (FT) - a quiescent embryonic rest located at the caudal extremity
of the adult spinal cord (Arvidsson et al., 2011; Jha et al., 2013b) - as a source of progenitor
cells. In vitro neurospheres could be obtained from Filum Terminale explants and included
combined neuronal and astroglial phenotypes (Jha et al., 2013a). Because FT-derived biopsies
provide a source of autologous progenitor cells with caudal properties, our aim in the present
chapter is to evaluate the technical feasibility and the relevance of grafting FT-derived neural
tissue for spinal cord repair in rodents.
5.3 RESULTS
POOR INTEGRITY OF FT-DERIVED CELL GRAFTS IN
VIVO
5.3.1 NEURAL TISSUE ARISES FROM ADULT RODENT FILUM TERMI-
NALE
Previous work from other groups documented the Filum Terminale as a niche of neural pro-
genitor cells (Chrenek et al., 2017) and in vitro development of neural tissue from rodent
neonatal Filum Terminale (Arvidsson et al., 2011; Jha et al., 2013a; Varghese et al., 2009).
To respect clinically relevant time points, we assessed the feasibility of growing neural ecosys-
tems from adult rats and mice in vitro. Whereas poor results were obtained in cultures grown
out of post-mortem FT explants from adult rats, we successfully cultured neurospheres from
the FT of adult subjects obtained during a live terminal surgical procedure. Whole Filum Ter-
minale structures were explanted, enzymatically and mechanically dissociated and successfully
grown free-ﬂoating in vitro (Fig 5.1a). Over the ﬁrst 48 hours of culture, cell aggregates
self-assembled and showed high metabolic activity resulting in a rotation spin. After a ﬁrst
week of culture, each Filum Terminale biopsy consistently induced the formation of 40-60
neurospheres, both in rats and mice. The newly formed neurospheres could grow progressively
over 3-4 weeks - with mechanical passages every two weeks - before reaching an apparent
developmental plateau. In vitro characterization of plated tissue was performed, showing
Section 5.3 Chapter 5 Page 91
a combined expression of late stage Tuj-1 and MAP2-positive neurons, embedded in GFAP
astroglial networks (Fig 5.1b-c).
To further characterize cell maturation, we plated neurospheres on a laminin-coated surface.
Both rodent and non-human primate derived spheres formed planar neural networks over
10 to 21 days, extending processes. At an early stage (day post-plating 12), most cells
expressed the GFAP marker, which we consider to indicate a neural progenitor state, more than
astroglial maturation and reactivity. Further supporting this progenitor state, a co-expression
of GFAP with the early neuronal marker Tuj-1 was documented, suggesting a pattern of
neuronal diﬀerentiation for a subpopulation of the plated cells (Fig 5.1c). At a later stage, we
observed fully diﬀerentiated MAP2-positive neurons in vitro, that lost the GFAP phenotype
and demonstrated morphological features of neurons forming networks. These networks were
embedded in a GFAP-positive astrocyte population.
With the perspective of in vivo grafting experiments, we tested cell-labelling options and were
able to infect full neurospheres in vitro with an [AAV2/dj-CBA-GFP] viral vector. Green
ﬂuorescent labelling was documented in free-ﬂoating neurospheres, which remained after cell
plating on a Laminin/Poly-L-Ornithine surface. Furthermore, FT explants were performed in
ubiquitously expressing GFP Lewis rats. In vitro expansion of progenitor cells was successful
and GFP ubiquitous neurospheres were derived from the GFP animals.
5.3.2 FT-DERIVED GRAFTS FAIL TO RESTORE SCI SITE INTEGRITY
FT-DERIVED CELLS ALONE FAILS TO COLONIZE SCI SITES
FT explantation and in vitro cell expansion to neurospheres were performed from GFP-positive
Lewis rats or wild-type Lewis rats with subsequent labelling using the [AAV2/dj-CBA-GFP]
viral vector. Our choice of involving Lewis the rat line was motivated by their inbred genetic
background, that is expected to reduce risks of rejecting foreign cells. Wild-type Lewis rats
received a complete crush SCI and full neurospheres from one Filum Terminale were pooled,
combined as a suspension in culture medium with 3% Dicopolypeptide Hydrogel (DCH) and
grafted into the lesion core without any additional factor. Cells were developed in vitro for
8 days, in order to obtained an optimized amount of neural progenitor cells, while preserving
immaturity for further spontaneous maturation in vivo. Cell grafting took place on day-14 post-
injury, in order to enable resolution of acute and subacute inﬂammatory events. Tissue analysis
took place after four weeks in vivo showing poor graft survival, but sparse GFP-expressing
cells. Strong green ﬂuorescence was observed across the lesion core, that we associated to
macrophages, based on their morphological aspect. We hypothesize that grafted cells were in
a large majority phagocyted by immune cell components within the lesion core. Obviously, no
neural bridging of the injured site could be obtained with Filum Terminale-derived progenitor
cells.
ESC-INSPIRED COCKTAIL OF TROPHIC FACTORS
Based on the poor survival of grafted cells deprived of exogenous trophic support, we next
explored options to support Filum-Terminale cell persistence into the lesion core. Previous work
on embryonic neural progenitor cells from the Tuszynski laboratory [UC San Diego, California]
relied on supplementing the graft with a cocktail of numerous growth factors as follows :
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Figure 5.1: In vitro expansion of Filum Terminale derived neural progenitor cells into neurospheres
and mature neural tissue. A. Transmitted light microscopy of Filum Terminale derived tissue incubated in vitro. A1.
Representative rat neurosphere obtained at day-8 of culture. A2. Precipitated neurosphere spreading progenitor cells on a laminin-
coated substrate. A3. Plated neural tissue in vitro, showing morphological features of mature neurons or late-stage neuronal
progenitor cells. B. Plated neurosphere expressing in combination the astroglial marker GFAP (magenta) and the mature neuronal
marker MAP2 (cyan). This neurosphere was plated after 14 days of free-ﬂoating culture. The phenotype and morphology of
the tissue suggest self-diﬀerentiation into mature neurons within the sphere C. Co-expression of the astroglial and early neuronal
marker GFAP (magenta) and the neuronal progenitor marker Tuj-1 (cyan). Morphological and phenotypical features correlate
with a late stage process of neuronal diﬀerentiation.
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Figure 5.2: Filum Terminale derived grafts poorly survive in vivo, but surviving cells are both located
in the lesion core and among the glial scar. A. Grafted cells located within the lesion core, as conﬁrmed by the
absence of colocalization between the graft (GFP, green) and the astroglial marker GFAP (red). We note a disorganized pattern
of the GFP-expressing neurites, as well as a dense presence of non-neural cells suggested by nuclear labelling with Dapi. B.
Grafted cells (GFP, green) located within the glial scar, as demonstrated by the dense astroglial matrix (GFAP, red). We note
that neurites from grafted cells tend to follow the pattern of endogenous astrocytes.
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), platelet-derived growth
factor (PDGF), insulin-like growth factor (IGF-1), epidermal growth factor (EGF), basic and
acidic ﬁbroblast growth factor (respectively aFGF and bFGF), glial derived neurotrophic factor
(GDNF), hepatocyte growth factor (HGF) and calpain inhibitor (MDL28170). After discussion
with Professor Tuszynski’s group, this cocktail was reduced to BDNF, bFGF and MDL28170,
and vascular endothelial growth factor (VEGF) was added to the molecular combination.
Rational for such a supplementation of the graft with exogenous growth factors was i) to
extend the period of cell division in vivo with bFGF, in order to increase the occupation of the
lesion cavity with grafted cells, ii) to promote neuronal survival and diﬀerentiation with BDNF,
iii) to diminish apoptotic signaling in neural progenitor cells with calpain inhibitor and iii) to
enhance vascular supply with VEGF and avoid ischemic events within the depot of exogenous
cells. This modiﬁed graft composition slightly enhanced cell survival, showing groups of GFP-
expressing cells inside the lesion core, located mainly at the proximal border of the lesion core.
However, Filum Terminale cell grafts still failed to ﬁll the lesion cavity, in spite of exogenous
trophic support.
LESION REMODELING SLIGHTLY ENHANCES SURVIVAL
In a last attempt to obtain satisfying survival of grafted FT-derived progenitor cells, we tested
wether - as for regenerating propriospinal axons (see 2) - a lack of permissive extracellular
matrix causes an apoptotic depletion of the grafts. Rational for this hypothesis was that sur-
viving cells in our previous experiment were mainly located near the glial scar. It was previously
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demonstrated that remodeling the injured site early after injury induces protective astrogliosis
and enhances extracellular substrates such as laminins (Anderson et al., 2016, 2018). Further,
laminins are known as key extracellular components that i) promote neurogenesis and neuronal
survival in vitro (Hall et al., 2008; Heaton and Swanson, 1988), and ii) support axonal growth
and maturation in vivo (Plantman et al., 2008; Gundersen, 1987; Anderson et al., 2016).
Therefore, we repeated Filum Terminale derived cell grafting - supplemented with BDNF,
GDNF, VEGF and calpain inhibitor - but primed the injured site in a ﬁrst place, in order to
remodel the lesion core into a more permissive environment for neural tissue. EGF and bFGF
were embedded in a biocompatible hydrogel and injected into the injury on day-2 post-SCI.
Again, cell grafting took place two weeks after the lesion. Tissue was analyzed four weeks after
grafting and demonstrated that areas that exhibit a denser laminin matrix within the lesion
core allow for better survival of grafted FT-derived cells. Still, Filum Terminale progenitor cells
failed to bridge the SCI site and did not extend neuronal projections into healthy tissue past
the glial scar (Fig 5.3).
5.4 DISCUSSION
INTEGRATING EXOGENOUS CELLS IN A LESION ENVI-
RONMENT
Neural cell replacement therapies have been encountering converse limitations between cell
survival and excessive proliferation. Indeed, both issues are well illustrated by the numerous
and diﬀerent trophic factors that were combined to support embryonic NSPC grafts (Lu et al.,
2012c), that were likely chosen in order to enable in vivo survival and proper ﬁlling of the
lesion cavity. However, such a strong trophic stimulus, associated to an intrinsic proliferative
state, caused ectopic metastatisation of grafted embryonic NSPCs (Steward et al., 2014).
Conversely and in spite of trophic support and intralesional laminin enhancement, cell survival
of Filum Terminale-derived grafts remained minimal. Mechanisms for cell depletion likely rely
on an immune response from sustained inﬂammatory components within the lesion core towards
grafted cells. Our trophic supplementation aimed at increasing in vivo proliferation, promoting
maturation and reducing apoptotic signaling, but did not address the immunologic response.
Our aim by using an adult-derived progenitor source was to develop a cell replacement paradigm
that can be applied in an autologous manner. In this circumstance, the receiver individual is
grafted with its own cells, in order to bypass graft rejection concerns. An option to increase
cell survival would be to immunosuppress the animal, in order to avoid phagocytation of
FT-derived cells by intralesional macrophages. However, by doing so we lose the beneﬁt of
using an autologous source of cells, which is independent from any anti-rejection treatment.
If we consider immunosuppressing animals with Cyclosporine-A or similar agents, involving
well-established embryonic NSPCs or iPSCs would remain the more promising approaches in
a functional perspective, compared to adult-derived neural progenitor grafts that struggle to
survive in vivo.
As another option to increase survival, we could revise our cocktail of trophic factors and
supplement the grafts with the exact same combination as the one applied by Mark Tuszyn-
ski’s group : BDNF, NT-3, PDGF, IGF-1, EGF, aFGF, bFGF, GDNF, HGF and MDL28170.
However and interestingly, we note that this cocktail includes EGF, bFGF and GDNF, that
are the components that promote propriospinal axon regrowth via lesion remodeling and axon
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Figure 5.3: In spite of enhanced intralesional permissive substrate, Filum Terminale derived grafts
fail to bridge complete SCI sites. A. Experimental design. Lewis rats received a complete spinal crush SCI. The injured
site was remodeled on day-2 post-lesion, in order to enhance permissive extracellular components. In parallel, Filum Terminale
biopsies were obtained from a second group of Lewis animals. The biopsies were developed in vitro for 8 days, labelled with
AAV-GFP when applicable, and grafted into the injured site on day-14 post-SCI. B. Histologic observation of the SCI site, four
weeks after grafting. Poor survival and no lesion bridging could be obtained. Grafted cells express GFP (green). SCI site is
delimited with immunohistochemistry for astroglia (GFAP, cyan). B1. Focus of GFP-expressing grafted cells, integrated at the
proximal border of the lesion, in an area located near the glial scar. B2. Sparse neurites from grafted cells, located at the lesion
center.
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guidance. Further, IGF-1 provided for NSPC graft survival is also part of our propriospinal re-
generation paradigm as an intrinsic growth inductor (see 2 and Anderson et al. 2018). Rational
for grafting neuronal progenitors is to provide relays for descending motor input, as theoretically
ascending relays are inexistent for somatosensory input (see 3.1). As propriospinal axons are
able to grow across non-neural lesion cores trophic molecular manipulations alone, cell replace-
ment becomes less relevant for information conduction. One could argue that propriospinal
axons alone may not suﬃce to carry supraspinal locomotor inputs to lumbosacral circuits, as
no recovery of function has yet been achieved. Indeed, NSPCs were shown to enable corti-
cospinal regrowth into - but not across - the graft (Dulin et al., 2018). Nevertheless, having
corticospinal axons reach for grafted cells appears similar to promoting corticospinal reorga-
nization that reaches for endogenous propriospinal neurons, as obtained with neuroprosthetic
rehabilitation (van den Brand et al., 2012). The beneﬁt of propriospinal regrowth over relay
cell grafting is the characterized phenotype of neuronal targets for reorganizing endogenous
axons. With propriospinal regeneration, supraspinal circuits - helped by volitional training -
will reach for propriospinal neurons, whereas grafted embryonic NSPCs or iPSCs likely pro-
vide various neuronal subtypes as targets for regrowing or reorganizing corticospinal axons.
Eventually, with the objective of restoring functional circuits after SCI, neural relay grafts are
known to extend axons in both the rostral and caudal directions from the lesion center (Lu
et al., 2012c). However, evidence suggests that undirected extension of neurites correlates
with worsened functional outcome after SCI (Beauparlant et al., 2013). Therefore and in the
light of recent developments in endogenous axon regeneration, we tend to consider neuronal
relay cell replacement as an obsolete paradigm for spinal cord repair.
In a context of large-volume SCIs, glial cell replacement - more than neuronal grafts - remain
an interesting approach. As propriospinal axons regenerate across complete, yet thin spinal
core injuries, we currently have no insight about their behavior when regrowth is required
over a long distance across non-neural tissue. In such circumstances and for translation to
non-human primates, it may become interesting to support regenerating axon with exogenous
reactive astrocytes and/or oligodendroglial progenitor cells. Considering the positive role of
endogenous astrogliosis after axotomy (Liddelow et al., 2017; Anderson et al., 2016), A2 reac-
tive astrocytes can contribute to permissive trophic support for propriospinal ﬁbers. Because
increased conduction was required for functional beneﬁts of regrown axons in other systems
(Bei et al., 2016), myelination of regenerated propriospinal axon may be crucial for restoring
motor control. As a last remark and as increased laminin improved Filum-Terminale derived
graft survival, priming the injured site with EGF/FGF before grafting may become a useful
tool for other groups developing cell replacement therapies after SCI.
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5.5 MATERIALS AND METHODS
5.5.1 ANIMALS
Inbred Lewis rats were involved in the described ex-
periments in accordance with the swiss veterinary leg-
islation applied in Vaud and Geneva. Local veterinary
committees accredited the experiments under Licenses
#VD3091 and #GE157/16. GFP-expressing Lewis
rats were obtained from Rat Resource & Research
Center (RRRC) [University of Missouri, Columbia,
MO] and bred in our own facility. Wild-type Lewis
rats were obtained from Charles River [Les Oncins,
Saint Germain sur l’Arbresle, France].
5.5.2 SURGERIES
CRUSH SPINAL CORD INJURY
Rats were maintained under anesthesia with Isoﬂu-
rane and Ketamine. A dorsal midline incision was per-
formed and muscles were carefully detached to access
the posterior aspects of the spine. Using a surgical mi-
croscope (Zeiss, Oberkochen, Germany), the inferior
interspinous ligament was removed with n°5 Dumont
forceps (Fine Science Tools, Foster City, CA) at the
targeted thoracic level T10. A complete laminectomy
was performed with n°2 forceps (Fine Science Tools,
Foster City, CA) and the cord was laterally compressed
for ﬁve seconds using tweezers with a tip width of
0.5mm. For SCI site labelling, the rats were then sus-
pended in a rodent stereotaxic frame (David Kopf, Tu-
junga, CA) and 100nL of dark dye were microinjected
using glass pipettes (50-100um tip width) controlled
by micro-infusion pumps. The back muscles and skin
were ﬁnally closed with respectively resorbable 6-0 and
non-resorbable 6-0 sutures.
FILUM TERMINALE BIOPSY
Rats and mice were maintained under terminal anes-
thesia with Isoﬂurane and Ketamine. A dorsal mid-
line incision was performed over the lumbar L4–L5-
L6 vertebral levels. Muscles were carefully detached
to expose dorsal aspects of the lumbosacral column
and three-level laminectomies were performed at lum-
bar L4-L5-L6 levels to reveal the dural sac. Using a
surgical microscope (Zeiss), the dura mater was in-
cised with microsurgical scissors to access the cauda
equinae. Lumbo-sacral roots were dissected with ﬁne
n°5 Dumont forceps (Fine Science Tools) to enable
identiﬁcation of the Filum Terminale extended from
the conus medullaris. A 5mm-long section of the
Filum Terminale was then explanted using microsur-
gical scissors and the biopsy was immediately trans-
ferred to dissociating medium. Animal were ﬁnally
euthanized with a barbiturate overdose.
INTRALESIONAL DEPOT OF GROWTH FACTORS
When applicable, a single depot of DCH-EGF/FGF
was performed on the second day post injury for SCI
remodeling. Rats were maintained under anesthesia
with Isoﬂurane and Ketamine. A midline skin incision
was performed and the previous surgical wound was re-
opened using n°5 Dumont forceps (Fine Science Tools,
Foster City, CA) to re-expose the SCI site. The animal
was suspended in a rodent stereotaxic frame (David
Kopf, Tujunga, CA) and a single midline site was in-
jected with 1μl (2nL/sec) of DCH loaded with bioac-
tive components (-1.1mm ventral from the cord sur-
face). The back muscles and skin were ﬁnally closed
with respectively resorbable 6-0 and non-resorbable 6-
0 sutures.
CELL GRAFTING
Cell grafting was performed as an intralesional de-
pot of biocompatible hydrogel loaded with full neuro-
spheres, culture medium, and exogenous trophic fac-
tors when applicable. Rats were maintained under
anesthesia with Isoﬂurane and Ketamine. A midline
skin incision was performed and the previous surgi-
cal wound was reopened to expose the SCI site la-
belled with dark dye. The animal was suspended in a
rodent stereotaxic frame (David Kopf, Tujunga, CA)
and bilateral injections of graft suspension were per-
formed into the lesion (2 sites, -1.1mm ventral from
the cord surface, +/-0.4mm from the cord midline,
0.75uL/site, 2nL/sec). Injections took place using
custom 30G needles mounted on a Hamilton syringe
(Hamilton, Bonaduz GR, Switzerland) controlled by a
microinfusion pump. The back muscles and skin were
ﬁnally closed with respectively resorbable 4-0 and non-
resorbable 4-0 sutures.
5.5.3 IN VITRO DEVELOPMENT OF FILUM
TERMINALE-DERIVED NEURAL TIS-
SUE
Following explantation, individual biopsies were incu-
bated and incubated overnight at 37°C in dissociating
medium combining : DMEM/F12 (1:1, Sigma), fe-
tal bovine serum (10%, Sigma), Collagenase type II
(100U/mL, Gibco) supplemented with CaCl2 (3mM,
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Sigma). After 24 hours, biopsies were rinsed with cul-
ture medium made of : DMEM/F12 (1:1, Sigma),
N2 supplement (1%, Gibco), B27 supplement (2%,
Gibco), epidermal growth factor (20ng/mL, Pepro-
tech), bFGF (20ng/mL, Peprotech). FT fragments
were then mechanically triturated with broad-end
pipette tips to complete dissociation. The obtained
cell suspension was transferred to ultra low attach-
ment culture plates (Corning) and kept for culture in
humid incubators at 37°C with 5% CO2. Passages
took place every two weeks by mechanical trituration
and re-suspension in a 1:1 combination of old and fresh
culture medium. For cell plating, neurospheres were
transferred on laminin-coated coverslips and kept until
cell conﬂuence.
5.5.4 GRAFT SUSPENSION
For homogeneity, neurospheres and tropic factors were
embedded in a biocompatible hydrogel. Biomate-
rial depots were prepared using amphiphile diblock
copolypeptide hydrogels (DCH) that are CNS biocom-
patible, biodegrade over several weeks in vivo and en-
able volume distribution of grafted cells and cargo
molecules. Diblock copolypeptide hydrogel (kindly
provided by Professor Deming’s group, UCLA) was
reconstituted to 6.0% in culture medium and, when
applicable, loaded with the following growth factors :
BDNF (ﬁnal conc. 50ng/μl, Peprotech), bFGF (ﬁ-
nal conc. 10ng/μl, Peprotech), VEGF (ﬁnal conc.
10ng/μl) and calpain inhibitor MDL28170 (ﬁnal conc.
50uM). After 8 days in vitro, neurospheres from sin-
gle biopsies were pooled and centrifuged. Supernatant
was removed to enable a 1:1 combination with the hy-
drogel. The graft suspension was the injected into the
SCI lesion core (2 sites, DV -1.1mm, 1μl per site).
5.5.5 HYDROGEL DEPOT WITH GROWTH
FACTORS
For sustained delivery, growth factors and guidance
cues were embedded in a biocompatible hydrogel. Bio-
material depots were prepared using well character-
ized diblock copolypeptide hydrogels (DCH) that are
CNS biocompatible, biodegrade over several weeks
in vivo and provide prolonged delivery of bioactive
growth factors in CNS tissue for two or more weeks af-
ter injection. Diblock copolypeptide hydrogel (kindly
provided by Professor Deming’s group, UCLA) was
loaded with growth factors and guidance molecules.
Cargo molecules were as follows human recombinant
FGF2 and EGF (PeproTech, Rocky Hill, NJ). Freeze
dried DCH powder was reconstituted to 3.0% or 3.5%
wt/vol in sterile PBS with a combination of FGF2
(1.0μg/μl), EGF (1.0μg/μl). The combined biomate-
rial with cargo was then injected into the SCI lesion
core [DV -1.1, 1μl] as a single site depot.
5.5.6 EX VITRO IMMUNOHISTOCHEM-
ISTRY AND HISTOLOGY
Laminin-coated coverslips carrying neural tissue were
recovered and ﬁxed with 4% paraformaldehyde for
10 minutes. Tissue was rinsed with PBS and im-
munohistochemistry was performed using the follow-
ing primary antibodies: rabbit anti-GFAP (1:1000,
Dako), mouse anti-GFAP (1:500, Sigma) mouse anti-
MAP2 (1:500, Sigma), rabbit anti-Tuj1 (1:500, Ab-
cam). Fluorescence secondary antibodies were con-
jugated to: 488 (green), 555 (red) or 647 (far red)
(Molecular Probes). Nuclear stain was added using
4’,6’-diamidino-2-phenylindole dihydrochloride (DAPI;
2ng/ml; Molecular Probes). Coverslips were mounted
on slides with Mowiol mounting medium (Sigma) and
imaged using a ﬂuorescence illumination microscope
or a scanning confocal microscope (Zeiss).
5.5.7 EX VIVO IMMUNOHISTOCHEMISTRY
AND HISTOLOGY
After terminal anesthesia by barbiturate overdose, rats
were perfused transcardially with 4% paraformalde-
hyde and the CNS was retrieved and processed for
immunoﬂuorescence. Primary antibodies were: rab-
bit anti-GFAP (1:1000 - Dako), mouse anti-GFAP
(1:500, Sigma), chicken anti-GFP (1:500, Abcam),
rabbit anti-laminin (1:80, Sigma). Fluorescence sec-
ondary antibodies were conjugated to: 488 (green),
555 (red) or 647 (far red) (Molecular Probes). Nuclear
stain was added using 4’,6’-diamidino-2-phenylindole
dihydrochloride (DAPI; 2ng/ml; Molecular Probes).
Sections were coverslipped using Mowiol mounting
medium (Sigma). Tiled scans of individual whole sec-
tions were prepared using a x10 objective and the scan-
ning function of a Leica Aperio Versa 200 Microscope
(Leica, Wetzlar, Germany).
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6.1 BUILDING BRIDGES
FACILITATING GROWTH IN SPITE OF INHIBITIONS
Intralesional inhibitory molecules and inﬂammatory processes have long been considered as
the main barrier to spontaneous and therapeutic spinal repair after SCI. Eﬀort has long been
focused on inhibiting this detrimental environment, providing limited yet undebatable eﬀects
on axonal regrowth. Beyond the speciﬁc manipulations that lead to robust propriospinal
regeneration, the real breakthrough in our data is to shift interest to facilitating factors that
can override inhibition. Indeed, propriospinal regeneration occurs through reactive astrocytes,
into the ﬁbrotic scar, in spite of a strong presence of CSPGs that were still considered lately
as a highly promising molecular target to inhibit for axon regrowth.
As discussed above 1.4.1, CSPGs have been proposed to interact with permissive extracellular
substrates, thus minimizing their disponibility for axons (Zuo et al., 1998; McKeon et al.,
1995), and with growth cone integrins as a competitive binder (Tan et al., 2011). Further,
CSPGs may exert chelation eﬀects on endogenous growth promoting factors (Nandini and
Sugahara, 2006; Deepa et al., 2002). Beyond upregulating intrinsic growth programs, our re-
generative approach relies on a saturation of the lesion core with growth factors and permissive
extracellular components. Therefore, it is likely that mechanisms overlap between inhibitors
degradation and lesion remodelling associated to guidance. Our recent ﬁndings likely induced
more robust regeneration than previous strategies due to a larger enhancement of facilitating
factors.
6.2 REORGANIZING INPUTS AFTER COMPLETE
SCI
6.2.1 DEFINING RELEVANT INPUTS AND TARGETS
Locomotor circuits within the healthy CNS are conceived with an extraordinary complex-
ity. Evidence has been gathered that gait patterns’ control is plural, involving cortical struc-
tures,subcortical nuclei, brainstem modulators and spinal circuits. Within the spinal cord, long
propriospinal neurons appear to coordinate fore- and hindlimbs, whereas sensory input modu-
lates stepping via local interneurons. After incomplete SCI, these complex circuits show plastic
abilities, so that therapeutic strategies can enhance spontaneous recovery of locomotion by
training spared eﬀerent - and likely aﬀerent - in order to optimize the interactions between
functional hotspots. It has been suggested that after incomplete spinal lesion, spared tracts’
activity can be recruited and reoriented to support recovery.
After complete SCI, even though bridging the injury is now possible with cell replacement
therapies or axon regeneration, a fundamental functional-anatomical exploration remains to
be performed. Research in incomplete models has been suggesting candidate structures to
rewire in order to restore functional control of locomotion. However, minimal requirements
remain to be deﬁned - in terms of anatomical rewiring between CNS structures - in order
to induce deﬁned behavioral beneﬁts after complete SCI. A ﬁrst challenge here will tend to
identify, with a minimum of relays, pathways that can sustain a required and functionally
suﬃcient exchange of eﬀerent and aﬀerent inputs following complete SCI. Such studies would
provide speciﬁc targets, by answering the questions where, how much and what. Where - below
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and above the lesion - are located the relevant centers to be reconnected in order to conduct
locomotor inputs ; how much neuronal density is required to restore functionally signiﬁcant
eﬀerent or aﬀerent control over the identiﬁed targeted regions - without overﬂowing it with
information ; and what neurotransmitter modalities are required to provide adequate control
over each of the targeted regions.
Coming developmental studies may provide new tools to help neuroscience mimic parts of the
CNS genesis after injury, and thus reﬁne and optimize axon regeneration, cell replacement
and chemotropic guidance. In the mean time, while biological options are being explored to
tune growth properties and reestablish molecular gradients, reconnecting locomotion-relevant
centers throughout the CNS will at ﬁrst rely on neuroprosthetics. Especially for interrupted
exchanges between distant ends of severed tracts, in neuronal pathways that oﬀer poor anatom-
ical options for relay recruitment, neuroprosthetics already oﬀers neuromodulatory technology
that can be combined with neuroregeneration and restore part of the required inputs. Future
progress in the engineering of biocompatible materials and implantable devices might even
wholly fulﬁll the ’post-SCI neuromodulation’ contract and render neuroregeneration obsolete.
6.2.2 INTEGRATING NEURONAL CELL GRAFTS
After decades of exploration, recent procedures have enabled signiﬁcant replacement of
anatomically complete SCI sites with endo- or exogenous neural tissue. Nevertheless, both
our and other regenerative paradigms (see 2), as well as cell replacement therapies, have failed
to produce consistent and reproducible behavioral beneﬁt. Whereas ESC and iPSC cell grafting
approaches have successfully ﬁlled SCI lesion cores with neurons de novo, endogenous axonal
tracts appear to penetrate the graft in an organotypic pattern, but fail to bridge the injury to-
wards functionally-relevant targets. Moreover, cell grafts were claimed to extend long-distance
axons throughout the CNS, away from the SCI/graft epicenter, that reach targets that may
not be involved in locomotor neural pathways. It has been shown that an excessive presence
of multiple inputs after SCI can prevent recovery of function, due to a disorganized input that
disrupts coherence within locomotor circuits. In that sense, grafted exogenous neurons may
oﬀer, within the SCI site, confounding targets to regenerating endogenous tracts - as suggested
by the failure of endogenous axons to exit and bridge ESC and iPSC grafts. So far, relay grafts
have not proven to conduct information to targeted structures, as their axonal projections will
require new strategies to follow pre-deﬁned patterns and build organized ﬁber tracts de novo.
Future developmental studies may provide molecular strategies to properly guide exogenous
grafts to the wanted targets.
6.2.3 INTEGRATING REGENERATED AXONS
Compared to relay cell replacement, axon regeneration appears more susceptible to restore
coherent conduction of information. Meanwhile, even though propriospinal axons have been
shown as a key component for functional recovery in selected models of incomplete SCI, guiding
them across the lesion to the vicinity of healthy infralesional circuits does not suﬃce to restore
hindlimb movements. Next research questions and mechanistic investigations will need to
deﬁne - or at least suggest - minimal requirements for neuro-regeneration to support voluntary
stepping. A ﬁrst concern addresses the recruitment of regenerated propriospinal neurons by
descending volitional inputs. Electrophysiological experiments will need to be conducted, in
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order to demonstrate evoked potentials below complete lesions from supraspinal stimulation.
Subsequently, chronic motor cortex recruitment may contribute to reinforcing reorganization
of infralesional propriospinal projections.
One could wonder wether the extent of propriospinal regeneration that we documented suﬃces
to conduct information to muscle synergies. Considering our electrophysiological, signal is
propagated three millimeters below the injury, corresponding to the level were the second depot
of guidance cues is performed, but does not reach further caudal circuits. Therefore, functional
information would rely on the recruitment of secondary endogenous relays below the lesion.
We are currently investigating the eﬀects of delivering delayed additional guidance caudally to
the ﬁrst two depots, in order to induce more distant regeneration. Evoked motor recruitment
can then assess the potential presence of restored muscle responses to cortical stimulation
with translesional conduction of descending input. It is however likely that neuroprosthetic
training will be required for reaﬀerented lumbosacral circuits to receive coherent input from
supraspinal structures.
6.2.4 RECRUITING MUSCLE SYNERGIES VIA REGENERATED AXONS
It is possible that propriospinal neurons alone do not suﬃce to support descending motor
commands through complete injuries. In such circumstances, promoting regeneration of com-
plimentary descending tracts may reinforce the coherence of information reaching infralesional
circuits. Reticulospinal axons appear as a promising source of descending input, in the light
of recent mechanistic developments about the functional beneﬁts induced by neuroprosthetic
rehabilitation in an incomplete contusion model of SCI (Asboth et al., 2018). Our attempts
to promote reticulospinal regrowth have for now yielded limited regeneration, but nevertheless
are encouraging and suggest that the ﬁeld of spinal cord repair will need to troubleshoot the
requirements for tract speciﬁc axon regeneration. Identifying proper determinants will likely
enhance the density of regrown reticulospinal axons.
However, the complete absence of any somatosensory feedback to the motor cortex after
complete SCI appears as a major obstacle to functional recovery. In the context of our current
exploration, motor thalamus neuromodulation is a robust candidate to restore gait-related
feedback to M1. Indeed, recent work has been conﬁrming the role of the rostral thalamus in
motor planning and motor learning (Tanaka et al., 2018; Gao et al., 2018). Recruiting motor
thalamic nuclei based on hindlimb muscle activity may enable the motor cortex to reorganize
around and reach for regenerated propriospinal neurons after complete lesion. Complimentary
neuroprosthetic activation of infralesional circuits may then enable rewiring of the locomotor
centers, in a similar manner to the eﬀects observed in an incomplete double hemisection model
of injury (van den Brand et al., 2012).
6.3 CLINICAL SIGNIFICANCE
Obviously, the successful regenerative work presented in the present document (see 2) remains
for now at a ’proof-of-concept’ state, and is neither functional nor safe enough for clinical
translation. In order to develop a clinically translatable paradigm for propriospinal regeneration,
functional beneﬁts will ﬁrst need to be achieved. Subsequently, the safety of manipulating
intrinsic growth programs will need to be addressed and optimized. To do so, temporary
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induicible viral vectors would enable an activation of signaling pathways, such as mTOR and
Jak-STAT, that relies on pharmacological agents. Such technology would avoid uncontrolled
and excessive growth that are susceptible to lead to tumorous transformation.
Conversely, if strong beneﬁts are induced by motor thalamus neuromodulation in animal mod-
els of incomplete or complete SCI, translation to clinics is already realistic. Indeed, commercial
Deep Brain Stimulation (DBS) electrodes currently enable the targeting of thalamic and sub-
thalamic nuclei in human conditions of movement disorders. Such DBS technology could as
well be applied to the motor thalamus with spinal cord injury indications.
6.4 CONCLUSION
FINAL WORDS
Spinal cord injuries, as well as other neuroscientiﬁc challenges, have seen over the last century
numerous empirical suggestions to restore integrity of tissues and promote functional recovery.
In the light of the present work and considering the coming challenges, neuroscientists will
need to build new methodological constructs in order to i) identify all dimensions of the
SCI problem, ii) investigate hypotheses and iii) develop technics and technologies aiming
at answering questions incrementally. Recent and current developments have been shifting
paradigms from empirism to mechanistic approaches, in order to unveil key therapeutic leads
and establish the minimal requirements to reach scientiﬁc landmarks - step by step - towards
clinically successful therapies. However, the complexity of both the neuroregenerative workﬂow
and reorganization requirements is such that expertise from most neurobiological subﬁelds will
need to interact in a collaborative manner, in order to recognize relevant questions, hypotheses
and solutions.
Eventually, as neuroregenerative mechanisms are only starting to be unveiled, biological strate-
gies might well be late to yield the ﬁrst functionally signiﬁcant breakthroughs in the ﬁeld of
complete SCIs. Indeed, current neuroengineering technologies already enable modulations of
circuits that may be applied after anatomically complete spinal lesions. Nevertheless, sus-
tained beneﬁts in human patients will likely require biological therapies to modulate tissues
and reorganize circuits, with potential contributions from temporary-applied neuroprosthetics.
Such therapies would enable neuroprosthetic-based beneﬁts and bypass long-term histologic
reactions to neuromodulatory foreign bodies.

Bibliography
Alto, L. T., Havton, L. A., Conner, J. M., Hollis, E. R., Blesch, A. and Tuszynski, M. H. (2009). Chemotropic guidance facilitates
axonal regeneration and synapse formation after spinal cord injury. Nature neuroscience 12, 1106–1113.
Anderson, M. A., Ao, Y. and Sofroniew, M. V. (2014). Heterogeneity of reactive astrocytes. Neuroscience letters 565, 23–29.
Anderson, M. A., Burda, J. E., Ren, Y., Ao, Y., O’Shea, T. M., Kawaguchi, R., Coppola, G., Khakh, B. S., Deming, T. J. and
Sofroniew, M. V. (2016). Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195–200.
Anderson, M. A., O’Shea, T. M., Burda, J. E., Ao, Y., Barlatey, S. L., Bernstein, A. M., Kim, J. H., James, N. D., Rogers, A.,
Kato, B., Wollenberg, A. L., Kawaguchi, R., Coppola, G., Wang, C., Deming, T. J., He, Z., Courtine, G. and Sofroniew, M. V.
(2018). Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature 561, 396–400.
Anderson, M. E. and DeVito, J. L. (1987). An analysis of potentially converging inputs to the rostral ventral thalamic nuclei of
the cat. Experimental brain research 68, 260–276.
Andrews, E. M., Richards, R. J., Yin, F. Q., Viapiano, M. S. and Jakeman, L. B. (2012). Alterations in chondroitin sulfate
proteoglycan expression occur both at and far from the site of spinal contusion injury. Experimental neurology 235, 174–187.
Angeli, C. A., Boakye, M., Morton, R. A., Vogt, J., Benton, K., Chen, Y., Ferreira, C. K. and Harkema, S. J. (2018). Recovery
of Over-Ground Walking after Chronic Motor Complete Spinal Cord Injury. The New England journal of medicine 379,
1244–1250.
Ankeny, D. P. and Popovich, P. G. (2009). Mechanisms and implications of adaptive immune responses after traumatic spinal
cord injury. Neuroscience 158, 1112–1121.
Antri, M., Mouﬄe, C., Orsal, D. and Barthe, J.-Y. (2003). 5-HT1A receptors are involved in short- and long-term processes
responsible for 5-HT-induced locomotor function recovery in chronic spinal rat. The European journal of neuroscience 18,
1963–1972.
Arbuthnott, G. W., MacLeod, N. K., Maxwell, D. J. and Wright, A. K. (1990). Distribution and synaptic contacts of the cortical
terminals arising from neurons in the rat ventromedial thalamic nucleus. Neuroscience 38, 47–60.
Arsenijevic, Y., Villemure, J. G., Brunet, J. F., Bloch, J. J., DÃ©glon, N., Kostic, C., Zurn, A. and Aebischer, P. (2001). Isolation
of multipotent neural precursors residing in the cortex of the adult human brain. Experimental neurology 170, 48–62.
Arvidsson, L., Fagerlund, M., Jaﬀ, N., Ossoinak, A., Jansson, K., Hägerstrand, A., Johansson, C. B., Brundin, L. and Svensson,
M. (2011). Distribution and characterization of progenitor cells within the human ﬁlum terminale. PloS one 6, e27393.
Asboth, L., Friedli, L., Beauparlant, J., Martinez-Gonzalez, C., Anil, S., Rey, E., Baud, L., Pidpruzhnykova, G., Anderson,
M. A., Shkorbatova, P., Batti, L., PagÃšs, S., Kreider, J., Schneider, B. L., Barraud, Q. and Courtine, G. (2018). Cortico-
reticulo-spinal circuit reorganization enables functional recovery after severe spinal cord contusion. Nature neuroscience 21,
576–588.
Assinck, P., Duncan, G. J., Hilton, B. J., Plemel, J. R. and Tetzlaﬀ, W. (2017). Cell transplantation therapy for spinal cord injury.
Nature neuroscience 20, 637–647.
Barbour, H. R., Plant, C. D., Harvey, A. R. and Plant, G. W. (2013). Tissue sparing, behavioral recovery, supraspinal axonal
sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion. BMC neuroscience 14,
106.
Bareyre, F. M., Garzorz, N., Lang, C., Misgeld, T., BÃŒning, H. and Kerschensteiner, M. (2011). In vivo imaging reveals a
phase-speciﬁc role of STAT3 during central and peripheral nervous system axon regeneration. Proceedings of the National
Academy of Sciences of the United States of America 108, 6282–6287.
Bareyre, F. M., Kerschensteiner, M., Raineteau, O., Mettenleiter, T. C., Weinmann, O. and Schwab, M. E. (2004). The injured
spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nature neuroscience 7, 269–277.
Basbaum, A. I. and Fields, H. L. (1978). Endogenous pain control mechanisms: review and hypothesis. Annals of neurology 4,
451–462.
105
Section 6.4 Chapter 6 Page 106
Beauparlant, J., van den Brand, R., Barraud, Q., Friedli, L., Musienko, P., Dietz, V. and Courtine, G. (2013). Undirected
compensatory plasticity contributes to neuronal dysfunction after severe spinal cord injury. Brain 136, 3347–3361.
Becerra, J. L., Puckett, W. R., Hiester, E. D., Quencer, R. M., Marcillo, A. E., Post, M. J. and Bunge, R. P. (1995). MR-
pathologic comparisons of wallerian degeneration in spinal cord injury. AJNR. American journal of neuroradiology 16,
125–133.
Beck, K. D., Nguyen, H. X., Galvan, M. D., Salazar, D. L., Woodruﬀ, T. M. and Anderson, A. J. (2010). Quantitative analysis
of cellular inﬂammation after traumatic spinal cord injury: evidence for a multiphasic inﬂammatory response in the acute to
chronic environment. Brain : a journal of neurology 133, 433–447.
Behar, O., Golden, J. A., Mashimo, H., Schoen, F. J. and Fishman, M. C. (1996). Semaphorin III is needed for normal patterning
and growth of nerves, bones and heart. Nature 383, 525–528.
Bei, F., Lee, H. H. C., Liu, X., Gunner, G., Jin, H., Ma, L., Wang, C., Hou, L., Hensch, T. K., Frank, E., Sanes, J. R., Chen, C.,
Fagiolini, M. and He, Z. (2016). Restoration of Visual Function by Enhancing Conduction in Regenerated Axons. Cell 164,
219–232.
Belin, S., Nawabi, H., Wang, C., Tang, S., Latremoliere, A., Warren, P., Schorle, H., Uncu, C., Woolf, C. J., He, Z. and
Steen, J. A. (2015). Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics. Neuron 86,
1000–1014.
Biernaskie, J., Sparling, J. S., Liu, J., Shannon, C. P., Plemel, J. R., Xie, Y., Miller, F. D. and Tetzlaﬀ, W. (2007). Skin-derived
precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord
injury. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 27, 9545–9559.
Bjoerklund, A. and Stenevi, U. (1977). Experimental reinnervation of the rat hippocampus by grafted sympathetic ganglia. I.
Axonal regeneration along the hippocampal ﬁmbria. Brain research 138, 259–270.
Bjoerklund, A., Stenevi, U. and Svendgaard, N. (1976). Growth of transplanted monoaminergic neurones into the adult hip-
pocampus along the perforant path. Nature 262, 787–790.
Bloch, J., Brunet, J.-F., McEntire, C. R. S. and Redmond, D. E. (2014). Primate adult brain cell autotransplantation produces
behavioral and biological recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian St. Kitts monkeys. The
Journal of comparative neurology 522, 2729–2740.
Bloch, J., Kaeser, M., Sadeghi, Y., Rouiller, E. M., Redmond, D. E. and Brunet, J.-F. (2011). Doublecortin-positive cells in the
adult primate cerebral cortex and possible role in brain plasticity and development. The Journal of comparative neurology
519, 775–789.
Bonizzato, M., Pidpruzhnykova, G., DiGiovanna, J., Shkorbatova, P., Pavlova, N., Micera, S. and Courtine, G. (2018). Brain-
controlled modulation of spinal circuits improves recovery from spinal cord injury. Nature communications 9, 3015.
Bouton, C. E., Shaikhouni, A., Annetta, N. V., Bockbrader, M. A., Friedenberg, D. A., Nielson, D. M., Sharma, G., Sederberg,
P. B., Glenn, B. C., Mysiw, W. J., Morgan, A. G., Deogaonkar, M. and Rezai, A. R. (2016). Restoring cortical control of
functional movement in a human with quadriplegia. Nature 533, 247–250.
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W. and McMahon, S. B.
(2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640.
Bradke, F., Fawcett, J. W. and Spira, M. E. (2012). Assembly of a new growth cone after axotomy: the precursor to axon
regeneration. Nature reviews. Neuroscience 13, 183–193.
Bregman, B. S., Kunkel-Bagden, E., Reier, P. J., Dai, H. N., McAtee, M. and Gao, D. (1993). Recovery of function after spinal
cord injury: mechanisms underlying transplant-mediated recovery of function diﬀer after spinal cord injury in newborn and
adult rats. Experimental neurology 123, 3–16.
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D. and Schwab, M. E. (1995). Recovery from spinal cord injury
mediated by antibodies to neurite growth inhibitors. Nature 378, 498–501.
Bregman, B. S. and Reier, P. J. (1986). Neural tissue transplants rescue axotomized rubrospinal cells from retrograde death. The
Journal of comparative neurology 244, 86–95.
Brown, J. M., Xia, J., Zhuang, B., Cho, K.-S., Rogers, C. J., Gama, C. I., Rawat, M., Tully, S. E., Uetani, N., Mason, D. E.,
Tremblay, M. L., Peters, E. C., Habuchi, O., Chen, D. F. and Hsieh-Wilson, L. C. (2012). A sulfated carbohydrate epitope
inhibits axon regeneration after injury. Proceedings of the National Academy of Sciences of the United States of America
109, 4768–4773.
Brunet, J.-F., Redmond, D. E. and Bloch, J. (2009). Primate adult brain cell autotransplantation, a pilot study in asymptomatic
MPTP-treated monkeys. Cell transplantation 18, 787–799.
Brunet, J.-F., Rouiller, E., Wannier, T., Villemure, J.-G. and Bloch, J. (2005). Primate adult brain cell autotransplantation, a
new tool for brain repair? Experimental neurology 196, 195–198.
Section 6.4 Chapter 6 Page 107
Bundesen, L. Q., Scheel, T. A., Bregman, B. S. and Kromer, L. F. (2003). Ephrin-B2 and EphB2 regulation of astrocyte-meningeal
ﬁbroblast interactions in response to spinal cord lesions in adult rats. The Journal of neuroscience : the oﬃcial journal of
the Society for Neuroscience 23, 7789–7800.
Burda, J. E. and Sofroniew, M. V. (2014). Reactive gliosis and the multicellular response to CNS damage and disease. Neuron
81, 229–248.
Caﬀerty, W. B. J., Duﬀy, P., Huebner, E. and Strittmatter, S. M. (2010). MAG and OMgp synergize with Nogo-A to restrict
axonal growth and neurological recovery after spinal cord trauma. The Journal of neuroscience : the oﬃcial journal of the
Society for Neuroscience 30, 6825–6837.
Cai, D., Qiu, J., Cao, Z., McAtee, M., Bregman, B. S. and Filbin, M. T. (2001). Neuronal cyclic AMP controls the developmental
loss in ability of axons to regenerate. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 21,
4731–4739.
Campenot, R. B. (1977). Local control of neurite development by nerve growth factor. Proceedings of the National Academy
of Sciences of the United States of America 74, 4516–4519.
Canty, A. J., Huang, L., Jackson, J. S., Little, G. E., Knott, G., Maco, B. and De Paola, V. (2013). In-vivo single neuron axotomy
triggers axon regeneration to restore synaptic density in speciﬁc cortical circuits. Nature communications 4, 2038.
Cao, Z., Gao, Y., Bryson, J. B., Hou, J., Chaudhry, N., Siddiq, M., Martinez, J., Spencer, T., Carmel, J., Hart, R. B. and Filbin,
M. T. (2006). The cytokine interleukin-6 is suﬃcient but not necessary to mimic the peripheral conditioning lesion eﬀect on
axonal growth. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 26, 5565–5573.
Capogrosso, M., Milekovic, T., Borton, D., Wagner, F., Moraud, E. M., Mignardot, J.-B., Buse, N., Gandar, J., Barraud, Q.,
Xing, D. et al. (2016). A brain–spine interface alleviating gait deﬁcits after spinal cord injury in primates. Nature 539, 284.
Caroni, P. and Schwab, M. E. (1988a). Two membrane protein fractions from rat central myelin with inhibitory properties for
neurite growth and ﬁbroblast spreading. The Journal of cell biology 106, 1281–1288.
Caroni, P. and Schwab, M. E. (1988b). Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive
substrate properties of CNS white matter. Neuron 1, 85–96.
Center, N. S. C. I. (2014). Spinal Cord Injury Facts and Figures at a Glance. The journal of spinal cord medicine 37, 355–356.
Chen, B., Li, Y., Yu, B., Zhang, Z., Brommer, B., Williams, P. R., Liu, Y., Hegarty, S. V., Zhou, S., Zhu, J., Guo, H., Lu, Y.,
Zhang, Y., Gu, X. and He, Z. (2018). Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.
Cell 174, 521–535.e13.
Chen, D. F., Jhaveri, S. and Schneider, G. E. (1995). Intrinsic changes in developing retinal neurons result in regenerative failure
of their axons. Proceedings of the National Academy of Sciences of the United States of America 92, 7287–7291.
Chen, D. F., Schneider, G. E., Martinou, J. C. and Tonegawa, S. (1997). Bcl-2 promotes regeneration of severed axons in
mammalian CNS. Nature 385, 434–439.
Chivatakarn, O., Kaneko, S., He, Z., Tessier-Lavigne, M. and Giger, R. J. (2007). The Nogo-66 receptor NgR1 is required
only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors. The Journal of
neuroscience : the oﬃcial journal of the Society for Neuroscience 27, 7117–7124.
Chrenek, R., Magnotti, L. M., Herrera, G. R., Jha, R. M. and Cardozo, D. L. (2017). Characterization of the Filum terminale as
a neural progenitor cell niche in both rats and humans. The Journal of comparative neurology 525, 661–675.
Courtine, G., Gerasimenko, Y., Van Den Brand, R., Yew, A., Musienko, P., Zhong, H., Song, B., Ao, Y., Ichiyama, R. M., Lavrov,
I. et al. (2009). Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nature
neuroscience 12, 1333.
Courtine, G., Song, B., Roy, R. R., Zhong, H., Herrmann, J. E., Ao, Y., Qi, J., Edgerton, V. R. and Sofroniew, M. V. (2008).
Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nature medicine
14, 69.
Cregg, J. M., DePaul, M. A., Filous, A. R., Lang, B. T., Tran, A. and Silver, J. (2014). Functional regeneration beyond the glial
scar. Experimental neurology 253, 197–207.
Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N. and Beattie, M. S. (1997). Apoptosis and delayed degeneration
after spinal cord injury in rats and monkeys. Nature medicine 3, 73–76.
David, S. and Aguayo, A. J. (1981). Axonal elongation into peripheral nervous system "bridges" after central nervous system
injury in adult rats. Science (New York, N.Y.) 214, 931–933.
David, S. and Kroner, A. (2011). Repertoire of microglial and macrophage responses after spinal cord injury. Nature reviews.
Neuroscience 12, 388–399.
Section 6.4 Chapter 6 Page 108
Davies, S. J., Fitch, M. T., Memberg, S. P., Hall, A. K., Raisman, G. and Silver, J. (1997). Regeneration of adult axons in white
matter tracts of the central nervous system. Nature 390, 680–683.
Davies, S. J., Goucher, D. R., Doller, C. and Silver, J. (1999). Robust regeneration of adult sensory axons in degenerating white
matter of the adult rat spinal cord. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 19,
5810–5822.
Deepa, S. S., Umehara, Y., Higashiyama, S., Itoh, N. and Sugahara, K. (2002). Speciﬁc molecular interactions of oversulfated
chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain
and other tissues. The Journal of biological chemistry 277, 43707–43716.
Deng, L.-X., Deng, P., Ruan, Y., Xu, Z. C., Liu, N.-K., Wen, X., Smith, G. M. and Xu, X.-M. (2013). A novel growth-promoting
pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal regeneration, synapse formation, and
partial recovery of function after spinal cord injury. Journal of Neuroscience 33, 5655–5667.
Dickendesher, T. L., Baldwin, K. T., Mironova, Y. A., Koriyama, Y., Raiker, S. J., Askew, K. L., Wood, A., Geoﬀroy, C. G.,
Zheng, B., Liepmann, C. D., Katagiri, Y., Benowitz, L. I., Geller, H. M. and Giger, R. J. (2012). NgR1 and NgR3 are receptors
for chondroitin sulfate proteoglycans. Nature neuroscience 15, 703–712.
Dolbeare, D. and Houle, J. D. (2003). Restriction of axonal retraction and promotion of axonal regeneration by chronically
injured neurons after intraspinal treatment with glial cell line-derived neurotrophic factor (GDNF). Journal of neurotrauma
20, 1251–1261.
Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K., Nikulina, E., Kimura, N., Cai, H., Deng, K., Gao, Y., He, Z.
and Filbin, M. (2002). Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron
35, 283–290.
Domeniconi, M., Zampieri, N., Spencer, T., Hilaire, M., Mellado, W., Chao, M. V. and Filbin, M. T. (2005). MAG induces
regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 46, 849–855.
Donnelly, D. J. and Popovich, P. G. (2008). Inﬂammation and its role in neuroprotection, axonal regeneration and functional
recovery after spinal cord injury. Experimental neurology 209, 378–388.
Duan, X., Qiao, M., Bei, F., Kim, I.-J., He, Z. and Sanes, J. R. (2015). Subtype-speciﬁc regeneration of retinal ganglion cells
following axotomy: eﬀects of osteopontin and mTOR signaling. Neuron 85, 1244–1256.
Duﬀy, P., Wang, X., Siegel, C. S., Seigel, C. S., Tu, N., Henkemeyer, M., Caﬀerty, W. B. J. and Strittmatter, S. M. (2012).
Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proceedings of the National
Academy of Sciences of the United States of America 109, 5063–5068.
Dulin, J. N., Adler, A. F., Kumamaru, H., Poplawski, G. H. D., Lee-Kubli, C., Strobl, H., Gibbs, D., Kadoya, K., Fawcett, J. W.,
Lu, P. and Tuszynski, M. H. (2018). Injured adult motor and sensory axons regenerate into appropriate organotypic domains
of neural progenitor grafts. Nature communications 9, 84.
Duzgun, Z., Eroglu, Z. and Biray Avci, C. (2016). Role of mTOR in glioblastoma. Gene 575, 187–190.
Enes, J., Langwieser, N., Ruschel, J., Carballosa-Gonzalez, M. M., Klug, A., Traut, M. H., Ylera, B., Tahirovic, S., Hofmann, F.,
Stein, V., Moosmang, S., Hentall, I. D. and Bradke, F. (2010). Electrical activity suppresses axon growth through Ca(v)1.2
channels in adult primary sensory neurons. Current biology : CB 20, 1154–1164.
Ethier, C., Oby, E. R., Bauman, M. J. and Miller, L. E. (2012). Restoration of grasp following paralysis through brain-controlled
stimulation of muscles. Nature 485, 368–371.
Fabes, J., Anderson, P., Brennan, C. and Bolsover, S. (2007). Regeneration-enhancing eﬀects of EphA4 blocking peptide following
corticospinal tract injury in adult rat spinal cord. The European journal of neuroscience 26, 2496–2505.
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B. and Sofroniew, M. V. (2004). Reactive astrocytes
protect tissue and preserve function after spinal cord injury. The Journal of neuroscience : the oﬃcial journal of the Society
for Neuroscience 24, 2143–2155.
Fawcett, J. W., Curt, A., Steeves, J. D., Coleman, W. P., Tuszynski, M. H., Lammertse, D., Bartlett, P. F., Blight, A. R., Dietz,
V., Ditunno, J., Dobkin, B. H., Havton, L. A., Ellaway, P. H., Fehlings, M. G., Privat, A., Grossman, R., Guest, J. D., Kleitman,
N., Nakamura, M., Gaviria, M. and Short, D. (2007). Guidelines for the conduct of clinical trials for spinal cord injury as
developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical
trials. Spinal cord 45, 190–205.
Ferguson, S. M., Phillips, P. E. M., Roth, B. L., Wess, J. and Neumaier, J. F. (2013). Direct-pathway striatal neurons regulate the
retention of decision-making strategies. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience
33, 11668–11676.
Fernandez-Klett, F. and Priller, J. (2014). The ﬁbrotic scar in neurological disorders. Brain pathology (Zurich, Switzerland)
24, 404–413.
Section 6.4 Chapter 6 Page 109
Fields, R. D., Eshete, F., Stevens, B. and Itoh, K. (1997). Action potential-dependent regulation of gene expression: temporal
speciﬁcity in Ca2+, cAMP-responsive element binding proteins, and mitogen-activated protein kinase signaling. Journal of
Neuroscience 17, 7252–7266.
Fields, R. D., Neale, E. A. and Nelson, P. G. (1990). Eﬀects of patterned electrical activity on neurite outgrowth from mouse
sensory neurons. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 10, 2950–2964.
Fisher, D., Xing, B., Dill, J., Li, H., Hoang, H. H., Zhao, Z., Yang, X.-L., Bachoo, R., Cannon, S., Longo, F. M., Sheng, M.,
Silver, J. and Li, S. (2011). Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate
proteoglycan axon growth inhibitors. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 31,
14051–14066.
Fitch, M. T. and Silver, J. (1997). Glial cell extracellular matrix: boundaries for axon growth in development and regeneration.
Cell and tissue research 290, 379–384.
Fitch, M. T. and Silver, J. (2008). CNS injury, glial scars, and inﬂammation: Inhibitory extracellular matrices and regeneration
failure. Experimental neurology 209, 294–301.
Fouad, K., Pedersen, V., Schwab, M. E. and BrÃ¶samle, C. (2001). Cervical sprouting of corticospinal ﬁbers after thoracic spinal
cord injury accompanies shifts in evoked motor responses. Current biology : CB 11, 1766–1770.
Fournier, A. E., GrandPre, T. and Strittmatter, S. M. (2001). Identiﬁcation of a receptor mediating Nogo-66 inhibition of axonal
regeneration. Nature 409, 341–346.
Fry, E. J., Chagnon, M. J., Lopez-Vales, R., Tremblay, M. L. and David, S. (2010). Corticospinal tract regeneration after spinal
cord injury in receptor protein tyrosine phosphatase sigma deﬁcient mice. Glia 58, 423–433.
Galtrey, C. M. and Fawcett, J. W. (2007). The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the
central nervous system. Brain research reviews 54, 1–18.
Gao, Y., Deng, K., Hou, J., Bryson, J. B., Barco, A., Nikulina, E., Spencer, T., Mellado, W., Kandel, E. R. and Filbin, M. T.
(2004). Activated CREB is suﬃcient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron
44, 609–621.
Gao, Z., Davis, C., Thomas, A. M., Economo, M. N., Abrego, A. M., Svoboda, K., De Zeeuw, C. I. and Li, N. (2018). A
cortico-cerebellar loop for motor planning. Nature tbd.
Geoﬀroy, C. G., Hilton, B. J., Tetzlaﬀ, W. and Zheng, B. (2016). Evidence for an Age-Dependent Decline in Axon Regeneration
in the Adult Mammalian Central Nervous System. Cell reports 15, 238–246.
Geoﬀroy, C. G. and Zheng, B. (2014). Myelin-associated inhibitors in axonal growth after CNS injury. Current opinion in
neurobiology 27, 31–38.
Gerasimenko, Y., Roy, R. R. and Edgerton, V. R. (2008). Epidural stimulation: comparison of the spinal circuits that generate
and control locomotion in rats, cats and humans. Experimental neurology 209, 417–425.
Gerasimenko, Y. P., Ichiyama, R. M., Lavrov, I. A., Courtine, G., Cai, L., Zhong, H., Roy, R. R. and Edgerton, V. R. (2007).
Epidural spinal cord stimulation plus quipazine administration enable stepping in complete spinal adult rats. Journal of
neurophysiology 98, 2525–2536.
Glebova, N. O. and Ginty, D. D. (2005). Growth and survival signals controlling sympathetic nervous system development. Annual
review of neuroscience 28, 191–222.
Goeritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O. and FrisÃ©n, J. (2011). A pericyte origin of spinal cord scar
tissue. Science (New York, N.Y.) 333, 238–242.
Goldberg, J. L., Klassen, M. P., Hua, Y. and Barres, B. A. (2002). Amacrine-signaled loss of intrinsic axon growth ability by
retinal ganglion cells. Science (New York, N.Y.) 296, 1860–1864.
Goldshmit, Y., Galea, M. P., Wise, G., Bartlett, P. F. and Turnley, A. M. (2004). Axonal regeneration and lack of astrocytic
gliosis in EphA4-deﬁcient mice. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 24,
10064–10073.
GrandPrÃ©, T., Nakamura, F., Vartanian, T. and Strittmatter, S. M. (2000). Identiﬁcation of the Nogo inhibitor of axon
regeneration as a Reticulon protein. Nature 403, 439–444.
Grimpe, B. and Silver, J. (2004). A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtrans-
planted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. The Journal of neuroscience : the oﬃcial
journal of the Society for Neuroscience 24, 1393–1397.
Guest, J. D., Hiester, E. D. and Bunge, R. P. (2005). Demyelination and Schwann cell responses adjacent to injury epicenter
cavities following chronic human spinal cord injury. Experimental neurology 192, 384–393.
Section 6.4 Chapter 6 Page 110
Gundersen, R. W. (1987). Response of sensory neurites and growth cones to patterned substrata of laminin and ﬁbronectin in
vitro. Developmental biology 121, 423–431.
Hagg, T. and Oudega, M. (2006). Degenerative and spontaneous regenerative processes after spinal cord injury. Journal of
neurotrauma 23, 264–280.
Hall, P. E., Lathia, J. D., Caldwell, M. A. and Ffrench-Constant, C. (2008). Laminin enhances the growth of human neural stem
cells in deﬁned culture media. BMC neuroscience 9, 71.
Harkema, S., Gerasimenko, Y., Hodes, J., Burdick, J., Angeli, C., Chen, Y., Ferreira, C., Willhite, A., Rejc, E., Grossman, R. G.
and Edgerton, V. R. (2011). Eﬀect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing,
and assisted stepping after motor complete paraplegia: a case study. Lancet (London, England) 377, 1938–1947.
He, Z. and Jin, Y. (2016). Intrinsic Control of Axon Regeneration. Neuron 90, 437–451.
Heaton, M. B. and Swanson, D. J. (1988). The inﬂuence of laminin on the initial diﬀerentiation of cultured neural tube neurons.
Journal of neuroscience research 19, 212–218.
Hentall, I. D., Mesigil, R., Pinzon, A. and Noga, B. R. (2003). Temporal and spatial proﬁles of pontine-evoked monoamine release
in the rat’s spinal cord. Journal of neurophysiology 89, 2943–2951.
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., Korsak, R. A., Takeda, K., Akira, S. and Sofroniew, M. V.
(2008). STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. The Journal of neuroscience :
the oﬃcial journal of the Society for Neuroscience 28, 7231–7243.
Hooks, B. M., Mao, T., Gutnisky, D. A., Yamawaki, N., Svoboda, K. and Shepherd, G. M. G. (2013). Organization of cortical
and thalamic input to pyramidal neurons in mouse motor cortex. The Journal of neuroscience : the oﬃcial journal of the
Society for Neuroscience 33, 748–760.
Huntwork-Rodriguez, S., Wang, B., Watkins, T., Ghosh, A. S., Pozniak, C. D., Bustos, D., Newton, K., Kirkpatrick, D. S. and
Lewcock, J. W. (2013). JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis.
The Journal of cell biology 202, 747–763.
Ichiyama, R. M., Courtine, G., Gerasimenko, Y. P., Yang, G. J., van den Brand, R., Lavrov, I. A., Zhong, H., Roy, R. R. and
Edgerton, V. R. (2008). Step training reinforces speciﬁc spinal locomotor circuitry in adult spinal rats. The Journal of
neuroscience : the oﬃcial journal of the Society for Neuroscience 28, 7370–7375.
Ichiyama, R. M., Gerasimenko, Y. P., Zhong, H., Roy, R. R. and Edgerton, V. R. (2005). Hindlimb stepping movements in
complete spinal rats induced by epidural spinal cord stimulation. Neuroscience letters 383, 339–344.
Irvine, K. A. and Blakemore, W. F. (2008). Remyelination protects axons from demyelination-associated axon degeneration.
Brain : a journal of neurology 131, 1464–1477.
Ito, Z., Sakamoto, K., Imagama, S., Matsuyama, Y., Zhang, H., Hirano, K., Ando, K., Yamashita, T., Ishiguro, N. and Kadomatsu,
K. (2010). N-acetylglucosamine 6-O-sulfotransferase-1-deﬁcient mice show better functional recovery after spinal cord injury.
The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 30, 5937–5947.
Jacobi, A., Loy, K., Schmalz, A. M., Hellsten, M., Umemori, H., Kerschensteiner, M. and Bareyre, F. M. (2015). FGF22 signaling
regulates synapse formation during post-injury remodeling of the spinal cord. The EMBO journal 34, 1231–1243.
Jain, N., Qi, H.-X., Collins, C. E. and Kaas, J. H. (2008). Large-scale reorganization in the somatosensory cortex and thalamus
after sensory loss in macaque monkeys. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience
28, 11042–11060.
Jakeman, L. B. and Reier, P. J. (1991). Axonal projections between fetal spinal cord transplants and the adult rat spinal cord: a
neuroanatomical tracing study of local interactions. The Journal of comparative neurology 307, 311–334.
Jha, R. M., Chrenek, R., Magnotti, L. M. and Cardozo, D. L. (2013a). The isolation, diﬀerentiation, and survival in vivo of
multipotent cells from the postnatal rat ﬁlum terminale. PloS one 8, e65974.
Jha, R. M., Liu, X., Chrenek, R., Madsen, J. R. and Cardozo, D. L. (2013b). The postnatal human ﬁlum terminale is a source
of autologous multipotent neurospheres capable of generating motor neurons. Neurosurgery 72, 118–29; discussion 129.
Jones, L. L., Margolis, R. U. and Tuszynski, M. H. (2003a). The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan,
and versican are diﬀerentially regulated following spinal cord injury. Experimental neurology 182, 399–411.
Jones, L. L., Sajed, D. and Tuszynski, M. H. (2003b). Axonal regeneration through regions of chondroitin sulfate proteoglycan
deposition after spinal cord injury: a balance of permissiveness and inhibition. The Journal of neuroscience : the oﬃcial
journal of the Society for Neuroscience 23, 9276–9288.
Kaas, J. H., Qi, H.-X., Burish, M. J., Gharbawie, O. A., Onifer, S. M. and Massey, J. M. (2008). Cortical and subcortical
plasticity in the brains of humans, primates, and rats after damage to sensory aﬀerents in the dorsal columns of the spinal
cord. Experimental neurology 209, 407–416.
Section 6.4 Chapter 6 Page 111
Kadoya, K., Lu, P., Nguyen, K., Lee-Kubli, C., Kumamaru, H., Yao, L., Knackert, J., Poplawski, G., Dulin, J. N., Strobl, H.,
Takashima, Y., Biane, J., Conner, J., Zhang, S.-C. and Tuszynski, M. H. (2016). Spinal cord reconstitution with homologous
neural grafts enables robust corticospinal regeneration. Nature medicine 22, 479–487.
Kadoya, K., Tsukada, S., Lu, P., Coppola, G., Geschwind, D., Filbin, M. T., Blesch, A. and Tuszynski, M. H. (2009). Combined
intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron
64, 165–172.
Kaeser, M., Brunet, J.-F., Wyss, A., Belhaj-Saif, A., Liu, Y., Hamadjida, A., Rouiller, E. M. and Bloch, J. (2011). Autologous
adult cortical cell transplantation enhances functional recovery following unilateral lesion of motor cortex in primates: a pilot
study. Neurosurgery 68, 1405–16; discussion 1416–7.
Kalsi-Ryan, S., Wilson, J., Yang, J. M. and Fehlings, M. G. (2014). Neurological grading in traumatic spinal cord injury. World
neurosurgery 82, 509–518.
Karumbaiah, L., Saxena, T., Carlson, D., Patil, K., Patkar, R., Gaupp, E. A., Betancur, M., Stanley, G. B., Carin, L. and
Bellamkonda, R. V. (2013). Relationship between intracortical electrode design and chronic recording function. Biomaterials
34, 8061–8074.
Kashpur, O., LaPointe, D., Ambady, S., Ryder, E. F. and Dominko, T. (2013). FGF2-induced eﬀects on transcriptome associated
with regeneration competence in adult human ﬁbroblasts. BMC genomics 14, 656.
Kawano, H., Kimura-Kuroda, J., Komuta, Y., Yoshioka, N., Li, H. P., Kawamura, K., Li, Y. and Raisman, G. (2012). Role of the
lesion scar in the response to damage and repair of the central nervous system. Cell and tissue research 349, 169–180.
Kiehn, O. (2016). Decoding the organization of spinal circuits that control locomotion. Nature reviews. Neuroscience 17,
224–238.
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J. and Popovich, P. G. (2009). Identiﬁcation of two
distinct macrophage subsets with divergent eﬀects causing either neurotoxicity or regeneration in the injured mouse spinal cord.
The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 29, 13435–13444.
Kikuchi, K., Kishino, A., Konishi, O., Kumagai, K., Hosotani, N., Saji, I., Nakayama, C. and Kimura, T. (2003). In vitro and
in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin. The Journal of biological chemistry
278, 42985–42991.
Kirshblum, S. C., Burns, S. P., Biering-Sorensen, F., Donovan, W., Graves, D. E., Jha, A., Johansen, M., Jones, L., Krassioukov,
A., Mulcahey, M. J., Schmidt-Read, M. and Waring, W. (2011). International standards for neurological classiﬁcation of spinal
cord injury (revised 2011). The journal of spinal cord medicine 34, 535–546.
Konishi, Y., StegmÃŒller, J., Matsuda, T., Bonni, S. and Bonni, A. (2004). Cdh1-APC controls axonal growth and patterning
in the mammalian brain. Science (New York, N.Y.) 303, 1026–1030.
Kottis, V., Thibault, P., Mikol, D., Xiao, Z.-C., Zhang, R., Dergham, P. and Braun, P. E. (2002). Oligodendrocyte-myelin
glycoprotein (OMgp) is an inhibitor of neurite outgrowth. Journal of neurochemistry 82, 1566–1569.
Kroeger, D., Ferrari, L. L., Petit, G., Mahoney, C. E., Fuller, P. M., Arrigoni, E. and Scammell, T. E. (2017). Cholinergic,
Glutamatergic, and GABAergic Neurons of the Pedunculopontine Tegmental Nucleus Have Distinct Eﬀects on Sleep/Wake
Behavior in Mice. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 37, 1352–1366.
Kuramoto, E., Furuta, T., Nakamura, K. C., Unzai, T., Hioki, H. and Kaneko, T. (2009). Two types of thalamocortical projections
from the motor thalamic nuclei of the rat: a single neuron-tracing study using viral vectors. Cerebral cortex (New York, N.Y.
: 1991) 19, 2065–2077.
Kuramoto, E., Ohno, S., Furuta, T., Unzai, T., Tanaka, Y. R., Hioki, H. and Kaneko, T. (2015). Ventral medial nucleus neurons
send thalamocortical aﬀerents more widely and more preferentially to layer 1 than neurons of the ventral anterior-ventral lateral
nuclear complex in the rat. Cerebral cortex (New York, N.Y. : 1991) 25, 221–235.
Landry, E. S., Lapointe, N. P., Rouillard, C., Levesque, D., Hedlund, P. B. and Guertin, P. A. (2006). Contribution of spinal 5-
HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice. The European
journal of neuroscience 24, 535–546.
Lavrov, I., Dy, C. J., Fong, A. J., Gerasimenko, Y., Courtine, G., Zhong, H., Roy, R. R. and Edgerton, V. R. (2008). Epidural
stimulation induced modulation of spinal locomotor networks in adult spinal rats. The Journal of neuroscience : the oﬃcial
journal of the Society for Neuroscience 28, 6022–6029.
Lee, J. K., Geoﬀroy, C. G., Chan, A. F., Tolentino, K. E., Crawford, M. J., Leal, M. A., Kang, B. and Zheng, B. (2010). Assessing
spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deﬁcient mice. Neuron 66, 663–670.
Lemon, R. N. and van der Burg, J. (1979). Short-latency peripheral inputs to thalamic neurones projecting to the motor cortex
in the monkey. Experimental brain research 36, 445–462.
Letourneau, P. C. (1975). Cell-to-substratum adhesion and guidance of axonal elongation. Developmental biology 44, 92–101.
Section 6.4 Chapter 6 Page 112
Li, S. and Stys, P. K. (2001). Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-
dependent transport in spinal cord white matter. Neuroscience 107, 675–683.
Li, S., Yang, C., Zhang, L., Gao, X., Wang, X., Liu, W., Wang, Y., Jiang, S., Wong, Y. H., Zhang, Y. and Liu, K. (2016).
Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling. Proceedings of the National
Academy of Sciences of the United States of America 113, 1937–1942.
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., MÃŒnch, A. E.,
Chung, W.-S., Peterson, T. C., Wilton, D. K., Frouin, A., Napier, B. A., Panicker, N., Kumar, M., Buckwalter, M. S., Rowitch,
D. H., Dawson, V. L., Dawson, T. M., Stevens, B. and Barres, B. A. (2017). Neurotoxic reactive astrocytes are induced by
activated microglia. Nature 541, 481–487.
Liu, K., Lu, Y., Lee, J. K., Samara, R., Willenberg, R., Sears-Kraxberger, I., Tedeschi, A., Park, K. K., Jin, D., Cai, B., Xu, B.,
Connolly, L., Steward, O., Zheng, B. and He, Z. (2010). PTEN deletion enhances the regenerative ability of adult corticospinal
neurons. Nature neuroscience 13, 1075–1081.
Liu, K., Tedeschi, A., Park, K. K. and He, Z. (2011). Neuronal intrinsic mechanisms of axon regeneration. Annual review of
neuroscience 34, 131–152.
Liu, R. Y. and Snider, W. D. (2001). Diﬀerent signaling pathways mediate regenerative versus developmental sensory axon growth.
The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 21, RC164.
Liu, Y., Wang, X., Li, W., Zhang, Q., Li, Y., Zhang, Z., Zhu, J., Chen, B., Williams, P. R., Zhang, Y., Yu, B., Gu, X. and He,
Z. (2017). A Sensitized IGF1 Treatment Restores Corticospinal Axon-Dependent Functions. Neuron 95, 817–833.e4.
Lonze, B. E., Riccio, A., Cohen, S. and Ginty, D. D. (2002). Apoptosis, axonal growth defects, and degeneration of peripheral
neurons in mice lacking CREB. Neuron 34, 371–385.
Lu, P., Blesch, A., Graham, L., Wang, Y., Samara, R., Banos, K., Haringer, V., Havton, L., Weishaupt, N., Bennett, D., Fouad,
K. and Tuszynski, M. H. (2012a). Motor axonal regeneration after partial and complete spinal cord transection. The Journal
of neuroscience : the oﬃcial journal of the Society for Neuroscience 32, 8208–8218.
Lu, P., Blesch, A., Graham, L., Wang, Y., Samara, R., Banos, K., Haringer, V., Havton, L., Weishaupt, N., Bennett, D.
et al. (2012b). Motor axonal regeneration after partial and complete spinal cord transection. Journal of Neuroscience 32,
8208–8218.
Lu, P., Wang, Y., Graham, L., McHale, K., Gao, M., Wu, D., Brock, J., Blesch, A., Rosenzweig, E. S., Havton, L. A. et al.
(2012c). Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150, 1264–1273.
Lu, P., Woodruﬀ, G., Wang, Y., Graham, L., Hunt, M., Wu, D., Boehle, E., Ahmad, R., Poplawski, G., Brock, J., Goldstein, L.
S. B. and Tuszynski, M. H. (2014). Long-distance axonal growth from human induced pluripotent stem cells after spinal cord
injury. Neuron 83, 789–796.
Lu, P., Yang, H., Jones, L. L., Filbin, M. T. and Tuszynski, M. H. (2004). Combinatorial therapy with neurotrophins and cAMP
promotes axonal regeneration beyond sites of spinal cord injury. The Journal of neuroscience : the oﬃcial journal of the
Society for Neuroscience 24, 6402–6409.
Mackel, R. and Miyashita, E. (1992). Dorsal column input to thalamic VL neurons: an intracellular study in the cat. Experimental
brain research 88, 551–559.
Mackel, R. and Miyashita, E. (1993). Nucleus Z: a somatosensory relay to motor thalamus. Journal of neurophysiology 69,
1607–1620.
Markus, A., Patel, T. D. and Snider, W. D. (2002). Neurotrophic factors and axonal growth. Current opinion in neurobiology
12, 523–531.
Mason, M. R. J., Lieberman, A. R. and Anderson, P. N. (2003). Corticospinal neurons up-regulate a range of growth-associated
genes following intracortical, but not spinal, axotomy. The European journal of neuroscience 18, 789–802.
Matute, C. (2011). Glutamate and ATP signalling in white matter pathology. Journal of anatomy 219, 53–64.
McAdoo, D. J., Xu, G., Robak, G., Hughes, M. G. and Price, E. M. (2000). Evidence that reversed glutamate uptake contributes
signiﬁcantly to glutamate release following experimental injury to the rat spinal cord. Brain research 865, 283–285.
McDonald, J. W. and Belegu, V. (2006). Demyelination and remyelination after spinal cord injury. Journal of neurotrauma 23,
345–359.
McKeon, R. J., HÃ¶ke, A. and Silver, J. (1995). Injury-induced proteoglycans inhibit the potential for laminin-mediated axon
growth on astrocytic scars. Experimental neurology 136, 32–43.
Messersmith, E. K., Leonardo, E. D., Shatz, C. J., Tessier-Lavigne, M., Goodman, C. S. and Kolodkin, A. L. (1995). Semaphorin
III can function as a selective chemorepellent to pattern sensory projections in the spinal cord. Neuron 14, 949–959.
Section 6.4 Chapter 6 Page 113
Meyer-Franke, A., Wilkinson, G. A., Kruttgen, A., Hu, M., Munro, E., Hanson, M. G., Reichardt, L. F. and Barres, B. A. (1998).
Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 21, 681–693.
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J., Levesque, M., Allaire, N., Perrin, S., Sands, B., Crowell, T., Cate, R. L.,
McCoy, J. M. and Pepinsky, R. B. (2004). LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nature
neuroscience 7, 221–228.
Miao, T., Wu, D., Zhang, Y., Bo, X., Subang, M. C., Wang, P. and Richardson, P. M. (2006). Suppressor of cytokine signaling-3
suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary
sensory neurons. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 26, 9512–9519.
Mills, C. D., Fullwood, S. D. and Hulsebosch, C. E. (2001a). Changes in metabotropic glutamate receptor expression following
spinal cord injury. Experimental neurology 170, 244–257.
Mills, C. D., Xu, G. Y., McAdoo, D. J. and Hulsebosch, C. E. (2001b). Involvement of metabotropic glutamate receptors in
excitatory amino acid and GABA release following spinal cord injury in rat. Journal of neurochemistry 79, 835–848.
Miranda, J. D., White, L. A., Marcillo, A. E., Willson, C. A., Jagid, J. and Whittemore, S. R. (1999). Induction of Eph B3 after
spinal cord injury. Experimental neurology 156, 218–222.
Moore, D. L., Blackmore, M. G., Hu, Y., Kaestner, K. H., Bixby, J. L., Lemmon, V. P. and Goldberg, J. L. (2009). KLF family
members regulate intrinsic axon regeneration ability. Science (New York, N.Y.) 326, 298–301.
Moore, D. L. and Goldberg, J. L. (2011). Multiple transcription factor families regulate axon growth and regeneration. Develop-
mental neurobiology 71, 1186–1211.
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R. and Filbin, M. T. (1994). A novel role for myelin-associated
glycoprotein as an inhibitor of axonal regeneration. Neuron 13, 757–767.
Musienko, P., van den Brand, R., Maerzendorfer, O., Larmagnac, A. and Courtine, G. (2009). Combinatory electrical and
pharmacological neuroprosthetic interfaces to regain motor function after spinal cord injury. IEEE transactions on bio-medical
engineering 56, 2707–2711.
Nakajima, H., Uchida, K., Guerrero, A. R., Watanabe, S., Sugita, D., Takeura, N., Yoshida, A., Long, G., Wright, K. T., Johnson,
W. E. B. and Baba, H. (2012). Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage
activation and functional recovery after spinal cord injury. Journal of neurotrauma 29, 1614–1625.
Nandini, C. D. and Sugahara, K. (2006). Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the
binding of growth factors. Advances in pharmacology (San Diego, Calif.) 53, 253–279.
Noble, L. J., Donovan, F., Igarashi, T., Goussev, S. and Werb, Z. (2002). Matrix metalloproteinases limit functional recovery
after spinal cord injury by modulation of early vascular events. The Journal of neuroscience : the oﬃcial journal of the
Society for Neuroscience 22, 7526–7535.
Nowak, A. P., Breedveld, V., Pakstis, L., Ozbas, B., Pine, D. J., Pochan, D. and Deming, T. J. (2002). Rapidly recovering
hydrogel scaﬀolds from self-assembling diblock copolypeptide amphiphiles. Nature 417, 424–428.
O’Shea, T. M., Burda, J. E. and Sofroniew, M. V. (2017). Cell biology of spinal cord injury and repair. The Journal of clinical
investigation 127, 3259–3270.
Ozdinler, P. H. and Macklis, J. D. (2006). IGF-I speciﬁcally enhances axon outgrowth of corticospinal motor neurons. Nature
neuroscience 9, 1371–1381.
Park, E., Velumian, A. A. and Fehlings, M. G. (2004). The role of excitotoxicity in secondary mechanisms of spinal cord injury:
a review with an emphasis on the implications for white matter degeneration. Journal of neurotrauma 21, 754–774.
Park, J. B., Yiu, G., Kaneko, S., Wang, J., Chang, J., He, X. L., Garcia, K. C. and He, Z. (2005). A TNF receptor family member,
TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45, 345–351.
Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M. and He, Z. (2008).
Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science (New York, N.Y.) 322,
963–966.
Pasterkamp, R. J., Giger, R. J., Ruitenberg, M. J., Holtmaat, A. J., De Wit, J., De Winter, F. and Verhaagen, J. (1999).
Expression of the gene encoding the chemorepellent semaphorin III is induced in the ﬁbroblast component of neural scar tissue
formed following injuries of adult but not neonatal CNS. Molecular and cellular neurosciences 13, 143–166.
Pearse, D. D., Pereira, F. C., Marcillo, A. E., Bates, M. L., Berrocal, Y. A., Filbin, M. T. and Bunge, M. B. (2004). cAMP and
Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nature medicine 10, 610–616.
Plantman, S., Patarroyo, M., Fried, K., Domogatskaya, A., Tryggvason, K., Hammarberg, H. and Cullheim, S. (2008). Integrin-
laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. Molecular and cellular neurosciences
39, 50–62.
Section 6.4 Chapter 6 Page 114
Plunet, W., Kwon, B. K. and Tetzlaﬀ, W. (2002). Promoting axonal regeneration in the central nervous system by enhancing
the cell body response to axotomy. Journal of neuroscience research 68, 1–6.
Puttagunta, R., Tedeschi, A., Soria, M. G., Hervera, A., Lindner, R., Rathore, K. I., Gaub, P., Joshi, Y., Nguyen, T., Schmandke,
A., Laskowski, C. J., Boutillier, A.-L., Bradke, F. and Di Giovanni, S. (2014). PCAF-dependent epigenetic changes promote
axonal regeneration in the central nervous system. Nature communications 5, 3527.
Qi, S., Hassabis, D., Sun, J., Guo, F., Daw, N. and Mobbs, D. (2018). How cognitive and reactive fear circuits optimize escape
decisions in humans. Proceedings of the National Academy of Sciences of the United States of America 115, 3186–3191.
Raisman, G. (2001). Olfactory ensheathing cells - another miracle cure for spinal cord injury? Nature reviews. Neuroscience 2,
369–375.
Redmond, L., Kashani, A. H. and Ghosh, A. (2002). Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated
transcription. Neuron 34, 999–1010.
Reier, P. J. (1985). Neural tissue grafts and repair of the injured spinal cord. Neuropathology and applied neurobiology 11,
81–104.
Richardson, P. M. and Issa, V. M. (1984). Peripheral injury enhances central regeneration of primary sensory neurones. Nature
309, 791–793.
Ritfeld, G. J., Patel, A., Chou, A., Novosat, T. L., Castillo, D. G., Roos, R. A. C. and Oudega, M. (2015). The role of brain-derived
neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair. Cell transplantation 24, 2209–2220.
Rosenzweig, E. S., Brock, J. H., Lu, P., Kumamaru, H., Salegio, E. A., Kadoya, K., Weber, J. L., Liang, J. J., Moseanko, R.,
Hawbecker, S., Huie, J. R., Havton, L. A., Nout-Lomas, Y. S., Ferguson, A. R., Beattie, M. S., Bresnahan, J. C. and Tuszynski,
M. H. (2018). Restorative eﬀects of human neural stem cell grafts on the primate spinal cord. Nature medicine 24, 484–490.
Rosenzweig, E. S., Courtine, G., Jindrich, D. L., Brock, J. H., Ferguson, A. R., Strand, S. C., Nout, Y. S., Roy, R. R., Miller,
D. M., Beattie, M. S., Havton, L. A., Bresnahan, J. C., Edgerton, V. R. and Tuszynski, M. H. (2010). Extensive spontaneous
plasticity of corticospinal projections after primate spinal cord injury. Nature neuroscience 13, 1505–1510.
Rowland, J. W., Hawryluk, G. W. J., Kwon, B. and Fehlings, M. G. (2008). Current status of acute spinal cord injury pathophys-
iology and emerging therapies: promise on the horizon. Neurosurgical focus 25, E2.
Rubio-Garrido, P., Perez-de Manzo, F., Porrero, C., Galazo, M. J. and Clasca, F. (2009). Thalamic input to distal apical dendrites
in neocortical layer 1 is massive and highly convergent. Cerebral cortex (New York, N.Y. : 1991) 19, 2380–2395.
Saadoun, S., Werndle, M. C., Lopez de Heredia, L. and Papadopoulos, M. C. (2016). The dura causes spinal cord compression
after spinal cord injury. British journal of neurosurgery 30, 582–584.
Schnell, L. and Schwab, M. E. (1990). Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated
neurite growth inhibitors. Nature 343, 269–272.
Schwab, J. M., Zhang, Y., Kopp, M. A., Brommer, B. and Popovich, P. G. (2014). The paradox of chronic neuroinﬂammation,
systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Experimental neurology 258, 121–129.
Schwab, M. E. and Bartholdi, D. (1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiological
reviews 76, 319–370.
Schwab, M. E. and Thoenen, H. (1985). Dissociated neurons regenerate into sciatic but not optic nerve explants in culture
irrespective of neurotrophic factors. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 5,
2415–2423.
Sendtner, M., Schmalbruch, H., StÃ¶ckli, K. A., Carroll, P., Kreutzberg, G. W. and Thoenen, H. (1992). Ciliary neurotrophic
factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358, 502–504.
Sharma, K., Selzer, M. E. and Li, S. (2012). Scar-mediated inhibition and CSPG receptors in the CNS. Experimental neurology
237, 370–378.
Sharp, K. G., Yee, K. M. and Steward, O. (2014). A re-assessment of long distance growth and connectivity of neural stem cells
after severe spinal cord injury. Experimental neurology 257, 186–204.
Shearer, M. C. and Fawcett, J. W. (2001). The astrocyte/meningeal cell interface–a barrier to successful nerve regeneration?
Cell and tissue research 305, 267–273.
Shen, Y., Tenney, A. P., Busch, S. A., Horn, K. P., Cuascut, F. X., Liu, K., He, Z., Silver, J. and Flanagan, J. G. (2009).
PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science (New York, N.Y.)
326, 592–596.
Shigematsu, N., Ueta, Y., Mohamed, A. A., Hatada, S., Fukuda, T., Kubota, Y. and Kawaguchi, Y. (2016). Selective Thalamic
Innervation of Rat Frontal Cortical Neurons. Cerebral cortex (New York, N.Y. : 1991) 26, 2689–2704.
Section 6.4 Chapter 6 Page 115
Siebert, J. R., Middelton, F. A. and Stelzner, D. J. (2010). Intrinsic response of thoracic propriospinal neurons to axotomy. BMC
neuroscience 11, 69.
Silver, J. and Miller, J. H. (2004). Regeneration beyond the glial scar. Nature reviews. Neuroscience 5, 146–156.
Singh, A., Tetreault, L., Kalsi-Ryan, S., Nouri, A. and Fehlings, M. G. (2014). Global prevalence and incidence of traumatic
spinal cord injury. Clinical epidemiology 6, 309–331.
Smith, K. J., Felts, P. A. and John, G. R. (2000). Eﬀects of 4-aminopyridine on demyelinated axons, synapses and muscle tension.
Brain : a journal of neurology 123 ( Pt 1), 171–184.
Smith, P. D., Sun, F., Park, K. K., Cai, B., Wang, C., Kuwako, K., Martinez-Carrasco, I., Connolly, L. and He, Z. (2009). SOCS3
deletion promotes optic nerve regeneration in vivo. Neuron 64, 617–623.
Snow, D. M., Brown, E. M. and Letourneau, P. C. (1996). Growth cone behavior in the presence of soluble chondroitin sulfate
proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or ﬁbronectin. International journal of developmental
neuroscience : the oﬃcial journal of the International Society for Developmental Neuroscience 14, 331–349.
Snow, D. M., Lemmon, V., Carrino, D. A., Caplan, A. I. and Silver, J. (1990a). Sulfated proteoglycans in astroglial barriers
inhibit neurite outgrowth in vitro. Experimental neurology 109, 111–130.
Snow, D. M., Steindler, D. A. and Silver, J. (1990b). Molecular and cellular characterization of the glial roof plate of the spinal
cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier. Developmental biology 138,
359–376.
Soderblom, C., Luo, X., Blumenthal, E., Bray, E., Lyapichev, K., Ramos, J., Krishnan, V., Lai-Hsu, C., Park, K. K., Tsoulfas,
P. and Lee, J. K. (2013). Perivascular ﬁbroblasts form the ﬁbrotic scar after contusive spinal cord injury. The Journal of
neuroscience : the oﬃcial journal of the Society for Neuroscience 33, 13882–13887.
Sofroniew, M. V. (2018). Dissecting spinal cord regeneration. Nature 557, 343–350.
Sofroniew, M. V. and Vinters, H. V. (2010). Astrocytes: biology and pathology. Acta neuropathologica 119, 7–35.
Song, H. J., Ming, G. L. and Poo, M. M. (1997). cAMP-induced switching in turning direction of nerve growth cones. Nature
388, 275–279.
Sperry, R. W. (1963). Chemoaﬃnity in the orderly growth of nerve ﬁber patterns and connections. Proceedings of the National
Academy of Sciences of the United States of America 50, 703–710.
Steward, O., Sharp, K. G., Yee, K. M., Hatch, M. N. and Bonner, J. F. (2014). Characterization of ectopic colonies that form
in widespread areas of the nervous system with neural stem cell transplants into the site of a severe spinal cord injury. The
Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 34, 14013–14021.
Sun, F., Park, K. K., Belin, S., Wang, D., Lu, T., Chen, G., Zhang, K., Yeung, C., Feng, G., Yankner, B. A. and He, Z. (2011).
Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480, 372–375.
Sun, W., Fu, Y., Shi, Y., Cheng, J.-X., Cao, P. and Shi, R. (2012). Paranodal myelin damage after acute stretch in Guinea pig
spinal cord. Journal of neurotrauma 29, 611–619.
Takami, T., Oudega, M., Bates, M. L., Wood, P. M., Kleitman, N. and Bunge, M. B. (2002). Schwann cell but not olfactory
ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal
cord. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 22, 6670–6681.
Takeoka, A., Jindrich, D. L., Munoz-Quiles, C., Zhong, H., van den Brand, R., Pham, D. L., Ziegler, M. D., Ramon-Cueto, A.,
Roy, R. R., Edgerton, V. R. and Phelps, P. E. (2011). Axon regeneration can facilitate or suppress hindlimb function after
olfactory ensheathing glia transplantation. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience
31, 4298–4310.
Tan, C. L., Kwok, J. C. F., Patani, R., Ffrench-Constant, C., Chandran, S. and Fawcett, J. W. (2011). Integrin activation promotes
axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. The Journal of neuroscience :
the oﬃcial journal of the Society for Neuroscience 31, 6289–6295.
Tanaka, S., Takehashi, M., Iida, S., Kitajima, T., Kamanaka, Y., Stedeford, T., Banasik, M. and Ueda, K. (2005). Mitochondrial
impairment induced by poly(ADP-ribose) polymerase-1 activation in cortical neurons after oxygen and glucose deprivation.
Journal of neurochemistry 95, 179–190.
Tanaka, Y. H., Tanaka, Y. R., Kondo, M., Terada, S.-I., Kawaguchi, Y. and Matsuzaki, M. (2018). Thalamocortical Axonal
Activity in Motor Cortex Exhibits Layer-Speciﬁc Dynamics during Motor Learning. Neuron 100, 244–258.e12.
Tang, X., Davies, J. E. and Davies, S. J. A. (2003). Changes in distribution, cell associations, and protein expression levels of
NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar
tissue. Journal of neuroscience research 71, 427–444.
Section 6.4 Chapter 6 Page 116
Tator, C. H. and Fehlings, M. G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on
vascular mechanisms. Journal of neurosurgery 75, 15–26.
Tedeschi, A., Dupraz, S., Laskowski, C. J., Xue, J., Ulas, T., Beyer, M., Schultze, J. L. and Bradke, F. (2016). The Calcium
Channel Subunit Alpha2delta2 Suppresses Axon Regeneration in the Adult CNS. Neuron 92, 419–434.
Tessier-Lavigne, M. and Goodman, C. S. (1996). The molecular biology of axon guidance. Science (New York, N.Y.) 274,
1123–1133.
Tetzlaﬀ, W., Alexander, S. W., Miller, F. D. and Bisby, M. A. (1991). Response of facial and rubrospinal neurons to axotomy:
changes in mRNA expression for cytoskeletal proteins and GAP-43. The Journal of neuroscience : the oﬃcial journal of the
Society for Neuroscience 11, 2528–2544.
Tetzlaﬀ, W., Okon, E. B., Karimi-Abdolrezaee, S., Hill, C. E., Sparling, J. S., Plemel, J. R., Plunet, W. T., Tsai, E. C., Baptiste,
D., Smithson, L. J., Kawaja, M. D., Fehlings, M. G. and Kwon, B. K. (2011). A systematic review of cellular transplantation
therapies for spinal cord injury. Journal of neurotrauma 28, 1611–1682.
Tom, V. J., Steinmetz, M. P., Miller, J. H., Doller, C. M. and Silver, J. (2004). Studies on the development and behavior of the
dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury.
The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 24, 6531–6539.
Totoiu, M. O. and Keirstead, H. S. (2005). Spinal cord injury is accompanied by chronic progressive demyelination. The Journal
of comparative neurology 486, 373–383.
Tuszynski, M. H. and Steward, O. (2012). Concepts and methods for the study of axonal regeneration in the CNS. Neuron 74,
777–791.
Tuszynski, M. H., Wang, Y., Graham, L., Gao, M., Wu, D., Brock, J., Blesch, A., Rosenzweig, E. S., Havton, L. A., Zheng, B.,
Conner, J. M., Marsala, M. and Lu, P. (2014). Neural stem cell dissemination after grafting to CNS injury sites. Cell 156,
388–389.
van den Brand, R., Heutschi, J., Barraud, Q., DiGiovanna, J., Bartholdi, K., Huerlimann, M., Friedli, L., Vollenweider, I., Moraud,
E. M., Duis, S. et al. (2012). Restoring voluntary control of locomotion after paralyzing spinal cord injury. science 336,
1182–1185.
Varghese, M., Olstorn, H., Berg-Johnsen, J., Moe, M. C., Murrell, W. and Langmoen, I. A. (2009). Isolation of human multipotent
neural progenitors from adult ﬁlum terminale. Stem cells and development 18, 603–613.
Veldman, M. B., Bemben, M. A., Thompson, R. C. and Goldman, D. (2007). Gene expression analysis of zebraﬁsh retinal ganglion
cells during optic nerve regeneration identiﬁes KLF6a and KLF7a as important regulators of axon regeneration. Developmental
biology 312, 596–612.
Wagner, F. B., Mignardot, J.-B., Le Goﬀ-Mignardot, C. G., Demesmaeker, R., Komi, S., Capogrosso, M., Rowald, A., Seanez,
I., Caban, M., Pirondini, E., Vat, M., McCracken, L. A., Heimgartner, R., Fodor, I., Watrin, A., Seguin, P., Paoles, E., Van
Den Keybus, K., Eberle, G., Schurch, B., Pralong, E., Becce, F., Prior, J., Buse, N., Buschman, R., Neufeld, E., Kuster,
N., Carda, S., von Zitzewitz, J., Delattre, V., Denison, T., Lambert, H., Minassian, K., Bloch, J. and Courtine, G. (2018).
Targeted neurotechnology restores walking in humans with spinal cord injury. Nature 563, 65–71.
Wahl, A. S., Omlor, W., Rubio, J. C., Chen, J. L., Zheng, H., SchrÃ¶ter, A., Gullo, M., Weinmann, O., Kobayashi, K., Helmchen,
F., Ommer, B. and Schwab, M. E. (2014). Neuronal repair. Asynchronous therapy restores motor control by rewiring of the
rat corticospinal tract after stroke. Science (New York, N.Y.) 344, 1250–1255.
Waltereit, R. and Weller, M. (2003). Signaling from cAMP/PKA to MAPK and synaptic plasticity. Molecular neurobiology 27,
99–106.
Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R. and He, Z. (2002a). P75 interacts with the Nogo receptor as a co-receptor
for Nogo, MAG and OMgp. Nature 420, 74–78.
Wang, K. C., Koprivica, V., Kim, J. A., Sivasankaran, R., Guo, Y., Neve, R. L. and He, Z. (2002b). Oligodendrocyte-myelin
glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417, 941–944.
Wanner, I. B., Anderson, M. A., Song, B., Levine, J., Fernandez, A., Gray-Thompson, Z., Ao, Y. and Sofroniew, M. V. (2013).
Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inﬂammatory and ﬁbrotic cells
via STAT3-dependent mechanisms after spinal cord injury. The Journal of neuroscience : the oﬃcial journal of the Society
for Neuroscience 33, 12870–12886.
Weidner, N., Ner, A., Salimi, N. and Tuszynski, M. H. (2001). Spontaneous corticospinal axonal plasticity and functional recovery
after adult central nervous system injury. Proceedings of the National Academy of Sciences of the United States of America
98, 3513–3518.
Section 6.4 Chapter 6 Page 117
Wenger, N., Moraud, E. M., Gandar, J., Musienko, P., Capogrosso, M., Baud, L., Le Goﬀ, C. G., Barraud, Q., Pavlova, N.,
Dominici, N., Minev, I. R., Asboth, L., Hirsch, A., Duis, S., Kreider, J., Mortera, A., Haverbeck, O., Kraus, S., Schmitz, F.,
DiGiovanna, J., van den Brand, R., Bloch, J., Detemple, P., Lacour, S. P., BÃ©zard, E., Micera, S. and Courtine, G. (2016).
Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury. Nature
medicine 22, 138–145.
White, R. E., Yin, F. Q. and Jakeman, L. B. (2008). TGF-alpha increases astrocyte invasion and promotes axonal growth into
the lesion following spinal cord injury in mice. Experimental neurology 214, 10–24.
Willson, C. A., Irizarry-RamÃrez, M., Gaskins, H. E., Cruz-Orengo, L., Figueroa, J. D., Whittemore, S. R. and Miranda, J. D.
(2002). Upregulation of EphA receptor expression in the injured adult rat spinal cord. Cell transplantation 11, 229–239.
Wirth, E. D., Reier, P. J., Fessler, R. G., Thompson, F. J., Uthman, B., Behrman, A., Beard, J., Vierck, C. J. and Anderson,
D. K. (2001). Feasibility and safety of neural tissue transplantation in patients with syringomyelia. Journal of neurotrauma
18, 911–929.
Xu, W., Chi, L., Xu, R., Ke, Y., Luo, C., Cai, J., Qiu, M., Gozal, D. and Liu, R. (2005). Increased production of reactive oxygen
species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal cord 43, 204–213.
Xu, X. M., Guenard, V., Kleitman, N. and Bunge, M. B. (1995a). Axonal regeneration into Schwann cell-seeded guidance channels
grafted into transected adult rat spinal cord. The Journal of comparative neurology 351, 145–160.
Xu, X. M., GuÃ©nard, V., Kleitman, N., Aebischer, P. and Bunge, M. B. (1995b). A combination of BDNF and NT-3 promotes
supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Experimental neurology 134,
261–272.
Yahiro, T., Kataoka, N., Nakamura, Y. and Nakamura, K. (2017). The lateral parabrachial nucleus, but not the thalamus,
mediates thermosensory pathways for behavioural thermoregulation. Scientiﬁc reports 7, 5031.
Yamawaki, N. and Shepherd, G. M. G. (2015). Synaptic circuit organization of motor corticothalamic neurons. The Journal of
neuroscience : the oﬃcial journal of the Society for Neuroscience 35, 2293–2307.
Yiu, G. and He, Z. (2006). Glial inhibition of CNS axon regeneration. Nature reviews. Neuroscience 7, 617–627.
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giﬀard, R. G. and Barres, B. A. (2012). Genomic analysis of reactive
astrogliosis. The Journal of neuroscience : the oﬃcial journal of the Society for Neuroscience 32, 6391–6410.
Zaporozhets, E., Cowley, K. C. and Schmidt, B. J. (2011). Neurochemical excitation of propriospinal neurons facilitates locomotor
command signal transmission in the lesioned spinal cord. Journal of neurophysiology 105, 2818–2829.
Zhang, X. P. and Ambron, R. T. (2000). Positive injury signals induce growth and prolong survival in Aplysia neurons. Journal
of neurobiology 45, 84–94.
Zheng, B., Atwal, J., Ho, C., Case, L., He, X.-l., Garcia, K. C., Steward, O. and Tessier-Lavigne, M. (2005). Genetic deletion of
the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proceedings
of the National Academy of Sciences of the United States of America 102, 1205–1210.
Zukor, K., Belin, S., Wang, C., Keelan, N., Wang, X. and He, Z. (2013). Short hairpin RNA against PTEN enhances regenerative
growth of corticospinal tract axons after spinal cord injury. The Journal of neuroscience : the oﬃcial journal of the Society
for Neuroscience 33, 15350–15361.
Zuo, J., Neubauer, D., Dyess, K., Ferguson, T. A. and Muir, D. (1998). Degradation of chondroitin sulfate proteoglycan enhances
the neurite-promoting potential of spinal cord tissue. Experimental neurology 154, 654–662.

????????????????????????
????????????????????????
????????????????????? ?? ????? ??????????????? ???????????
????????????????????????????????????????????
?
?
????????? ?????? ?????????????????????????
?????????????????????????????????????????????
•? ?????? ???????????????????????????????????? ? ? ? ? ????????????????????????
?????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
????????????? ????????????????????????? ?????????????? ????????
•? ?????????????????? ?? ??????????????? ??????? ?? ??????? ????????????
•? ????????????????????? ???????????????????????????????????? ???????????
•? ??????????????????????????? ????????????????????????????????????????? ? ??????????? ????????
?
????????????????????????????????
????????? ?????????????
•? ??????????????? ?????????? ???????? ?? ???????????????????? ?? ? ? ??????????? ??????????
•? ???????????? ?????????? ???????? ????????????? ?????? ??? ? ? ?????????????????????
????????????????????????? ? ? ? ? ? ? ? ???????????? ???????
•? ????????? ??????????? ?????????????????????? ???????? ???????????? ??
??????????????????? ???????? ???????? ???????? ????????? ??
?????????????? ??????? ?????????? ?????????????????????? ?????????
?
?????????????? ?????? ?
??????????? ??????????????????????????????????????
•? ???????????????????????? ????? ???????? ? ? ? ? ? ??????????????????????
•? ????????????????????????????? ???????????? ? ? ? ? ?????????????????????
??????????????????????????????????????????????
?????????????????????????????????????????????
???????????????????????? ????????????????????????????????????????
???????????????????????
•? ???????????? ????? ???????? ? ? ? ? ? ? ??????????????????????
??????????????? ????? ?? ?????????????
• ?????????????????????? ??????? ??????????? ? ? ? ? ??????????????????????
• ????????? ????????????
• ???????????????????????????????????????????????????????? ???????? ? ? ??????????? ??????????
?
??????????
?????? ?????????????????????????????? ?????????????????
??????????????????????? ?????????????? ????????????
?????????????????? ????????????????????? ???????????????
??????????????????
• ???????????? ?????????????????????????? ??????????? ???????
•? ????????????? ??????????????? ?????????????? ???????? ??????????
Ce document a été imprimé au Centre d’impression EPFL, 
imprimerie climatiquement neutre, certifiée myClimate.
